Delaware |
7374 |
84-3884690 | ||
(State or other jurisdiction of incorporation or organization) |
(Primary Standard Industrial Classification Code Number) |
(I.R.S. Employer Identification No.) |
Kenneth B. Wallach, Esq. Xiaohui (Hui) Lin, Esq. Simpson Thacher & Bartlett LLP 425 Lexington Avenue New York, New York 10017 (212) 455-2000 |
Alan F. Denenberg, Esq. Davis Polk & Wardwell LLP 1600 El Camino Real Menlo Park, California 94025 (650) 752-2000 |
John G. Crowley, Esq. Davis Polk & Wardwell LLP 450 Lexington Avenue New York, New York 10017 (212) 450-4000 |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ||||
Emerging growth company |
| ||||||||
Title of Each Class of Securities to be Registered |
Amount to be Registered(1) |
Proposed Maximum Aggregate Offering Price Per Share(2) |
Proposed Maximum Aggregate Offering Price(1)(2) |
Amount of Registration Fee | ||||
Common Stock, $0.001 par value per share |
17,250,000 |
$18.9975 |
$327,706,875 |
$30,379 | ||||
| ||||||||
|
(1) |
Includes 2,250,000 shares of common stock that the underwriters have the option to purchase. See “Underwriting.” |
(2) |
Estimated solely for the purpose of determining the amount of the registration fee in accordance with Rule 457(c) promulgated under the Securities Act of 1933, as amended. The proposed maximum offering price per share and proposed maximum aggregate offering price are based on the average of the high and low sales prices of the Registrant’s common stock as reported on the Nasdaq Global Select Market on November 1, 2021. |
Per share |
Total |
|||||||
Public offering price |
$ | $ | ||||||
Underwriting discounts and commissions (1) |
$ | $ | ||||||
Proceeds, before expenses, to the selling stockholders |
$ | $ |
(1) | See “Underwriting” for additional information regarding underwriting compensation. |
Barclays |
BofA Securities |
Citigroup |
Evercore ISI |
Jefferies |
RBC Capital Markets |
Stifel |
HSBC |
Citizens Capital Markets |
KKR |
MUFG |
Loop Capital Markets |
R. Seelaus & Co., LLC |
Ramirez & Co., Inc. |
Roberts & Ryan |
Page |
||||
ii | ||||
ii | ||||
ii | ||||
iv | ||||
1 | ||||
20 | ||||
48 | ||||
50 | ||||
51 | ||||
52 | ||||
53 | ||||
65 | ||||
104 | ||||
121 | ||||
127 | ||||
146 | ||||
148 | ||||
151 | ||||
159 | ||||
162 | ||||
165 | ||||
174 | ||||
174 | ||||
174 | ||||
F-1 |
• | “Enterprise customers” means our customers who contribute $500,000 or more to our revenues in a calendar year; |
• | “First Advantage,” the “Company,” “we,” “us,” and “our” mean the business of First Advantage Corporation and its subsidiaries; |
• | “Follow-On Offering” means the sale of 15,000,000 shares of common stock by selling stockholders in this offering; |
• | “gross retention rate” for the current year is a percentage, where the numerator is prior year revenues less the revenue impact of lost accounts; the denominator is prior year revenues. We calculate the revenue impact of lost accounts as the difference between the customer’s current year and prior year revenues for the months after which they are identified as lost. Therefore, the attrition impact of customers lost in the current year may be partially captured in both the current and following years’ retention rates depending on what point during the year they are lost. Our retention rate does not factor in revenue impact, whether growth or decline, attributable to existing customers or the incremental revenue impact of new customers; |
• | “IPO” means the initial public offering of our common stock, which closed on June 25, 2021; |
• | “IPO Transactions” refers to the sale by the Company of 22,856,250 shares of common stock in the IPO at the initial public offering price of $15.00 per share for aggregate net proceeds of $316.5 million (after deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company in connection therewith) and the application of the net proceeds to repay $200.0 million of borrowings under its term loan facility and the remainder for general corporate purposes; |
• | “pro forma” or “pro forma basis” means (i) giving effect to the Transactions with respect to the year ended December 31, 2020 and the nine months ended September 30, 2020 and (ii) giving effect to the IPO Transactions, this Follow-On Offering, and the SLP Distribution with respect to the nine months ended September 30, 2021, in each case, as further described in “Unaudited Pro Forma Consolidated Financial Information”; |
• | “Silver Lake” or “Sponsor” means Silver Lake Group, L.L.C., together with its affiliated entities, successors and assignees; |
• | “SLP Distribution” means the in-kind distribution of 4,659,403 shares of our common stock held by SLP Fastball Aggregator, L.P. to its direct and indirect equityholders (or 5,358,537 shares if the underwriters’ option to purchase additional shares of our common stock is exercised in full). The number of shares to be distributed is based upon an assumed offering price of $21.05 per share, which is the closing sales price of our common stock as reported on Nasdaq on November 5, 2021, less estimated underwriters’ discounts and commissions. The SLP Distribution is expected to occur following the closing of this Follow-On Offering. A $1.00 increase or decrease in the assumed offering price would result in an increase of 76,674 shares or a decrease of 86,386 shares, respectively, of our common stock to be distributed in the SLP Distribution; and |
• | “Transactions” refers, collectively, to (i) the Silver Lake Transaction (as further described below); (ii) the Silver Lake Transaction Refinancing (as described in “Unaudited Pro Forma Consolidated Financial Information”); (iii) the IPO Transactions, (iv) this Follow-On Offering, and (v) the SLP Distribution. |
• | Our large, Enterprise customers have increased from 122 companies at the beginning of 2018 to 141 at the end of 2020. |
• | From 2018 to 2020 and despite the impact of COVID-19 on the macroeconomic environment, our revenues grew at a compound annual growth rate (“CAGR”) of 7%, all of which was organic growth from new customer wins or growth within our existing customer base. Our gross retention rate averaged approximately 95% over those three years. |
• | We generated net income of $34 million for the year ended December 31, 2019, and a net loss of $(62) million for the year ended December 31, 2020, on a pro forma basis. We generated a net loss of $(59) million for the nine months ended September 30, 2020 and net income of $5 million for the nine months ended September 30, 2021, in each case, on a pro forma basis. |
• | Our Adjusted EBITDA was $124 million for the year ended December 31, 2019. Our Adjusted EBITDA for the year ended December 31, 2020, on a pro forma basis, was $147 million. Our Adjusted EBITDA was $102 million for the nine months ended September 30, 2020 and $157 million for the nine months ended September 30, 2021, in each case, on a pro forma basis. |
• | Driven by scale, automation, and operational discipline, our Adjusted EBITDA Margins expanded, resulting in an Adjusted EBITDA CAGR of 21% from 2018 to 2020, on a pro forma basis. |
• | Increased Workforce Mobility and Job Turnover: one-third of the U.S. workforce in 2020 and are three times as likely to change jobs as other generations in pursuit of earning higher wages, faster career development, and better workplace culture fit. In addition, as the economy evolves and resource needs differ significantly by sector, geography, and skill set, this is driving dynamism in the hiring environment. |
• | Increasing Use of Contingent and Flexible Workforces: 25-30% of the U.S. workforce are contingent workers, including freelancers, independent contractors, consultants, or other outsourced and non-permanent workers, and a majority of large corporations plan to substantially increase their use of a flexible workforce. When independent contractors, external consultants, and temporary workers have access to sensitive information, company facilities, or directly interact with customers, it is important for companies to screen such flexible workforce personnel diligently. |
• | C-Suite Focus on Safety and Reputational Risks: |
• | Heightened Regulatory and Compliance Scrutiny: |
(“FCPA”), the United Kingdom Bribery Act, Fair Credit Reporting Act (“FCRA”), California Consumer Privacy Act (“CCPA”), E.U. General Data Protection Regulation (“GDPR”), the United Kingdom General Data Protection Regulation (“U.K. GDPR”), and Illinois Biometric Information Privacy Act (“IBIPA”), in addition to other anti-corruption requirements with respect to anti-money laundering and politically exposed persons. These requirements are driving many companies to perform more extensive and exhaustive checks and to partner with screening providers that have the scale, scope, heightened compliance standards, and auditability that they require. Our products and solutions help strengthen companies’ corporate governance through bolstering their compliance and risk management practices. |
• | Growth in Post-Onboarding Monitoring: “one-and-done” pre-onboarding measure, which has historically been the norm in markets like the U.S. and U.K. We have invested in and continue to innovate our post-onboarding products and solutions and believe we are well-positioned to capture share in this growing market. |
• | Development of International Markets: non-U.S.-based companies are initiating screening programs for the first time and are seeking reliable, compliant, and high quality providers. |
• | Investment in Enterprise Software: software-as-a-service |
• | Proliferation of Relevant Data Sources: |
• | Advances in Analytics to Increase Value of Data: |
• | Market Leadership Built on Outstanding Customer Experience. end-to-end |
and customer relationships are evidenced by our approximately 95% average gross retention rate from 2018 to 2020, our industry-leading NPS, and the average 12-year tenure of our top 100 customers. |
• | Verticalized Go-to-Market e-commerce, essential retail, transportation and home delivery, warehousing, healthcare, technology, and staffing. |
• | Leading Technology & Analytics Drive Customer Value Proposition AI-powered applicant experience, Profile Advantage, offers an intuitive user interface with chatbots, digital camera-enabled document uploads, and embedded machine learning to reduce missing information dramatically and compress the timeframe of the entire application process. Since Profile Advantage manages a critical interaction between our customers and their applicants, we offer our customers the option to white-label the product as an extension of their own brand, enhancing applicant engagement and satisfaction during the onboarding process. We also deliver value to customers through robust analytics solutions that allow them to aggregate, analyze, and act on recruitment and screening data in real-time. This allows our customers to derive actionable insights and make critical and informed decisions to improve the performance of their organization’s recruitment, onboarding, safety, and screening programs. |
• | Product and Compliance Strength Across Geographies right-to-work |
• | Technology-Driven Operational Excellence and Profitability end-to-end front-end technology creates a superior applicant experience. Our back-end technology drives operational excellence, with more than 2,750 active intelligent bots yielding significant improvements in speed, accuracy, and cost savings. The intelligent bots have enabled us to improve the average turnaround |
time for criminal searches in the U.S. by over 10% from 2019 to 2020. Driven by these efficiency gains, we achieved more than 600 basis points of Adjusted EBITDA Margin expansion from 2018 to 2020. We expect our investments in technology and automation will help drive further improvement in our long-term margin profile. |
• | Experienced and Visionary Management Team with Complementary Skills. |
• | Continue to Win New Customers. e-commerce, essential retail, and transportation and home delivery, and sectors that are increasingly requiring deeper, more frequent checks with high compliance standards such as healthcare and technology. We are also prioritizing new verticals that align with positive secular macroeconomic trends. We primarily focus on large Enterprise customers, which we believe are well-positioned for durable, long-term growth, have complex and diverse global operations, and, as a result, have the highest demand for our products and solutions. We believe our innovative and differentiated solutions, high-performing Sales and Customer Success teams, operational excellence, and industry-leading reputation and brand will enable us to expand our customer base successfully. |
• | Growth within Our Existing Customer Base through Upselling and Cross-selling. pre-onboarding products. We also cross-sell additional risk mitigation and compliance solutions such as post-onboarding screening, hiring tax credits, and fleet solutions. Our Sales and Customer Success teams frequently engage with our existing customers and identify areas where we can provide additional value and products. Our deeply entrenched, dedicated Customer Success teams work closely with our customers to develop robust and rigorous compliance and risk management programs within their organizations. We believe that our total revenue opportunity with current customers is twice the size of our current revenue base when taking into account cross-selling and upselling opportunities. Revenues from cross-sell and upsell added approximately 5 and 4 percentage points to our revenue growth rate in 2019 and 2020, respectively. We will continue to hone our sales and marketing engine to increase product penetration within our existing customer base. |
• | Continue to Innovate Our Product Offerings. |
• | Expand Internationally. |
• | Selectively Pursue Complementary Acquisitions and Strategic Partnerships. |
• | The impact of COVID-19 and related risks could materially affect our results of operations, financial position, and/or liquidity. |
• | We operate in a highly regulated industry and are subject to numerous and evolving laws and regulations, including those relating to consumer protection, intellectual property, cybersecurity, and data privacy, among others. |
• | We rely on a variety of third-party data providers, and if our relationships with any of them deteriorate, or if they are unable to deliver or perform as expected, our ability to operate effectively may be impaired, and our business may be materially and adversely affected. |
• | Negative changes in external events beyond our control, including our customers’ onboarding volumes, economic drivers which are sensitive to macroeconomic cycles, and the COVID-19 pandemic, could adversely affect us. |
• | Our business, brand, and reputation may be harmed as a result of security breaches, cyber-attacks, or the mishandling of personal data. |
• | Our business depends on the continued integration of our platforms and solutions with human resource providers such as applicant tracking systems and human capital management systems, as well as our relationships with such human resource providers. |
• | Disruptions, outages, or other errors with our technology and network infrastructure, including our data centers, servers, and third-party cloud and internet providers, and our migration to the cloud, could have a materially adverse effect on our business. |
• | If we are unable to obtain, maintain, protect, and enforce our intellectual property and other proprietary information, or if we infringe, misappropriate, or otherwise violate the intellectual property rights of others, the value of our brands and other intangible assets may be diminished, and our business may be adversely affected. |
• | Our indebtedness could adversely affect our ability to raise additional capital to fund our operations, limit our ability to react to changes in the economy or our industry, and prevent us from meeting our obligations. As of September 30, 2021, we had $564.7 million of total debt outstanding and $100.0 million available under our revolving credit facility. |
• | Our Sponsor controls us and its interests may conflict with yours in the future. |
• | engage an independent registered public accounting firm to report on our internal controls over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”); |
• | disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the chief executive officer’s compensation to median employee compensation; or |
• | submit certain executive compensation matters to stockholder advisory votes, such as “say-on-pay,” “say-on-frequency” “say-on-golden |
• | our reporting of $1.07 billion or more in annual gross revenue; |
• | our becoming a “large accelerated filer,” with at least $700 million of equity securities held by non-affiliates; |
• | our issuance, in any three year period, of more than $1.0 billion in non-convertible debt; and |
• | the fiscal year commencing on January 1, 2027. |
Issuer |
First Advantage Corporation |
Common stock offered by the selling stockholders |
15,000,000 shares |
Option to purchase additional shares of common stock |
The selling stockholders have granted the underwriters a 30-day option from the date of this prospectus to purchase up to 2,250,000 additional shares of our common stock at the public offering price, less underwriting discounts and commissions. |
Common stock outstanding |
152,875,076 shares as of November 5, 2021. |
Use of proceeds |
We will not be selling any shares in this offering and we will not receive any proceeds from the sale of shares being sold in this offering, including from any exercise by the underwriters of their option to purchase additional shares from the selling stockholders. The selling stockholders will receive all of the net proceeds and bear all commissions and discounts from the sale of our common stock by the selling stockholders. See “Principal and Selling Stockholders.” |
Dividend policy |
We have no current plans to pay dividends on our common stock. Any decision to declare and pay dividends in the future will be made at the sole discretion of our board of directors and will depend on, among other things, our results of operations, cash requirements, financial condition, contractual restrictions, including restrictions in the agreements governing our indebtedness, and other factors that our board of directors may deem relevant. See “Dividend Policy.” |
Risk factors |
Investing in shares of our common stock involves a high degree of risk. See “Risk Factors” for a discussion of factors you should carefully consider before investing in shares of our common stock. |
Trading symbol |
“FA” |
• | reflects and assumes no exercise of the underwriters’ option to purchase additional shares of our common stock; |
• | does not reflect 12,864,126 shares of common stock reserved for future issuance pursuant to our First Advantage Corporation 2021 Omnibus Incentive Plan (the “2021 Equity Plan”) and First Advantage Corporation 2021 Employee Stock Purchase Plan (the “ESPP”). As of the date of this prospectus, pursuant to the 2021 Equity Plan, we have issued 3,222,790 options, 2,918,084 shares of restricted stock and 45,000 restricted stock units, which remain outstanding. Additionally, we have 3,476,665 options outstanding under our legacy equity incentive plan. See “Management—Executive Compensation—Long-Term Equity Incentive Compensation”; and |
• | reflects the SLP Distribution, which refers to the in-kind distribution of 4,659,403 shares of our common stock held by SLP Fastball Aggregator, L.P. to its partners. The number of shares to be |
distributed is based upon an assumed offering price of $21.05 per share, which is the closing sales price of our common stock as reported on Nasdaq on November 5, 2021, less estimated underwriters’ discounts and commissions. The SLP Distribution is expected to occur following the closing of this Follow-On Offering. A $1.00 increase or decrease in the assumed offering price would result in an increase of 76,674 shares or a decrease of 86,386 shares, respectively, of our common stock to be distributed in the SLP Distribution; and |
• | does not reflect any additional in-kind distributions of up to 699,134 shares of our common stock held by SLP Fastball Aggregator, L.P. that it may choose to effect in the event that the underwriters’ option to purchase additional shares of our common stock is exercised in full. The number of shares to be distributed is based upon an assumed offering price of $21.05 per share, which is the closing sales price of our common stock as reported on Nasdaq on November 5, 2021, less estimated underwriters’ discounts and commissions. |
Annual Periods |
Interim Periods |
|||||||||||||||||||||||||||||||||||||||||
Predecessor |
Successor |
Predecessor |
Successor |
Pro Forma |
||||||||||||||||||||||||||||||||||||||
Year Ended December 31, |
Period from January 1 through January 31, |
Period from February 1 through December 31, |
Period from January 1 through January 31, |
Period from February 1, 2020 through September 30, |
Nine Months Ended September 30, |
Year Ended December 31, |
Nine Months Ended September 30, |
Nine Months Ended September 30, |
||||||||||||||||||||||||||||||||||
2019 |
2020 |
2020 |
2020 |
2020 |
2021 |
2020 |
2020 |
2021 |
||||||||||||||||||||||||||||||||||
(In thousands, except share and per share amounts) |
||||||||||||||||||||||||||||||||||||||||||
Statement of Operations Data |
||||||||||||||||||||||||||||||||||||||||||
Revenues |
$ | 481,767 | $ | 36,785 | $ | 472,369 | $ | 36,785 | $ | 315,825 | $ | 499,763 | $ | 509,154 | $ | 352,610 | $ | 499,763 | ||||||||||||||||||||||||
Operating expenses |
||||||||||||||||||||||||||||||||||||||||||
Cost of services |
245,324 | 20,265 | 240,287 | 20,265 | 156,703 | 244,964 | 260,613 | 177,012 | 244,968 | |||||||||||||||||||||||||||||||||
Product and technology expense |
33,239 | 3,189 | 32,201 | 3,189 | 20,495 | 33,546 | 35,565 | 23,808 | 33,563 | |||||||||||||||||||||||||||||||||
Selling, general, and administrative expense |
85,084 | 11,235 | 66,864 | 11,235 | 46,206 | 76,256 | 81,256 | 59,723 | 76,336 | |||||||||||||||||||||||||||||||||
Depreciation and amortization |
25,953 | 2,105 | 135,057 | 2,105 | 97,815 | 106,493 | 143,286 | 108,240 | 106,493 | |||||||||||||||||||||||||||||||||
Total operating expenses |
389,600 | 36,794 | 474,409 | 36,794 | 321,219 | 461,259 | 520,720 | 368,783 | 461,360 | |||||||||||||||||||||||||||||||||
Income (loss) from operations |
92,167 | (9 | ) | (2,040 | ) | (9 | ) | (5,394 | ) | 38,504 | (11,566 | ) | (16,173 | ) | 38,403 | |||||||||||||||||||||||||||
Other expense (income) |
||||||||||||||||||||||||||||||||||||||||||
Interest expense |
51,964 | 4,514 | 47,914 | 4,514 | 38,405 | 22,015 | 46,684 | 39,202 | 16,174 | |||||||||||||||||||||||||||||||||
Interest income |
(945 | ) | (25 | ) | (530 | ) | (25 | ) | (282 | ) | (140 | ) | (555 | ) | (307 | ) | (140 | ) | ||||||||||||||||||||||||
Loss on extinguishment of debt |
— | 10,533 | — | 10,533 | — | 13,938 | — | — | 13,938 | |||||||||||||||||||||||||||||||||
Transaction expenses, change in control |
— | 22,370 | 9,423 | 22,370 | 9,423 | — | 9,423 | 9,423 | — | |||||||||||||||||||||||||||||||||
Total other expense |
51,019 | 37,392 | 56,807 | 37,392 | 47,546 | 35,813 | 55,552 | 48,318 | 29,972 | |||||||||||||||||||||||||||||||||
Income (loss) before provision for income taxes |
41,148 | (37,401 | ) | (58,847 | ) | (37,401 | ) | (52,940 | ) | 2,691 | (67,118 | ) | (64,491 | ) | 8,431 | |||||||||||||||||||||||||||
Provision for income taxes |
6,898 | (871 | ) | (11,355 | ) | (871 | ) | (11,308 | ) | 2,025 | (4,739 | ) | (5,535 | ) | 3,509 | |||||||||||||||||||||||||||
Net income (loss) |
$ | 34,250 | $ | (36,530 | ) | $ | (47,492 | ) | $ | (36,530 | ) | $ | (41,632 | ) | $ | 666 | $ | (62,379 | ) | $ | (58,956 | ) | $ | 4,922 | ||||||||||||||||||
Net income (loss) |
$ | 34,250 | $ | (36,530 | ) | $ | (47,492 | ) | $ | (36,530 | ) | $ | (41,632 | ) | $ | 666 | ||||||||||||||||||||||||||
Foreign currency translation adjustments |
(341 | ) | (31 | ) | 2,484 | (31 | ) | (1,164 | ) | (1,594 | ) | |||||||||||||||||||||||||||||||
Comprehensive income (loss) |
$ | 33,909 | $ | (36,561 | ) | $ | (45,008 | ) | $ | (36,561 | ) | $ | (42,796 | ) | $ | (928 | ) | |||||||||||||||||||||||||
Per Share Data (unaudited) |
||||||||||||||||||||||||||||||||||||||||||
Net income (loss) per share: |
||||||||||||||||||||||||||||||||||||||||||
Basic |
$ | 0.23 | $ | (0.24 | ) | $ | (0.37 | ) | $ | (0.24 | ) | $ | (0.32 | ) | $ | 0.00 | $ | (0.42 | ) | $ | (0.39 | ) | $ | 0.03 | ||||||||||||||||||
Diluted |
$ | 0.21 | $ | (0.24 | ) | $ | (0.37 | ) | $ | (0.24 | ) | $ | (0.32 | ) | $ | 0.00 | $ | (0.42 | ) | $ | (0.39 | ) | $ | 0.03 | ||||||||||||||||||
Weighted average shares outstanding: |
||||||||||||||||||||||||||||||||||||||||||
Basic |
149,686,460 | 149,686,460 | 130,000,000 | 149,686,460 | 130,000,000 | 137,232,289 | 149,938,166 | 149,938,166 | 149,940,131 | |||||||||||||||||||||||||||||||||
Diluted |
163,879,766 | 149,686,460 | 130,000,000 | 149,686,460 | 130,000,000 | 138,170,488 | 149,938,166 | 149,938,166 | 150,878,330 |
Annual Periods |
Interim Periods |
|||||||||||||||||||||||||||||||||||||||||
Predecessor |
Successor |
Predecessor |
Successor |
Pro Forma |
||||||||||||||||||||||||||||||||||||||
Year Ended December 31, |
Period from January 1 through January 31, |
Period from February 1 through December 31, |
Period from January 1 through January 31, |
Period from February 1, 2020 through September 30, |
Nine Months Ended September 30, |
Year Ended December 31, |
Nine Months Ended September 30, |
Nine Months Ended September 30, |
||||||||||||||||||||||||||||||||||
2019 |
2020 |
2020 |
2020 |
2020 |
2021 |
2020 |
2020 |
2021 |
||||||||||||||||||||||||||||||||||
(In thousands, except share and per share amounts) |
||||||||||||||||||||||||||||||||||||||||||
Balance Sheet Data (end of period) |
||||||||||||||||||||||||||||||||||||||||||
Cash, cash equivalents and restricted cash |
$ | 80,746 | $ | 152,970 | $ | 275,688 | $ | 275,688 | ||||||||||||||||||||||||||||||||||
Total assets |
$ | 544,733 | $ | 1,763,691 | $ | 1,856,693 | $ | 1,856,693 | ||||||||||||||||||||||||||||||||||
Total liabilities |
$ | 638,950 | $ | 969,421 | $ | 742,474 | $ | 742,474 | ||||||||||||||||||||||||||||||||||
Total (deficit) equity |
$ | (94,217 | ) | $ | 794,270 | $ | 1,114,219 | $ | 1,114,219 | |||||||||||||||||||||||||||||||||
Cash Flow Data |
||||||||||||||||||||||||||||||||||||||||||
Cash flows from operating activities |
$ | 71,583 | $ | (19,216 | ) | $ | 72,851 | $ | (19,216 | ) | $ | 37,626 | $ | 83,860 | ||||||||||||||||||||||||||||
Cash flows from investing activities |
$ | (17,789 | ) | $ | (2,043 | ) | $ | (15,569 | ) | $ | (2,043 | ) | $ | (10,798 | ) | $ | (24,992 | ) | ||||||||||||||||||||||||
Cash flows from financing activities |
$ | (3,176 | ) | $ | (11,122 | ) | $ | 46,404 | $ | (11,122 | ) | $ | 50,356 | $ | 64,372 | |||||||||||||||||||||||||||
Capital expenditures |
$ | 16,703 | $ | 1,880 | $ | 15,826 | $ | 1,880 | $ | 11,506 | $ | 17,709 | ||||||||||||||||||||||||||||||
Purchases of property and equipment |
$ | 6,578 | $ | 951 | $ | 5,304 | $ | 951 | $ | 4,083 | $ | 5,743 | ||||||||||||||||||||||||||||||
Capitalized software development costs |
$ | 10,125 | $ | 929 | $ | 10,522 | $ | 929 | $ | 7,423 | $ | 11,966 | ||||||||||||||||||||||||||||||
Other Financial Data |
||||||||||||||||||||||||||||||||||||||||||
Adjusted EBITDA (1) |
$ | 123,773 | $ | 7,022 | $ | 139,776 | $ | 7,022 | $ | 95,131 | $ | 156,856 | $ | 146,798 | $ | 102,153 | $ | 156,856 | ||||||||||||||||||||||||
Net Income (Loss) Margin (2) |
7.1 | % | (99.3 | )% | (10.1 | )% | (99.3 | )% | (13.2 | )% | 0.1 | % | (12.3 | )% | (16.7 | )% | 1.0 | % | ||||||||||||||||||||||||
Adjusted EBITDA Margin (3) |
25.7 | % | 19.1 | % | 29.6 | % | 19.1 | % | 30.1 | % | 31.4 | % | 28.8 | % | 29.0 | % | 31.4 | % | ||||||||||||||||||||||||
Adjusted Net Income (4) |
$ | 44,932 | $ | 1,371 | $ | 63,895 | $ | 1,371 | $ | 39,146 | $ | 95,869 | $ | 73,533 | $ | 47,425 | $ | 99,767 | ||||||||||||||||||||||||
Adjusted Diluted Earnings Per Share (5) |
$ | 0.27 | $ | 0.01 | $ | 0.49 | $ | 0.01 | $ | 0.30 | $ | 0.69 | $ | 0.49 | $ | 0.32 | $ | 0.66 |
(1) | We define Adjusted EBITDA as net income before interest, taxes, depreciation, and amortization, and as further adjusted for loss on extinguishment of debt, share-based compensation, transaction and acquisition-related charges, integration and restructuring charges, and other and non-cash charges. We describe these adjustments reconciling net income (loss) to Adjusted EBITDA in the table below. |
• | it does not reflect costs or cash outlays for capital expenditures or contractual commitments; |
• | it does not reflect changes in, or cash requirements for, our working capital needs; |
• | it does not reflect the interest expense, or the cash requirements necessary to service interest or principal payments, on our debt; |
• | it does not reflect period to period changes in taxes, income tax expense, or the cash necessary to pay income taxes; |
• | it does not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations; |
• | although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and they do not reflect cash requirements for such replacements; and |
• | other companies in our industry may calculate this measure differently than we do, limiting their usefulness as comparative measures. |
Annual Periods |
Interim Periods |
|||||||||||||||||||||||||||||||||||||||||||
Predecessor |
|
Successor |
Predecessor |
|
Successor |
Pro Forma |
||||||||||||||||||||||||||||||||||||||
Year Ended December 31, |
Period from January 1 through January 31, |
|
Period from February 1 through December 31, |
Period from January 1 through January 31, |
|
Period from February 1, 2020 through September 30, |
Nine Months Ended September 30, |
Year Ended December 31, |
Nine Months Ended September 30, |
Nine Months Ended September 30, |
||||||||||||||||||||||||||||||||||
2019 |
2020 |
|
2020 |
2020 |
|
2020 |
2021 |
2020 |
2020 |
2021 |
||||||||||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) |
$ | 34,250 | $ | (36,530 | ) | $ | (47,492 | ) | $ | (36,530 | ) | $ | (41,632 | ) | $ | 666 | $ | (62,379 | ) | $ | (58,956 | ) | $ | 4,922 | ||||||||||||||||||||
Interest expense, net |
51,019 | 4,489 | 47,384 | 4,489 | 38,123 | 21,875 | 46,129 | 38,895 | 16,034 | |||||||||||||||||||||||||||||||||||
Provision (benefit) for income taxes |
6,898 | (871 | ) | (11,355 | ) | (871 | ) | (11,308 | ) | 2,025 | (4,739 | ) | (5,535 | ) | 3,509 | |||||||||||||||||||||||||||||
Depreciation and amortization |
25,953 | 2,105 | 135,057 | 2,105 | 97,815 | 106,493 | 143,286 | 108,240 | 106,493 | |||||||||||||||||||||||||||||||||||
Loss on extinguishment of debt |
— | 10,533 | — | 10,533 | — | 13,938 | — | — | 13,938 | |||||||||||||||||||||||||||||||||||
Share-based compensation |
1,216 | 3,976 | 1,876 | 3,976 | 1,331 | 4,569 | 9,245 | 7,757 | 4,670 | |||||||||||||||||||||||||||||||||||
Transaction and acquisition related charges(a) |
1,198 | 22,840 | 10,146 | 22,840 | 9,578 | 6,510 | 10,616 | 10,048 | 6,510 |
Annual Periods |
Interim Periods |
|||||||||||||||||||||||||||||||||||||||||||
Predecessor |
|
Successor |
Predecessor |
|
Successor |
Pro Forma |
||||||||||||||||||||||||||||||||||||||
Year Ended December 31, |
Period from January 1 through January 31, |
|
Period from February 1 through December 31, |
Period from January 1 through January 31, |
|
Period from February 1, 2020 through September 30, |
Nine Months Ended September 30, |
Year Ended December 31, |
Nine Months Ended September 30, |
Nine Months Ended September 30, |
||||||||||||||||||||||||||||||||||
2019 |
2020 |
|
2020 |
2020 |
|
2020 |
2021 |
2020 |
2020 |
2021 |
||||||||||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||||||||||||||
(continued) | ||||||||||||||||||||||||||||||||||||||||||||
Integration and restructuring charges(b) |
— | 327 | 3,413 | 327 | 288 | 584 | 3,740 | 615 | 584 | |||||||||||||||||||||||||||||||||||
Other(c) |
3,239 | 153 | 747 | 153 | 936 | 196 | 900 | 1,089 | 196 | |||||||||||||||||||||||||||||||||||
Adjusted EBITDA |
$ | 123,773 | $ | 7,022 | $ | 139,776 | $ | 7,022 | $ | 95,131 | $ | 156,856 | $ | 146,798 | $ | 102,153 | $ | 156,856 |
(a) | Represents charges incurred related to acquisitions and similar transactions, primarily consisting of change in control-related costs, professional service fees, and other third-party costs. Additionally, the nine months ended September 30, 2021 includes incremental professional service fees incurred related to the IPO. |
(b) | Represents charges from organizational restructuring and integration activities outside the ordinary course of business. |
(c) | Represents non-cash and other charges primarily related to litigation-related expenses related to legal exposures inherited from legacy acquisitions, foreign currency (gains) losses, and (gains) losses on the sale of assets. |
(2) | Represents net income (loss) divided by total revenues. |
(3) | We define Adjusted EBITDA Margin as Adjusted EBITDA divided by total revenues. |
(4) | We define Adjusted Net Income as net income before taxes adjusted for debt-related costs, acquisition-related depreciation and amortization, share-based compensation, transaction and acquisition-related charges, integration and restructuring charges, and other and non-cash charges, to which we then apply an effective tax rate of 26.4%, 25.7%, and 25.9% for the 2019, 2020, and 2021 periods, respectively. We describe these adjustments reconciling net income (loss) to Adjusted Net Income in the table below. |
• | it does not reflect costs or cash outlays for capital expenditures or contractual commitments; |
• | it does not reflect changes in, or cash requirements for, our working capital needs; |
• | it does not reflect the interest expense, or the cash requirements necessary to service interest or principal payments, on our debt; |
• | it does not reflect period to period changes in taxes, income tax expense, or the cash necessary to pay income taxes; |
• | it does not reflect the impact of earnings or charges resulting from certain matters we consider not to be indicative of our ongoing operations; and |
• | other companies in our industry may calculate this measure differently than we do, limiting their usefulness as comparative measures. |
Annual Periods |
Interim Periods |
|||||||||||||||||||||||||||||||||||||||||||
Predecessor |
|
Successor |
Predecessor |
|
Successor |
Pro Forma |
||||||||||||||||||||||||||||||||||||||
Year Ended December 31, |
Period from January 1 through January 31, |
|
Period from February 1 through December 31, |
Period from January 1 through January 31, |
|
Period from February 1, 2020 through September 30, |
Nine Months Ended September 30, |
Year Ended December 31, |
Nine Months Ended September 30, |
Nine Months Ended September 30, |
||||||||||||||||||||||||||||||||||
2019 |
2020 |
|
2020 |
2020 |
|
2020 |
2021 |
2020 |
2020 |
2021 |
||||||||||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) |
$ | 34,250 | $ | (36,530 | ) | $ | (47,492 | ) | $ | (36,530 | ) | $ | (41,632 | ) | $ | 666 | $ | (62,379 | ) | $ | (58,956 | ) | $ | 4,922 | ||||||||||||||||||||
Provision (benefit) for income taxes |
6,898 | (871 | ) | (11,355 | ) | (871 | ) | (11,308 | ) | 2,025 | (4,739 | ) | (5,535 | ) | 3,509 | |||||||||||||||||||||||||||||
Income (loss) before income taxes |
41,148 | (37,401 | ) | (58,847 | ) | (37,401 | ) | (52,940 | ) | 2,691 | (67,118 | ) | (64,491 | ) | 8,431 | |||||||||||||||||||||||||||||
Debt-related costs(a) |
3,174 | 11,102 | 3,242 | 11,102 | 2,344 | 19,703 | 9,194 | 8,494 | 19,110 | |||||||||||||||||||||||||||||||||||
Acquisition-related depreciation and amortization(b) |
11,074 | 848 | 125,419 | 848 | 91,149 | 95,047 | 132,391 | 100,317 | 95,047 | |||||||||||||||||||||||||||||||||||
Share-based compensation |
1,216 | 3,976 | 1,876 | 3,976 | 1,331 | 4,569 | 9,245 | 7,757 | 4,670 | |||||||||||||||||||||||||||||||||||
Transaction and acquisition related charges(c) |
1,198 | 22,840 | 10,146 | 22,840 | 9,578 | 6,510 | 10,616 | 10,048 | 6,510 | |||||||||||||||||||||||||||||||||||
Integration and restructuring charges(d) |
— | 327 | 3,413 | 327 | 288 | 584 | 3,740 | 615 | 584 | |||||||||||||||||||||||||||||||||||
Other(e) |
3,239 | 153 | 747 | 153 | 936 | 196 | 900 | 1,089 | 196 | |||||||||||||||||||||||||||||||||||
Adjusted income before income tax effect |
61,049 | 1,845 | 85,996 | 1,845 | 52,686 | 129,300 | 98,968 | 63,829 | 134,548 | |||||||||||||||||||||||||||||||||||
Less: Income tax effect(f) |
16,117 | 474 | 22,101 | 474 | 13,540 | 33,431 | 25,435 | 16,404 | 34,781 | |||||||||||||||||||||||||||||||||||
Adjusted Net Income |
$ | 44,932 | $ | 1,371 | $ | 63,895 | $ | 1,371 | $ | 39,146 | $ | 95,869 | $ | 73,533 | $ | 47,425 | $ | 99,767 |
(a) | Represents the loss on extinguishment of debt and non-cash interest expense related to the amortization of debt issuance costs for the financing for the Silver Lake Transaction. |
(b) | Represents the depreciation and amortization expense related to intangible assets and developed technology assets recorded due to the application of ASC 805, Business Combinations |
(c) | Represents charges incurred related to acquisitions and similar transactions, primarily consisting of change in control-related costs, professional service fees, and other third-party costs. Additionally, the nine months ended September 30, 2021 includes incremental professional service fees incurred related to the IPO. |
(d) | Represents charges from organizational restructuring and integration activities outside the ordinary course of business. |
(e) | Represents non-cash and other charges primarily related to legal exposures inherited from legacy acquisitions, foreign currency (gains) losses, and (gains) losses on the sale of assets. |
(f) | Effective tax rates of 26.4%, 25.7%, and 25.9% have been used to compute Adjusted Net Income for the 2019, 2020, and 2021 periods, respectively. As of December 31, 2020, we had net operating loss carryforwards of approximately $197.6 million, $166.2 million, and $36.0 million for federal, state, and foreign income tax purposes, respectively, available to reduce future income subject to income taxes. As a result, the amount of actual cash taxes we pay for federal, state, and foreign income taxes differs significantly from the effective income tax rate computed in accordance with GAAP and from the normalized rate shown above. |
(5) | The following table presents the calculation of Adjusted Diluted Earnings Per Share for the periods presented. Prior to the IPO, the equity awards under certain individual grant agreements were issued by the Company’s prior direct parent entity. As a result, these awards were not considered equity awards issued by the Company, and therefore not included in the calculation of adjusted weighted average number of shares outstanding—diluted. |
Annual Periods |
Interim Periods |
|||||||||||||||||||||||||||||||||||||||||
Predecessor |
Successor |
Predecessor |
Successor |
Pro Forma |
||||||||||||||||||||||||||||||||||||||
Year Ended December 31, |
Period from January 1 through January 31, |
Period from February 1 through December 31, |
Period from January 1 through January 31, |
Period from February 1, 2020 through September 30, |
Nine Months Ended September 30, |
Year Ended December 31, |
Nine Months Ended September 30, |
Nine Months Ended September 30, |
||||||||||||||||||||||||||||||||||
2019 |
2020 |
2020 |
2020 |
2020 |
2021 |
2020 |
2020 |
2021 |
||||||||||||||||||||||||||||||||||
Diluted net income (loss) per share (GAAP) |
$ | 0.21 | $ | (0.24 | ) | $ | (0.37 | ) | $ | (0.24 | ) | (0.32 | ) | 0.00 | $ | (0.42 | ) | $ | (0.39 | ) | $ | 0.03 | ||||||||||||||||||||
Adjusted Net Income adjustments per share |
||||||||||||||||||||||||||||||||||||||||||
Income taxes |
0.04 | (0.01 | ) | (0.09 | ) | (0.01 | ) | (0.09 | ) | 0.01 | (0.03 | ) | (0.04 | ) | 0.02 | |||||||||||||||||||||||||||
Debt-related costs(a) |
0.02 | 0.07 | 0.02 | 0.07 | 0.02 | 0.14 | 0.06 | 0.06 | 0.13 | |||||||||||||||||||||||||||||||||
Acquisition-related depreciation and amortization(b) |
0.07 | 0.01 | 0.96 | 0.01 | 0.70 | 0.69 | 0.88 | 0.67 | 0.63 | |||||||||||||||||||||||||||||||||
Share-based compensation |
0.01 | 0.03 | 0.01 | 0.03 | 0.01 | 0.03 | 0.06 | 0.05 | 0.03 | |||||||||||||||||||||||||||||||||
Transaction and acquisition related charges(c) |
0.01 | 0.15 | 0.08 | 0.15 | 0.07 | 0.05 | 0.07 | 0.07 | 0.04 | |||||||||||||||||||||||||||||||||
Integration and restructuring charges(d) |
— | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | |||||||||||||||||||||||||||||||||
Other(e) |
0.02 | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 | |||||||||||||||||||||||||||||||||
Adjusted income tax effect(f) |
(0.10 | ) | (0.00 | ) | (0.17 | ) | (0.00 | ) | (0.10 | ) | (0.24 | ) | (0.17 | ) | (0.11 | ) | (0.23 | ) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Adjusted Diluted Earnings Per Share (Non-GAAP) |
$ | 0.27 | $ | 0.01 | $ | 0.49 | $ | 0.01 | 0.30 | 0.69 | $ | 0.49 | $ | 0.32 | $ | 0.66 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Weighted average number of shares outstanding used in computation of Adjusted Diluted Earnings Per Share: |
||||||||||||||||||||||||||||||||||||||||||
Weighted average number of shares outstanding—diluted (GAAP) |
163,879,766 | 149,686,460 | 130,000,000 | 149,686,460 | 130,000,000 | 138,170,488 | 149,938,166 | 149,938,166 | 150,878,330 |
Annual Periods |
Interim Periods |
|||||||||||||||||||||||||||||||||||||||||
Predecessor |
Successor |
Predecessor |
Successor |
Pro Forma |
||||||||||||||||||||||||||||||||||||||
Year Ended December 31, |
Period from January 1 through January 31, |
Period from February 1 through December 31, |
Period from January 1 through January 31, |
Period from February 1, 2020 through September 30, |
Nine Months Ended September 30, |
Year Ended December 31, |
Nine Months Ended September 30, |
Nine Months Ended September 30, |
||||||||||||||||||||||||||||||||||
2019 |
2020 |
2020 |
2020 |
2020 |
2021 |
2020 |
2020 |
2021 |
||||||||||||||||||||||||||||||||||
(continued) | ||||||||||||||||||||||||||||||||||||||||||
Options and restricted stock not included in weighted average number of shares outstanding—diluted (GAAP) (using treasury stock method) |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Adjusted weighted average number of shares outstanding—diluted (Non-GAAP) |
163,879,766 | 149,686,460 | 130,000,000 | 149,686,460 | 130,000,000 | 138,170,488 | 149,938,166 | 149,938,166 | 150,878,330 | |||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Represents the loss on extinguishment of debt and non-cash interest expense related to the amortization of debt issuance costs for the financing for the Silver Lake Transaction. |
(b) | Represents the depreciation and amortization expense related to intangible assets and developed technology assets recorded due to the application of ASC 805, Business Combinations |
(c) | Represents charges incurred related to acquisitions and similar transactions, primarily consisting of change in control-related costs, professional service fees, and other third-party costs. Additionally, the nine months ended September 30, 2021 (Successor) includes incremental professional service fees incurred related to the IPO. |
(d) | Represents charges from organizational restructuring and integration activities outside of the ordinary course of business. |
(e) | Represents non-cash and other charges primarily related to legal exposures inherited from legacy acquisitions, foreign currency (gains) losses, and (gains) losses on the sale of assets. |
(f) | Effective tax rates of 26.4%, 25.7%, and 25.9% have been used to compute Adjusted Diluted Earnings Per Share for the 2019, 2020, and 2021 periods, respectively. As of December 31, 2020, we had net operating loss carryforwards of approximately $197.6 million, $166.2 million, and $36.0 million for federal, state, and foreign income tax purposes, respectively, available to reduce future income subject to income taxes. As a result, the amount of actual cash taxes we pay for federal, state, and foreign income taxes differs significantly from the effective income tax rate computed in accordance with GAAP and from the normalized rate shown above. |
• | Operational Disruptions COVID-19 outbreak, many data sources were not available or current as workers were unable to access and update them. In some instances, where public record information was not digitized or available through electronic means, certain information and reports were inaccessible as they had to be retrieved in person. In certain courthouses around the country and other instances where public record information was only available through manual retrieval, and those data sources were closed due to COVID-19 measures, information could not be retrieved or was delayed in being retrieved in order to fulfill background screening orders. This resulted in longer turnaround times, and depending on our customers’ preferences, delayed or required modification of customer deliverables. Courthouses and public record information sources may continue to be closed, or close again, due to resurgences of COVID-19, such as the current resurgence as a result of the Delta variant, and may continue to affect our access to data sources and interfere with customer deliverables. |
• | Customers COVID-19 pandemic, could also cease their business operations on a temporary or permanent basis. Certain sectors such as travel, live entertainment, dining, and non-essential retail, have been especially impacted by the pandemic. While the decrease in demand from customers in such sectors has been offset by increased demand from our customers in other sectors such as e-commerce, essential retail, and transportation and home delivery, such other |
industries may experience downturns in the future. In addition, demand for our products and solutions from our international customers has generally been more impacted by the ongoing effects of the COVID-19 pandemic than demand from our U.S. customers. In addition, because many of our existing and potential customers are also operating from a similar remote environment, we may face difficulties maintaining relationships with our current customers and winning new customers in the same manner as we would have operated before the outbreak of COVID-19. For example, we have been unable to attend or present at various tradeshows and conferences as we did before the outbreak of the pandemic, and the limitations of travel have impacted our ability to visit customer locations. |
• | Increased Expenses COVID-19 pandemic, including costs related to furloughs and severance, increased overtime, and personal protective equipment. Additionally, certain of our expenses, such as office space leases and software, are not variable with revenues and will continue regardless of the level of our activity or employee base. |
• | Heightened Operational Risks |
• | our ability to oversee and staff our international operations; |
• | foreign exchange controls that might prevent us from repatriating cash to the United States; |
• | unfavorable foreign tax rules; |
• | language and cultural differences; |
• | trade relations, political and economic instability, and international conflicts; |
• | non-compliance with applicable currency exchange control regulations, transfer pricing regulations, or other similar regulations; |
• | violations of the Foreign Corrupt Practices Act or similar anticorruption laws by acts of agents and other intermediaries whom we have limited or no ability to control; and |
• | violations of regulations enforced by the U.S. Department of The Treasury’s Office of Foreign Asset Control. |
• | increase our vulnerability to adverse changes in the general economic, industry, and competitive conditions; |
• | require us to dedicate a substantial portion of our cash flow from operations to make payments on our indebtedness, thereby reducing the availability of our cash flow to fund working capital, capital expenditures, and other general corporate purposes; |
• | limit our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate; |
• | require us to repatriate cash from our foreign subsidiaries to accommodate debt service payments; |
• | expose us to the risk of increased interest rates as certain of our borrowings, including borrowings under our term loan facility and revolving credit facility, are at variable rates, and we may not be able to enter into interest rate swaps, and any swaps we enter into may not fully mitigate our interest rate risk; |
• | restrict us from capitalizing on business opportunities; |
• | make it more difficult to satisfy our financial obligations, including payments on our indebtedness; |
• | place us at a competitive disadvantage compared to our competitors that have less debt; and |
• | limit our ability to borrow additional funds for working capital, capital expenditures, acquisitions, debt service requirements, execution of our business strategy, or other general corporate purposes. |
• | incur additional indebtedness and guarantee indebtedness; |
• | pay dividends or make other distributions in respect of, or repurchase or redeem, capital stock; |
• | prepay, redeem or repurchase certain debt; |
• | make acquisitions, investments, loans, and advances; |
• | sell or otherwise dispose of assets; |
• | incur liens; |
• | enter into transactions with affiliates; |
• | enter into agreements restricting our subsidiaries’ ability to pay dividends; |
• | consolidate, merge or sell all or substantially all of our assets; and |
• | engage in certain fundamental changes, including changes in the nature of our business. |
• | we are not be required to comply with the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act, |
• | we are subject to reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and |
• | we are not be required to hold nonbinding advisory votes on executive compensation or stockholder approval of any golden parachute payments not previously approved. |
• | a majority of our board of directors consist of “independent directors” as defined under the Nasdaq rules; |
• | our director nominees be selected, or recommended for our board of directors’ selection by a nominating/governance committee comprised solely of independent directors; and |
• | the compensation of our executive officers be determined, or recommended to our board of directors for determination, by a compensation committee comprised solely of independent directors. |
• | results of operations that vary from the expectations of securities analysts and investors; |
• | results of operations that vary from those of our competitors; |
• | changes in expectations as to our future financial performance, including financial estimates and investment recommendations by securities analysts and investors; |
• | changes in economic conditions for companies in our industry; |
• | changes in market valuations of, or earnings and other announcements by, companies in our industry; |
• | declines in the market prices of stocks generally; |
• | additions or departures of key management personnel; |
• | strategic actions by us or our competitors; |
• | announcements by us, our competitors, our suppliers or our distributors of significant contracts, price reductions, new products or technologies, acquisitions, dispositions, joint marketing relationships, joint ventures, other strategic relationships or capital commitments; |
• | changes in preference of our customers and our market share; |
• | changes in general economic or market conditions or trends in our industry or the economy as a whole; |
• | changes in business or regulatory conditions; |
• | future sales of our common stock or other securities; |
• | investor perceptions of or the investment opportunity associated with our common stock relative to other investment alternatives; |
• | the public’s response to press releases or other public announcements by us or third parties, including our filings with the SEC; |
• | changes or proposed changes in laws or regulations or differing interpretations or enforcement thereof affecting our business; |
• | announcements relating to litigation or governmental investigations; |
• | guidance, if any, that we provide to the public, any changes in this guidance or our failure to meet this guidance; |
• | the development and sustainability of an active trading market for our stock; |
• | changes in accounting principles; and |
• | other events or factors, including those resulting from informational technology system failures and disruptions, natural disasters, war, acts of terrorism or responses to these events. |
• | a classified board of directors, as a result of which our board of directors is divided into three classes, with each class serving for staggered three-year terms; |
• | the ability of our board of directors to issue one or more series of preferred stock; |
• | advance notice requirements for nominations of directors by stockholders and for stockholders to include matters to be considered at our annual meetings; |
• | certain limitations on convening special stockholder meetings; |
• | the removal of directors only for cause and only upon the affirmative vote of the holders of at least 66 2 /3 % of the shares of common stock entitled to vote generally in the election of directors if the Sponsor and its affiliates cease to beneficially own at least 50% of shares of common stock entitled to vote generally in the election of directors; and |
• | that certain provisions may be amended only by the affirmative vote of at least 66 2 /3 % of shares of common stock entitled to vote generally in the election of directors if the Sponsor and its affiliates cease to beneficially own at least 50% of shares of common stock entitled to vote generally in the election of directors. |
• | the impact of COVID-19 and related risks on our results of operations, financial position and/or liquidity; |
• | our operations in a highly regulated industry and the fact that we are subject to numerous and evolving laws and regulations, including with respect to personal data and data security; |
• | our reliance on third-party data providers; |
• | negative changes in external events beyond our control, including our customers’ onboarding volumes, economic drivers which are sensitive to macroeconomic cycles, and the COVID-19 pandemic; |
• | potential harm to our business, brand and reputation as a result of security breaches, cyber-attacks or the mishandling of personal data; |
• | liability and litigation due to the sensitive and privacy-driven nature of our products and solutions, which could be costly and time-consuming to defend and may not be fully covered by insurance; |
• | the continued integration of our platforms and solutions with human resource providers such as applicant tracking systems and human capital management systems as well as our relationships with such human resource providers; |
• | risks relating to public opinion, which may be magnified by incidents or adverse publicity concerning our industry or operations; |
• | our contracts with our customers, which do not guarantee exclusivity or contracted volumes; |
• | our reliance on third-party vendors to carry out certain portions of our operations; |
• | disruptions, outages or other errors with our technology and network infrastructure, including our data centers, servers and third-party cloud and internet providers and our migration to the cloud; |
• | disruptions at our Global Operating Center and other operating centers; |
• | operating in a penetrated and competitive market; |
• | our ability to obtain, maintain, protect and enforce our intellectual property and other proprietary information; |
• | our indebtedness could adversely affect our ability to raise additional capital to fund our operations, limit our ability to react to changes in the economy or our industry, and prevent us from meeting our obligations; |
• | our Sponsor controls us and may have interests that conflict with ours or those of our stockholders. |
• | our ability to maintain, protect and enforce the confidentiality of our trade secrets; |
• | the use of open-source software in our applications; |
• | the indemnification provisions in our contracts with our customers and third-party data suppliers; |
• | our ability to identify acquisition targets or successfully complete such transactions; |
• | our international business; |
• | our dependence on the service of our key executive and other employees, and our ability to find and retain qualified employees; |
• | seasonality in our operations from quarter to quarter; |
• | failure to comply with anti-corruption laws and regulations; and |
• | changing interpretations of tax laws. |
(In thousands, except share and par value) | As of September 30, 2021 |
|||
Cash and cash equivalents |
$ | 275,538 | ||
|
|
|||
Debt: |
||||
Term loan facility (1) |
564,724 | |||
Revolving credit facility (2) |
— | |||
|
|
|||
Total debt |
564,724 | |||
|
|
|||
Stockholders’ equity: |
||||
Common stock, $0.001 par value per share, 1,000,000,000 shares authorized; 152,870,750 shares issued and outstanding |
153 | |||
Additional paid-in capital |
1,160,002 | |||
Accumulated deficit |
(46,826 | ) | ||
Accumulated other comprehensive income |
890 | |||
|
|
|||
Total stockholders’ equity |
1,114,219 | |||
|
|
|||
Total capitalization |
$ | 1,678,943 | ||
|
|
(1) | For a further description of our term loan facility, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Long-Term Debt.” |
(2) | For a further description of our revolving credit facility, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Long-Term Debt.” |
• | the issuance of 22,856,250 shares of our common stock to the investors in the IPO in exchange for net proceeds of approximately $316.5 million, after deducting the underwriting discount but before estimated offering expenses payable by us; |
• | the payment of fees and expenses related to the IPO; and, |
• | the use of proceeds from the IPO to repay $200.0 million of borrowings under our term loan facility, with the remainder for general corporate purposes. |
• | the recognition of the performance-based vesting of certain share-based compensation awards related to Silver Lake’s selling of a portion of its interests in the Company and Silver Lake’s distribution of a portion of its interests in the Company to its partners. |
First Advantage Corporation (Successor) |
Follow-On Offering and SLP Distribution Adjustments |
Pro Forma Total |
||||||||||||||
Assets |
||||||||||||||||
Cash and cash equivalents |
$ | 275,538 | $ | — | $ | 275,538 | ||||||||||
Restricted cash |
150 | — | 150 | |||||||||||||
Short-term investments |
958 | — | 958 | |||||||||||||
Accounts receivable, net |
147,138 | — | 147,138 | |||||||||||||
Prepaid expenses and other current assets |
17,294 | — | 17,294 | |||||||||||||
Income tax receivable |
2,426 | — | 2,426 | |||||||||||||
|
|
|
|
|
|
|||||||||||
Total current assets |
443,504 | — | 443,504 | |||||||||||||
Property and equipment, net |
161,330 | — | 161,330 | |||||||||||||
Goodwill |
772,669 | — | 772,669 | |||||||||||||
Trade name, net |
81,691 | — | 81,691 | |||||||||||||
Customer lists, net |
389,216 | — | 389,216 | |||||||||||||
Deferred tax asset, net |
1,442 | — | 1,442 | |||||||||||||
Other assets |
6,841 | — | 6,841 | |||||||||||||
|
|
|
|
|
|
|||||||||||
Total assets |
$ | 1,856,693 | $ | — | $ | 1,856,693 | ||||||||||
|
|
|
|
|
|
|||||||||||
Liabilities and Equity |
||||||||||||||||
Accounts payable |
$ | 46,078 | $ | — | $ | 46,078 | ||||||||||
Accrued compensation |
26,173 | — | 26,173 | |||||||||||||
Accrued liabilities |
23,966 | — | 23,966 | |||||||||||||
Current portion of long-term debt |
— | — | — | |||||||||||||
Income tax payable |
2,578 | — | 2,578 | |||||||||||||
Deferred income |
504 | — | 504 | |||||||||||||
|
|
|
|
|
|
|||||||||||
Total current liabilities |
99,299 | — | 99,299 | |||||||||||||
Long-term debt, net |
554,405 | — | 554,405 | |||||||||||||
Deferred tax liability, net |
82,163 | — | 82,163 | |||||||||||||
Other liabilities |
6,607 | — | 6,607 | |||||||||||||
|
|
|
|
|
|
|||||||||||
Total liabilities |
742,474 | 742,474 | ||||||||||||||
Commitments and contingencies |
||||||||||||||||
Equity: |
||||||||||||||||
Common stock |
153 | — | 153 | |||||||||||||
Additional paid-in-capital |
1,160,002 | 3,494 | (2a) | 1,163,496 | ||||||||||||
Accumulated deficit |
(46,826 | ) | (3,494 | ) | (2a) | (50,320 | ) | |||||||||
Accumulated other comprehensive loss |
890 | — | 890 | |||||||||||||
|
|
|
|
|
|
|||||||||||
Total equity |
1,114,219 | — | 1,114,219 | |||||||||||||
|
|
|
|
|
|
|||||||||||
Total liabilities and equity |
$ | 1,856,693 | $ | — | $ | 1,856,693 | ||||||||||
|
|
|
|
|
|
First Advantage Corporation Period from January 1, 2020 through January 31, 2020 (Predecessor) |
First Advantage Corporation Period from February 1, 2020 through December 31, 2020 (Successor) |
Silver Lake Transaction Accounting Adjustments |
Silver Lake Transaction Refinancing Accounting Adjustments |
Pro Forma for the Silver Lake Transaction |
IPO Adjustments |
Follow-On Offering and SLP Distribution Adjustments |
Pro Forma Total |
|||||||||||||||||||||||||||||||||||||||||||||||||
Revenues |
$ | 36,785 | $ | 472,369 | $ | — | $ | — | $ | 509,154 | $ | — | $ | — | $ | 509,154 | ||||||||||||||||||||||||||||||||||||||||
Operating expenses: |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cost of services (exclusive of depreciation and amortization below) |
20,265 | 240,287 | — | — | 260,552 | — | 61 | (3i | ) | 260,613 | ||||||||||||||||||||||||||||||||||||||||||||||
Product and technology expense |
3,189 | 32,201 | — | — | 35,390 | — | 175 | (3i | ) | 35,565 | ||||||||||||||||||||||||||||||||||||||||||||||
Selling, general, and administrative expense |
11,235 | 66,864 | — | — | 78,099 | — | 3,157 | (3i | ) | 81,256 | ||||||||||||||||||||||||||||||||||||||||||||||
Depreciation and amortization |
2,105 | 135,057 | 6,124 | (3a | ) | — | 143,286 | — | — | 143,286 | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
Total operating expenses |
36,794 | 474,409 | 6,124 | — | 517,327 | — | 3,393 | 520,720 | ||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
(Loss) from operations: |
(9 | ) | (2,040 | ) | (6,124 | ) | — | (8,173 | ) | — | (3,393 | ) | (11,566 | ) | ||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
Other expense (income): |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest expense |
4,514 | 47,914 | — | (741 | ) | (3d | ) | 51,687 | (5,003 | ) | (3g | ) | — | 46,684 | ||||||||||||||||||||||||||||||||||||||||||
Interest income |
(25 | ) | (530 | ) | — | — | (555 | ) | — | — | (555 | ) | ||||||||||||||||||||||||||||||||||||||||||||
Loss on extinguishment of debt |
10,533 | — | — | (10,533 | ) | (3e | ) | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||
Transaction expenses, change in control |
22,370 | 9,423 | (22,370 | ) | (3b | ) | — | 9,423 | — | — | 9,423 | |||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
Total other expense |
37,392 | 56,807 | (22,370 | ) | (11,274 | ) | 60,555 | (5,003 | ) | — | 55,552 | |||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
(Loss) before provision for income taxes |
(37,401 | ) | (58,847 | ) | 16,246 | 11,274 | (68,728 | ) | 5,003 | (3,393 | ) | (67,118 | ) | |||||||||||||||||||||||||||||||||||||||||||
Provision for income taxes |
(871 | ) | (11,355 | ) | 4,175 | (3c | ) | 2,898 | (3f | ) | (5,153 | ) | 1,286 | (3h | ) | (872 | ) | (3j | ) | (4,739 | ) | |||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
Net (loss) |
$ | (36,530 | ) | $ | (47,492 | ) | $ | 12,071 | $ | 8,376 | $ | (63,575 | ) | $ | 3,717 | $ | (2,521 | ) | $ | (62,379 | ) | |||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
Net (loss) per share— basic and diluted |
$ | (0.24 | ) | $ | (0.37 | ) | $ | (0.42 | ) | |||||||||||||||||||||||||||||||||||||||||||||||
Weighted average number of shares outstanding—basic and diluted |
149,686,460 | 130,000,000 | 149,938,166 |
First Advantage Corporation Period from January 1, 2020 through January 31, 2020 (Predecessor) |
First Advantage Corporation Period from February 1, 2020 through September 30, 2020 (Successor) |
Silver Lake Transaction Accounting Adjustments |
Silver Lake Transaction Refinancing Accounting Adjustments |
Pro Forma for the Silver Lake Transaction |
IPO Adjustments |
Follow-On Offering and SLP Distribution Adjustments |
Pro Forma Total |
|||||||||||||||||||||||||||||||||||||||||||||||||
Revenues |
$ | 36,785 | $ | 315,825 | $ | — | $ | — | $ | 352,610 | $ | — | $ | — | $ | 352,610 | ||||||||||||||||||||||||||||||||||||||||
Operating expenses: |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cost of services (exclusive of depreciation and amortization below) |
20,265 | 156,703 | — | — | 176,968 | — | 44 | (3i | ) | 177,012 | ||||||||||||||||||||||||||||||||||||||||||||||
Product and technology expense |
3,189 | 20,495 | — | — | 23,684 | — | 124 | (3i | ) | 23,808 | ||||||||||||||||||||||||||||||||||||||||||||||
Selling, general, and administrative expense |
11,235 | 46,206 | — | — | 57,441 | — | 2,282 | (3i | ) | 59,723 | ||||||||||||||||||||||||||||||||||||||||||||||
Depreciation and amortization. |
2,105 | 97,815 | 8,320 | (3a | ) | — | 108,240 | — | — | 108,240 | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
Total operating expenses |
36,794 | 321,219 | 8,320 | — | 366,333 | — | 2,450 | 368,783 | ||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
(Loss) from operations |
(9 | ) | (5,394 | ) | (8,320 | ) | — | (13,723 | ) | — | (2,450 | ) | (16,173 | ) | ||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
Other expense (income): |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest expense |
4,514 | 38,405 | — | (1,228 | ) | (3d | ) | 41,691 | (2,489 | ) | (3g | ) | — | 39,202 | ||||||||||||||||||||||||||||||||||||||||||
Interest income |
(25 | ) | (282 | ) | — | — | (307 | ) | — | — | (307 | ) | ||||||||||||||||||||||||||||||||||||||||||||
Loss on extinguishment of debt |
10,533 | — | — | (10,533 | ) | (3e | ) | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||
Transaction expenses, change in control |
22,370 | 9,423 | (22,370 | ) | (3b | ) | — | 9,423 | — | — | 9,423 | |||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
Total other expense |
37,392 | 47,546 | (22,370 | ) | (11,761 | ) | 50,807 | (2,489 | ) | — | 48,318 | |||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
(Loss) before provision for income taxes |
(37,401 | ) | (52,940 | ) | 14,050 | 11,761 | (64,530 | ) | 2,489 | (2,450 | ) | (64,491 | ) | |||||||||||||||||||||||||||||||||||||||||||
Provision for income taxes |
(871 | ) | (11,308 | ) | 3,611 | (3c | ) | 3,023 | (3f | ) | (5,545 | ) | 640 | (3h | ) | (630 | ) | (3j | ) | (5,535 | ) | |||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
Net (loss) |
$ | (36,530 | ) | $ | (41,632 | ) | $ | 10,439 | $ | 8,738 | $ | (58,985 | ) | $ | 1,849 | $ | (1,820 | ) | $ | (58,956 | ) | |||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
Net (loss) per share—basic and diluted |
$ | (0.24 | ) | $ | (0.32 | ) | $ | (0.39 | ) | |||||||||||||||||||||||||||||||||||||||||||||||
Weighted average number of shares outstanding— basic and diluted |
149,686,460 | 130,000,000 | 149,938,166 |
First Advantage Corporation (Successor) |
IPO Adjustments |
Follow-On Offering and SLP Distribution Adjustments |
Pro Forma Total |
|||||||||||||||||||||
Revenues |
$ | 499,763 | $ | — | $ | — | $ | 499,763 | ||||||||||||||||
Operating expenses: |
||||||||||||||||||||||||
Cost of services (exclusive of depreciation and amortization below) |
244,964 | — | 4 | (3i | ) | 244,968 | ||||||||||||||||||
Product and technology expense |
33,546 | — | 17 | (3i | ) | 33,563 | ||||||||||||||||||
Selling, general, and administrative expense |
76,256 | — | 80 | (3i | ) | 76,336 | ||||||||||||||||||
Depreciation and amortization |
106,493 | — | — | 106,493 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||
Total operating expenses |
461,259 | — | 101 | 461,360 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||
Income from operations |
38,504 | — | (101 | ) | 38,403 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||
Other expense (income): |
||||||||||||||||||||||||
Interest expense |
22,015 | (5,841 | ) | (3g | ) | — | 16,174 | |||||||||||||||||
Interest income |
(140 | ) | — | — | (140 | ) | ||||||||||||||||||
Loss on extinguishment of debt |
13,938 | — | — | 13,938 | ||||||||||||||||||||
Transaction expenses, change in control |
— | — | — | — | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||
Total other expense |
35,813 | (5,841 | ) | — | 29,972 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||
Income before provision for income taxes |
2,691 | 5,841 | (101 | ) | 8,431 | |||||||||||||||||||
Provision for income taxes |
2,025 | 1,510 | (3h | ) | (26 | ) | (3j | ) | 3,509 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||
Net income |
$ | 666 | $ | 4,331 | $ | (75 | ) | $ | 4,922 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||
Net income per share—basic |
$ | 0.00 | $ | 0.03 | ||||||||||||||||||||
Net income per share—diluted |
$ | 0.00 | $ | 0.03 | ||||||||||||||||||||
Weighted average number of shares outstanding—basic |
137,232,289 | 149,940,131 | ||||||||||||||||||||||
Weighted average number of shares outstanding—diluted |
138,170,488 | 150,878,330 |
1. |
Basis of Presentation & Description of the Transactions |
Consideration |
||||
Cash, net of cash acquired |
$ | 1,556,810 | ||
Rollover management equity interests |
19,148 | |||
|
|
|||
Total fair value of consideration transferred |
$ | 1,575,958 | ||
|
|
|||
Current assets |
$ | 145,277 | ||
Property and equipment, including software developed for internal use |
236,775 | |||
Trade name |
95,000 | |||
Customer lists |
500,000 | |||
Deferred tax asset |
106,327 | |||
Other assets |
1,429 | |||
Current liabilities |
(71,496 | ) | ||
Deferred tax liability |
(198,535 | ) | ||
Other liabilities |
(6,616 | ) | ||
|
|
|||
Total identifiable net assets |
$ | 808,161 | ||
|
|
|||
Goodwill |
$ | 767,797 | ||
|
|
2. | Notes to Unaudited Pro Forma Consolidated Balance Sheet |
a) | Reflects (i) the pro forma adjustment of $2.7 million to additional paid-in capital, with an offsetting adjustment of $2.7 million to accumulated deficit related to the accelerated vesting of certain share-based compensation awards as a result of Silver Lake’s sale of common stock in this Follow-On Offering and (ii) the pro forma adjustment of $0.8 million to additional paid-in capital, with an offsetting adjustment of $0.8 million to accumulated deficit related to the accelerated vesting of certain share-based compensation awards as a result of the SLP Distribution. |
3. |
Notes to Unaudited Pro Forma Consolidated Statements of Operations |
a) | Reflects the incremental amortization expense related to certain definite-lived intangible assets, reflected in the purchase price allocation at the date of the Silver Lake Transaction, as if those certain definite-lived intangible assets were put into place on January 1, 2020. The following table shows the pro forma adjustment to estimated amortization expense for the year ended December 31, 2020 and for the nine months ended September 30, 2020: |
Description (in thousands) |
Estimated Fair Value at Silver Lake Transaction |
Estimated Useful Life |
Year Ended December 31, 2020 |
Nine Months Ended September 30, 2020 |
||||||||||||
Capitalized software for internal use |
$ | 220,000 | 5 years | $ | 57,081 | $ | 43,101 | |||||||||
Trade name |
95,000 | 20 years | 8,171 | 6,145 | ||||||||||||
Customer lists |
500,000 | 14 years | 70,807 | 53,501 | ||||||||||||
|
|
|
|
|||||||||||||
Pro forma amortization expense |
$ | 136,059 | $ | 102,747 | ||||||||||||
Less historical amortization expense recorded |
(129,935 | ) | (94,427 | ) | ||||||||||||
|
|
|
|
|||||||||||||
Pro forma adjustment for amortization expense |
$ | 6,124 | $ | 8,320 | ||||||||||||
|
|
|
|
b) | Reflects the adjustment to remove Predecessor transaction expenses related to the Silver Lake Transaction which would have been incurred and recorded during the year ended December 31, 2019 if the Silver Lake Transaction had occurred on January 1, 2020. |
c) | Reflects the adjustment to the provision for income taxes attributable to the tax impacts of the preceding Silver Lake Transaction Accounting Adjustment for amortization, assuming an effective tax rate of 25.7%. |
d) | Reflects the adjustment to interest expense resulting from (i) the elimination of interest expense related to the debt financing in place during the Predecessor period, and (ii) the incremental interest expense |
and amortization of deferred financing costs associated with the first lien term loan facility and second lien term loan facility to give effect to the Silver Lake Transaction Refinancing as if it had occurred on January 1, 2020, calculated as follows: |
Description (in thousands) |
Year Ended December 31, 2020 |
Nine Months Ended September 30, 2020 |
||||||
Interest expense on first lien term loan facility |
$ | 29,835 | $ | 23,505 | ||||
Interest expense on second lien term loan facility |
13,713 | 10,526 | ||||||
Amortization of deferred financing costs |
3,543 | 2,643 | ||||||
|
|
|
|
|||||
Pro forma interest expense |
$ | 47,091 | $ | 36,674 | ||||
Less historical interest expense recorded |
(47,832 | ) | (37,902 | ) | ||||
|
|
|
|
|||||
Pro forma adjustment for interest expense |
$ | (741 | ) | $ | (1,228 | ) | ||
|
|
|
|
e) | Reflects an adjustment to the historical loss on extinguishment of Predecessor debt for the unaudited pro forma condensed consolidated statements of operations for the year ended December 31, 2020 and for the nine months ended September 30, 2020 as if the Silver Lake Transaction Refinancing had been consummated on January 1, 2020. |
f) | Reflects the adjustment to the provision for income taxes attributable to the tax impacts of the preceding Silver Lake Transaction Refinancing Accounting Adjustments, assuming an effective tax rate of 25.7%. |
g) | Reflects the decrease in interest expense of $11.4 million, $8.9 million, and $5.8 million for the year ended December 31, 2020, for the nine months ended September 30, 2020 and for the nine months ended September 30, 2021, respectively, as well as the accelerated amortization of deferred financing costs of $6.4 million and $6.4 million for the year ended December 31, 2020 and for the nine months ended September 30, 2020, respectively, associated with the repayment of $200.0 million of outstanding first lien indebtedness using the net proceeds from the IPO and a 0.25% interest rate reduction that went into effect upon consummation of the IPO. |
h) | Reflects the adjustment to the provision for income taxes attributable to the tax impacts of the preceding IPO Adjustments, assuming an effective tax rate of 25.7% and 25.9% for 2020 and 2021, respectively. |
i) | Reflects the increase in share-based compensation expense of (i) $2.7 million, $1.9 million, and $0.0 million for the year ended December 31, 2020, for the nine months ended September 30, 2020 and the nine months ended September 30, 2021, respectively, related to the vesting of certain share-based compensation awards as a result of Silver Lake’s sale of common stock in this Follow-On Offering and (ii) $0.7 million, $0.6 million, and $0.1 million for the year ended December 31, 2020, for the nine months ended September 30, 2020 and the nine months ended September 30, 2021, respectively, related to the vesting of certain share-based compensation awards as a result of the SLP Distribution. |
j) | Reflects the adjustment to the provision for income taxes attributable to the tax impacts of the preceding Follow-On Offering and SLP Distribution Adjustments, assuming an effective tax rate of 25.7% and 25.9% for 2020 and 2021, respectively. |
4. | Unaudited Pro Forma Net (Loss) Income Per Share |
Pro forma net (loss) income per share—basic and diluted (in thousands, except share and per share amounts) |
Year Ended December 31, 2020 |
Nine Months Ended September 30, 2020 |
Nine Months Ended September 30, 2021 |
|||||||||
Numerator: |
||||||||||||
Pro forma net (loss) income—basic and diluted |
$ | (62,379 | ) | $ | (58,956 | ) | $ | 4,922 | ||||
Denominator: |
||||||||||||
Weighted average number of shares outstanding—basic (1) |
149,938,166 | 149,938,166 | 149,940,131 | |||||||||
Weighted average number of shares outstanding—diluted (1) |
149,938,166 | 149,938,166 | 150,878,330 | |||||||||
Pro forma net (loss) income per share—basic |
$ | (0.42 | ) | $ | (0.39 | ) | $ | 0.03 | ||||
Pro forma net (loss) income per share—diluted |
$ | (0.42 | ) | $ | (0.39 | ) | $ | 0.03 | ||||
|
||||||||||||
(1) Consists of the following: |
||||||||||||
Common stock issued as a result of the IPO |
22,856,250 | 22,856,250 | n/a | |||||||||
Common stock previously issued and outstanding less nonvested restricted stock |
127,081,916 | 127,081,916 | 149,940,131 | |||||||||
|
|
|
|
|
|
|||||||
Weighted average number of shares outstanding—basic |
149,938,166 | 149,938,166 | 149,940,131 | |||||||||
Options and restricted stock units to purchase units |
— | — | 938,199 | |||||||||
|
|
|
|
|
|
|||||||
Weighted average number of shares outstanding—diluted |
149,938,166 | 149,938,166 | 150,878,330 | |||||||||
|
|
|
|
|
|
• | Cost of Services |
• | Product and Technology Expense |
• | Selling, General, and Administrative Expense |
• | Depreciation and Amortizatio |
• | Interest Expense |
• | Interest Income |
• | Loss on Extinguishment of Debt |
• | Transaction Expenses, Change in Control |
Predecessor |
Successor |
Pro Forma Adjustments for the Nine Months Ended September 30, 2020 |
Pro Forma Nine Months Ended September 30, 2020 |
Pro Forma Adjustments for the Nine Months Ended September 30, 2021 |
Pro Forma Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||||||
(In thousands) |
Period from January 1 through January 31, 2020 |
Period from February 1 through September 30, 2020 |
Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||||||||
Revenues |
$ | 36,785 | $ | 315,825 | $ | 499,763 | $ | — | $ | 352,610 | $ | — | $ | 499,763 | ||||||||||||||||||||||
Operating expenses: |
||||||||||||||||||||||||||||||||||||
Cost of services (exclusive of depreciation and amortization below) |
20,265 | 156,703 | 244,964 | 44 | 177,012 | 4 | 244,968 | |||||||||||||||||||||||||||||
Product and technology expense |
3,189 | 20,495 | 33,546 | 124 | 23,808 | 17 | 33,563 | |||||||||||||||||||||||||||||
Selling, general, and administrative expense |
11,235 | 46,206 | 76,256 | 2,282 | 59,723 | 80 | 76,336 | |||||||||||||||||||||||||||||
Depreciation and amortization |
2,105 | 97,815 | 106,493 | 8,320 | 108,240 | — | 106,493 | |||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total operating expenses |
36,794 | 321,219 | 461,259 | 10,770 | 368,783 | 101 | 461,360 | |||||||||||||||||||||||||||||
(Loss) income from operations |
(9 | ) | (5,394 | ) | 38,504 | (10,770 | ) | (16,173 | ) | (101 | ) | 38,403 | ||||||||||||||||||||||||
Other expense (income) |
||||||||||||||||||||||||||||||||||||
Interest expense |
4,514 | 38,405 | 22,015 | (3,717 | ) | 39,202 | (5,841 | ) | 16,174 | |||||||||||||||||||||||||||
Interest income |
(25 | ) | (282 | ) | (140 | ) | — | (307 | ) | — | (140 | ) | ||||||||||||||||||||||||
Loss on extinguishment of debt |
10,533 | — | 13,938 | (10,533 | ) | — | — | 13,938 | ||||||||||||||||||||||||||||
Transaction expenses change in control |
22,370 | 9,423 | — | (22,370 | ) | 9,423 | — | — | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total other expense |
37,392 | 47,546 | 35,813 | (36,620 | ) | 48,318 | (5,841 | ) | 29,972 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
(Loss) income before provision for income taxes |
(37,401 | ) | (52,940 | ) | 2,691 | 25,850 | (64,491 | ) | 5,740 | 8,431 | ||||||||||||||||||||||||||
(Benefit) provision for income taxes |
(871 | ) | (11,308 | ) | 2,025 | 6,644 | (5,535 | ) | 1,484 | 3,509 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Net (loss) income |
$ | (36,530 | ) | $ | (41,632 | ) | $ | 666 | $ | 19,206 | $ | (58,956 | ) | $ | 4,256 | $ | 4,922 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Net (loss) income margin |
(99.3 | )% | (13.2 | )% | 0.1 | % | — | (16.7 | )% | — | 1.0 | % | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor |
Successor |
Pro Forma Adjustments for the Nine Months Ended September 30, 2020 |
Pro Forma Nine Months Ended September 30, 2020 |
Pro Forma Adjustments for the Nine Months Ended September 30, 2021 |
Pro Forma Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||
(in thousands) |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through September 30, 2020 |
Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||||
Revenues |
$ | 36,785 | $ | 315,825 | $ | 499,763 | $ | — | $ | 352,610 | $ | — | $ | 499,763 |
• | a net increase of $99.9 million in existing customer revenues, primarily driven by a strong, broad-based recovery in demand as compared to the second and third quarters of 2020 which were negatively impacted by the COVID-19 pandemic, increased revenue growth in key verticals and geographies, and on-going strength in upsell and cross-sell. These existing customer increases were offset by the impact of lost accounts, |
• | increased revenues of $31.4 million attributable to new customers, and |
• | revenues of $15.9 million attributable to the U.K. screening business acquisition. |
Predecessor |
Successor |
Pro Forma Adjustments for the Nine Months Ended September 30, 2020 |
Pro Forma Nine Months Ended September 30, 2020 |
Pro Forma Adjustments for the Nine Months Ended September 30, 2021 |
Pro Forma Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||
( in thousands, except percentages |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through September 30, 2020 |
Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||||
Revenues |
$ | 36,785 | $ | 315,825 | $ | 499,763 | $ | — | $ | 352,610 | $ | — | $ | 499,763 | ||||||||||||||||||
Cost of services |
20,265 | 156,703 | 244,964 | 44 | 177,012 | 4 | 244,968 | |||||||||||||||||||||||||
Cost of services as a % of revenue |
55.1 | % | 49.6 | % | 49.0 | % | — | 50.2 | % | — | 49.0 | % |
• | an increase in variable third-party data expenses of $57.4 million as a direct result of increased revenues, |
• | an $8.1 million increase in personnel related expenses in our operations and customer service functions as a result of additional operational support headcount to process and fulfill the Company’s high levels of order volume growth, particularly in the second and third quarters of 2021. This increase is further impacted by the COVID-19 related personnel and benefit expense reduction actions taken in the second and third quarters of 2020 that did not continue into 2021, |
• | foreign currency exchange losses of $0.8 million due to the impact of foreign exchange rate volatility, and |
• | a number of cost of services related operating expense increases attributable to the increased revenue volumes experienced in 2021. |
• | a $0.3 million decrease in travel-related expenses due to COVID-19 related restrictions. |
Predecessor |
Successor |
Pro Forma Adjustments for the Nine Months Ended September 30, 2020 |
Pro Forma Nine Months Ended September 30, 2020 |
Pro Forma Adjustments for the Nine Months Ended September 30, 2021 |
Pro Forma Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||
( in thousands |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through September 30, 2020 |
Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||||
Product and technology expense |
$ | 3,189 | $ | 20,495 | $ | 33,546 | $ | 124 | $ | 23,808 | $ | 17 | $ | 33,563 |
• | a $5.7 million increase in personnel-related expenses as a result of additional investments made to enhance our product, solutions, and technology platform, |
• | a $3.2 million increase in software licensing related expenses, and |
• | a $1.1 million increase in professional service fees. |
Predecessor |
Successor |
Pro Forma Adjustments for the Nine Months Ended September 30, 2020 |
Pro Forma Nine Months Ended September 30, 2020 |
Pro Forma Adjustments for the Nine Months Ended September 30, 2021 |
Pro Forma Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||
( in thousands |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through September 30, 2020 |
Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||||
Selling, general, and administrative expense |
$ | 11,235 | $ | 46,206 | $ | 76,256 | $ | 2,282 | $ | 59,723 | $ | 80 | $ | 76,336 |
• | a $6.2 million increase in professional service fees incurred related to the Company’s IPO, related readiness expenses, and insurance expenses incurred related to the Company becoming a publicly traded company, |
• | a $5.3 million increase in commissions and bonus related expenses due to the Company’s improved operating results in 2021, |
• | a $4.6 million increase in personnel related expenses primarily due to additional investments made in the Company’s Sales and Customer Success functions, additional headcount related to operating as a public company and COVID-19 related personnel and benefit expense reduction actions taken in 2020 that did not continue into 2021, |
• | a $1.9 million increase in legal expenses (see Note 12 to the condensed consolidated financial statements), and |
• | a number of other corporate expenses that increased primarily as a result of the Company now being a publicly traded company and COVID-19 related expense reductions in 2020 that did not continue into 2021. |
• | a $2.8 million decrease in stock-based compensation expenses primarily as a result of accelerated vesting related to the Silver Lake Transaction that did not reoccur in 2021 and the pro forma impact of the proposed Follow-On Offering and SLP Distribution, offset by performance related vesting as a result of the IPO and incremental awards granted in conjunction with the Company’s IPO. |
Predecessor |
Successor |
Pro Forma Adjustments for the Nine Months Ended September 30, 2020 |
Pro Forma Nine Months Ended September 30, 2020 |
Pro Forma Adjustments for the Nine Months Ended September 30, 2021 |
Pro Forma Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||
( in thousands |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through September 30, 2020 |
Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||||
Depreciation and amortization |
$ | 2,105 | $ | 97,815 | $ | 106,493 | $ | 8,320 | $ | 108,240 | $ | — | $ | 106,493 |
Predecessor |
Successor |
Pro Forma Adjustments for the Nine Months Ended September 30, 2020 |
Pro Forma Nine Months Ended September 30, 2020 |
Pro Forma Adjustments for the Nine Months Ended September 30, 2021 |
Pro Forma Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||
( in thousands ) |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through September 30, 2020 |
Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||||
Interest expense |
$ | 4,514 | $ | 38,405 | $ | 22,015 | $ | (3,717 | ) | $ | 39,202 | $ | (5,841 | ) | $ | 16,174 |
Predecessor |
Successor |
Pro Forma Adjustments for the Nine Months Ended September 30, 2020 |
Pro Forma Nine Months Ended September 30, 2020 |
Pro Forma Adjustments for the Nine Months Ended September 30, 2021 |
Pro Forma Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||
( in thousands ) |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through September 30, 2020 |
Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||||
Interest income |
$ | (25 | ) | $ | (282 | ) | $ | (140 | ) | $ | — | $ | (307 | ) | $ | — | $ | (140 | ) |
Predecessor |
Successor |
Pro Forma Adjustments for the Nine Months Ended September 30, 2020 |
Pro Forma Nine Months Ended September 30, 2020 |
Pro Forma Adjustments for the Nine Months Ended September 30, 2021 |
Pro Forma Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||
( in thousands ) |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through September 30, 2020 |
Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||||
Loss on extinguishment of debt |
$ | 10,533 | $ | — | $ | 13,938 | $ | (10,533 | ) | $ | — | $ | — | $ | 13,938 |
Predecessor |
Successor |
Pro Forma Adjustments for the Nine Months Ended September 30, 2020 |
Pro Forma Nine Months Ended September 30, 2020 |
Pro Forma Adjustments for the Nine Months Ended September 30, 2021 |
Pro Forma Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||
( in thousands ) |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through September 30, 2020 |
Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||||
Transaction expenses, change in control |
$ | 22,370 | $ | 9,423 | $ | — | $ | (22,370 | ) | $ | 9,423 | $ | — | $ | — |
Predecessor |
Successor |
Pro Forma Adjustments for the Nine Months Ended September 30, 2020 |
Pro Forma Nine Months Ended September 30, 2020 |
Pro Forma Adjustments for the Nine Months Ended September 30, 2021 |
Pro Forma Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||
( in thousands ) |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through September 30, 2020 |
Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||||
(Benefit) provision for income taxes |
$ | (871 | ) | $ | (11,308 | ) | $ | 2,025 | $ | 6,644 | $ | (5,535 | ) | $ | 1,484 | $ | 3,509 |
Predecessor |
Successor |
Pro Forma Adjustments for the Nine Month Ended September 30, 2020 |
Pro Forma Nine Month Ended September 30, 2020 |
Pro Forma Adjustments for the Nine Month Ended September 30, 2021 |
Pro Forma Nine Month Ended September 30, 2021 |
|||||||||||||||||||||||||||
( in thousands, except percentages ) |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through September 30, 2020 |
Nine Month Ended September 30, 2021 |
|||||||||||||||||||||||||||||
Net (loss) income |
$ | (36,530 | ) | $ | (41,632 | ) | $ | 666 | $ | 19,206 | $ | (58,956 | ) | $ | 4,256 | $ | 4,922 | |||||||||||||||
Net (loss) income margin |
(99.3 | )% | (13.2 | )% | 0.1 | % | — | (16.7 | )% | — | 1.0 | % |
(In thousands) |
Predecessor |
Predecessor |
Successor |
Pro Forma Adjustments for the Year Ended December 31, 2020 |
Pro Forma Twelve Months Ended December 31, 2020 |
|||||||||||||||||||
For the Year Ended December 31, 2019 |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through December 31, 2020 |
||||||||||||||||||||||
Revenues |
$ | 481,767 | $ | 36,785 | $ | 472,369 | $ | — | $ | 509,154 | ||||||||||||||
Operating expenses: |
||||||||||||||||||||||||
Cost of services (exclusive of depreciation and amortization below) |
245,324 | 20,265 | 240,287 | 61 | 260,613 | |||||||||||||||||||
Product and technology expense |
33,239 | 3,189 | 32,201 | 175 | 35,565 | |||||||||||||||||||
Selling, general, and administrative expense |
85,084 | 11,235 | 66,864 | 3,157 | 81,256 | |||||||||||||||||||
Depreciation and amortization |
25,953 | 2,105 | 135,057 | 6,124 | 143,286 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total operating expenses |
389,600 | 36,794 | 474,409 | 9,517 | 520,720 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Income (loss) from operations |
92,167 | (9 | ) | (2,040 | ) | (9,517 | ) | (11,566 | ) | |||||||||||||||
Other expense (income) |
||||||||||||||||||||||||
Interest expense |
51,964 | 4,514 | 47,914 | (5,744 | ) | 46,684 | ||||||||||||||||||
Interest income |
(945 | ) | (25 | ) | (530 | ) | — | (555 | ) | |||||||||||||||
Loss on extinguishment of debt: |
— | 10,533 | — | (10,533 | ) | — | ||||||||||||||||||
Transaction expenses change in control |
— | 22,370 | 9,423 | (22,370 | ) | 9,423 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total other expense |
51,019 | 37,392 | 56,807 | (38,647 | ) | 55,552 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Income (loss) before provision for income taxes |
41,148 | (37,401 | ) | (58,847 | ) | 29,130 | (67,118 | ) | ||||||||||||||||
Provision (benefit) for income taxes |
6,898 | (871 | ) | (11,355 | ) | 7,487 | (4,739 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net income (loss) |
$ | 34,250 | $ | (36,530 | ) | $ | (47,492 | ) | $ | 21,643 | $ | (62,379 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Net income (loss) margin |
7.1 | % | (99.3 | )% | (10.1 | )% | — | (12.3 | )% | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
Predecessor |
Predecessor |
Successor |
Pro Forma Adjustments for the Year Ended December 31, 2020 |
Pro Forma Twelve Months Ended December 31, 2020 |
||||||||||||||||||||
(in thousands) |
For the Year Ended December 31, 2019 |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through December 31, 2020 |
|||||||||||||||||||||
Revenues |
$ | 481,767 | $ | 36,785 | $ | 472,369 | $ | — | $ | 509,154 |
• | increased revenues of $44.6 million from new customers. |
• | a $17.2 million net decrease in existing customer revenue, primarily driven by reduced demand from certain customers more impacted by COVID-19 and the impact of lost accounts. These decreases were partially offset by increased revenue from certain existing customers, including ongoing strength in demand, upselling and cross-selling. |
Predecessor |
Predecessor |
Successor |
Pro Forma Adjustments for the Year Ended December 31, 2020 |
Pro Forma Twelve Months Ended December 31, 2020 |
||||||||||||||||||||
(in thousands) |
For the Year Ended December 31, 2019 |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through December 31, 2020 |
|||||||||||||||||||||
Revenues |
$ | 481,767 | $ | 36,785 | $ | 472,369 | $ | — | $ | 509,154 | ||||||||||||||
Cost of services |
245,324 | 20,265 | 240,287 | 61 | 260,613 | |||||||||||||||||||
Cost of services as a % of revenue |
50.9 | % | 55.1 | % | 50.9 | % | — | 51.2 | % |
• | an increase in variable third-party data expenses of $23.2 million as a direct result of the increased revenues. |
• | a $6.0 million decrease in personnel related expenses in our operations and customer service functions as a result of our continued investment in robotics process automation and productivity efficiencies, and |
• | a $1.7 million decrease in travel-related expenses due to COVID-19 related restrictions |
Predecessor |
Predecessor |
Successor |
Pro Forma Adjustments for the Year Ended December 31, 2020 |
Pro Forma Twelve Months Ended December 31, 2020 |
||||||||||||||||||||
(in thousands) |
For the Year Ended December 31, 2019 |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through December 31, 2020 |
|||||||||||||||||||||
Product and technology expense |
$ | 33,239 | $ | 3,189 | $ | 32,201 | $ | 175 | $ | 35,565 |
• | a $1.7 million increase in personnel-related expenses as a result of additional investments made to enhance our product, solutions and technology platform, and |
• | an increase in software licensing expenses. |
Predecessor |
Predecessor |
Successor |
Pro Forma Adjustments for the Year Ended December 31, 2020 |
Pro Forma Twelve Months Ended December 31, 2020 |
||||||||||||||||||||
(in thousands) |
For the Year Ended December 31, 2019 |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through December 31, 2020 |
|||||||||||||||||||||
Selling, general, and administrative expense |
$ | 85,084 | $ | 11,235 | $ | 66,864 | $ | 3,157 | $ | 81,256 |
• | a $4.5 million reduction in travel and marketing related expenses as a result of COVID-19 related restrictions, |
• | a $3.4 million decrease in legal expenses (see Note 13 to the consolidated financial statements included elsewhere in this prospectus), and |
• | decreases in various other expenses primarily related to COVID-19 cost saving measures. The decrease in selling, general, and administrative expense was partially offset by: |
• | a $7.7 million increase in stock-based compensation expenses primarily the result of accelerated vesting related to the Silver Lake Transaction and the pro forma impact of the proposed Follow-On Offering and the SLP Distribution. |
Predecessor |
Predecessor |
Successor |
Pro Forma Adjustments for the Year Ended December 31, 2020 |
Pro Forma Twelve Months Ended December 31, 2020 |
||||||||||||||||||||
(in thousands) |
For the Year Ended December 31, 2019 |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through December 31, 2020 |
|||||||||||||||||||||
Depreciation and amortization |
$ | 25,953 | $ | 2,105 | $ | 135,057 | $ | 6,124 | $ | 143,286 |
Predecessor |
Predecessor |
Successor |
Pro Forma Adjustments for the Year Ended December 31, 2020 |
Pro Forma Twelve Months Ended December 31, 2020 |
||||||||||||||||||||
(in thousands) |
For the Year Ended December 31, 2019 |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through December 31, 2020 |
|||||||||||||||||||||
Interest expense |
$ | 51,964 | $ | 4,514 | $ | 47,914 | $ | (5,744 | ) | $ | 46,684 |
Predecessor |
Predecessor |
Successor |
Pro Forma Adjustments for the Year Ended December 31, 2020 |
Pro Forma Twelve Months Ended December 31, 2020 |
||||||||||||||||||||
(in thousands) |
For the Year Ended December 31, 2019 |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through December 31, 2020 |
|||||||||||||||||||||
Interest income |
$ | (945 | ) | $ | (25 | ) | $ | (530 | ) | $ | — | $ | (555 | ) |
Predecessor |
Predecessor |
Successor |
Pro Forma Adjustments for the Year Ended December 31, 2020 |
Pro Forma Twelve Months Ended December 31, 2020 |
||||||||||||||||||||
(in thousands) |
For the Year Ended December 31, 2019 |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through December 31, 2020 |
|||||||||||||||||||||
Loss on extinguishment of debt |
$ | — | $ | 10,533 | $ | — | $ | (10,533 | ) | $ | — |
Predecessor |
Predecessor |
Successor |
Pro Forma Adjustments for the Year Ended December 31, 2020 |
Pro Forma Twelve Months Ended December 31, 2020 |
||||||||||||||||||||
(in thousands) |
For the Year Ended December 31, 2019 |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through December 31, 2020 |
|||||||||||||||||||||
Transaction expenses, change in control |
$ | — | $ | 22,370 | $ | 9,423 | $ | (22,370 | ) | $ | 9,423 |
Predecessor |
Predecessor |
Successor |
Pro Forma Adjustments for the Year Ended December 31, 2020 |
Pro Forma Twelve Months Ended December 31, 2020 |
||||||||||||||||||||
(in thousands) |
For the Year Ended December 31, 2019 |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through December 31, 2020 |
|||||||||||||||||||||
Provision (benefit) for income taxes |
$ | 6,898 | $ | (871 | ) | $ | (11,355 | ) | $ | 7,487 | $ | (4,739 | ) |
Predecessor |
Predecessor |
Successor |
Pro Forma Adjustments for the Year Ended December 31, 2020 |
Pro Forma Twelve Months Ended December 31, 2020 |
||||||||||||||||||||
(in thousands) |
For the Year Ended December 31, 2019 |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through December 31, 2020 |
|||||||||||||||||||||
Net income (loss) |
$ | 34,250 | $ | (36,530 | ) | $ | (47,492 | ) | $ | 21,643 | $ | (62,379 | ) | |||||||||||
Net income (loss) margin |
7.1 | % | (99.3 | )% | (10.1 | )% | — | (12.3 | )% |
Predecessor |
Successor |
Pro Forma Adjustments for the Nine Months Ended September 30, 2020 |
Pro Forma Nine Months Ended September 30, 2020 |
Pro Forma Adjustments for the Nine Months Ended September 30, 2021 |
Pro Forma Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||
(In thousands) |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through September 30, 2020 |
Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||||
Net (loss) income |
$ | (36,530 | ) | $ | (41,632 | ) | $ | 666 | $ | 19,206 | $ | (58,956 | ) | $ | 4,256 | $ | 4,922 | |||||||||||||||
Interest expense, net |
4,489 | 38,123 | 21,875 | (3,717 | ) | |
38,895 |
|
|
(5,841 |
) |
|
16,034 |
| ||||||||||||||||||
(Benefit) provision for income taxes |
(871 | ) | (11,308 | ) | 2,025 | 6,644 | (5,535 | ) | 1,484 | 3,509 | ||||||||||||||||||||||
Depreciation and amortization |
2,105 | 97,815 | 106,493 | 8,320 | 108,240 | — | 106,493 | |||||||||||||||||||||||||
Loss on extinguishment of debt |
10,533 | — | 13,938 | (10,533 | ) | — | — | 13,938 | ||||||||||||||||||||||||
Share-based compensation |
3,976 | 1,331 | 4,569 | 2,450 | 7,757 | 101 | 4,670 | |||||||||||||||||||||||||
Transaction and acquisition-related charges (a) |
22,840 | 9,578 | 6,510 | (22,370 | ) | 10,048 | — | 6,510 | ||||||||||||||||||||||||
Integration and restructuring charges (b) |
327 | 288 | 584 | — | 615 | — | 584 | |||||||||||||||||||||||||
Other (c) |
153 | 936 | 196 | — | 1,089 | — | 196 | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Adjusted EBITDA |
$ |
7,022 |
$ |
95,131 |
$ |
156,856 |
$ |
— |
$ |
102,153 |
$ |
— |
$ |
156,856 |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor |
Successor |
Pro Forma Adjustments for the Year Ended December 31, 2020 |
Pro Forma Twelve Months Ended December 31, 2020 |
|||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||
(In thousands) |
Year Ended December 31, 2019 |
Period from January 1 through January 31, 2020 |
Period from February 1 through December 31, 2020 |
|||||||||||||||||||||
Net income (loss) |
$ | 34,250 | $ | (36,530 | ) | $ | (47,492 | ) | $ | 21,643 | $ | (62,379 | ) | |||||||||||
Interest expense, net |
51,019 | 4,489 | 47,384 | (5,744 | ) | 46,129 | ||||||||||||||||||
Provision (benefit) for income taxes |
6,898 | (871 | ) | (11,355 | ) | 7,487 | (4,739 | ) | ||||||||||||||||
Depreciation and amortization |
25,953 | 2,105 | 135,057 | 6,124 | 143,286 | |||||||||||||||||||
Loss on extinguishment of debt |
— | 10,533 | — | (10,533 | ) | — | ||||||||||||||||||
Share-based compensation |
1,216 | 3,976 | 1,876 | 3,393 | 9,245 | |||||||||||||||||||
Transaction and acquisition-related charges (a) |
1,198 | 22,840 | 10,146 | (22,370 | ) | 10,616 | ||||||||||||||||||
Integration and restructuring charges (b) |
— | 327 | 3,413 | — | 3,740 | |||||||||||||||||||
Other (c) |
3,239 | 153 | 747 | 900 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Adjusted EBITDA |
$ |
123,773 |
$ |
7,022 |
$ |
139,776 |
$ |
— |
$ |
146,798 |
||||||||||||||
|
|
|
|
|
|
|
|
|
|
(a) | Represents charges incurred related to acquisitions and similar transactions, primarily consisting of change in control-related costs, professional service fees, and other third-party costs. Additionally, the nine months ended September 30, 2021 includes incremental professional service fees incurred related to the IPO. |
(b) | Represents charges from organizational restructuring and integration activities outside of the ordinary course of business. |
(c) | Represents non-cash and other charges primarily related to legal exposures inherited from legacy acquisitions, foreign currency (gains) losses, and (gains) losses on the sale of assets. Additionally, the period from February 1, 2020 through December 31, 2020 (Successor) includes the incremental costs incurred due to COVID-19. |
Predecessor |
Successor |
Pro Forma Adjustments for the Nine Months Ended September 30, 2020 |
Pro Forma Nine Months Ended September 30, 2020 |
Pro Forma Adjustments for the Nine Months Ended September 30, 2021 |
Pro Forma Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||
( in thousands ) |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through September 30, 2020 |
Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||||
Adjusted EBITDA |
$ | 7,022 | $ | 95,131 | $ | 156,856 | $ | — | $ | 102,153 | $ | — | $ | 156,856 | ||||||||||||||||||
Revenues |
36,785 | 315,825 | 499,763 | — | 352,610 | — | 499,763 | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Adjusted EBITDA Margin |
19 |
% |
30 |
% |
31 |
% |
— |
29 |
% |
— |
31 |
% | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor |
Successor |
|||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||
( In thousands ) |
Year Ended December 31, 2019 |
Period from January 1 through January 31, 2020 |
Period from February 1 through December 31, 2020 |
Pro Forma Adjustments for the Year Ended December 31, 2020 |
Pro Forma Twelve Months Ended December 31, 2020 |
|||||||||||||||||||
Adjusted EBITDA |
$ | 123,773 | $ | 7,022 | $ | 139,776 | $ | — | $ | 146,798 | ||||||||||||||
Total Revenues |
481,767 | 36,785 | 472,369 | — | 509,154 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Adjusted EBITDA Margin |
26 |
% |
19 |
% |
30 |
% |
— |
29 |
% | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
Predecessor |
Successor |
Pro Forma Adjustments for the Nine Months Ended September 30, 2020 |
Pro Forma Nine Months Ended September 30, 2020 |
Pro Forma Adjustments for the Nine Months Ended September 30, 2021 |
Pro Forma Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||||||
(in thousands) |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through September 30, 2020 |
Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||||||||
Net (loss) income |
$ | (36,530 | ) | $ | (41,632 | ) | $ | 666 | $ | 19,206 | $ | (58,956 | ) | $ | 4,256 | $ | 4,922 | |||||||||||||||||||
(Benefit) provision for income taxes |
(871 | ) | (11,308 | ) | 2,025 | 6,644 | (5,535 | ) | 1,484 | 3,509 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
(Loss) income before provision for income taxes |
(37,401 | ) | (52,940 | ) | 2,691 | 25,850 | (64,491 | ) | 5,740 | 8,431 | ||||||||||||||||||||||||||
Debt-related costs (a) |
11,102 | 2,344 | 19,703 | (4,952 | ) | 8,494 | (593 | ) | 19,110 | |||||||||||||||||||||||||||
Acquisition-related depreciation and amortization (b) |
848 | 91,149 | 95,047 | 8,320 | 100,317 | — | 95,047 | |||||||||||||||||||||||||||||
Share-based compensation |
3,976 | 1,331 | 4,569 | 2,450 | 7,757 | 101 | 4,670 | |||||||||||||||||||||||||||||
Transaction and acquisition-related charges (c) |
22,840 | 9,578 | 6,510 | (22,370 | ) | 10,048 | — | 6,510 | ||||||||||||||||||||||||||||
Integration and restructuring charges (d) |
327 | 288 | 584 | — | 615 | — | 584 | |||||||||||||||||||||||||||||
Other (e) |
153 | 936 | 196 | — | 1,089 | — | 196 | |||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Adjusted net income before income tax effect |
1,845 | 52,686 | 129,300 | 9,298 | 63,829 | 5,248 | 134,548 | |||||||||||||||||||||||||||||
Less: Income tax effect (f) |
474 | 13,540 | 33,431 | 2,390 | 16,404 | 1,357 | 34,781 | |||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Adjusted Net Income |
$ |
1,371 |
$ |
39,146 |
$ |
95,869 |
$ |
6,908 |
$ |
47,425 |
$ |
3,891 |
$ |
99,767 |
||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor |
Successor |
Pro Forma Adjustments for the Year Ended December 31, 2020 |
Pro Forma Twelve Months Ended December 31, 2020 |
|||||||||||||||||||||
Year Ended December 31, 2019 |
Period from January 1 through January 31, 2020 |
Period from February 1 through December 31, 2020 |
||||||||||||||||||||||
( In thousands |
||||||||||||||||||||||||
Net income (loss) |
$ | 34,250 | $ | (36,530 | ) | $ | (47,492 | ) | $ | 21,643 | $ | (62,379 | ) | |||||||||||
Provision for income taxes |
6,898 | (871 | ) | (11,355 | ) | 7,487 | (4,739 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Income (loss) before provision for income taxes |
41,148 | (37,401 | ) | (58,847 | ) | 29,130 | (67,118 | ) | ||||||||||||||||
Debt-related costs (a) |
3,174 | 11,102 | 3,242 | (5,150 | ) | 9,194 | ||||||||||||||||||
Acquisition-related depreciation and amortization (b) |
11,074 | 848 | 125,419 | 6,124 | 132,391 | |||||||||||||||||||
Share-based compensation |
1,216 | 3,976 | 1,876 | 3,393 | 9,245 | |||||||||||||||||||
Transaction and acquisition-related charges (c) |
1,198 | 22,840 | 10,146 | (22,370 | ) | 10,616 | ||||||||||||||||||
Integration and restructuring charges (d) |
— | 327 | 3,413 | — | 3,740 | |||||||||||||||||||
Other (e) |
3,239 | 153 | 747 | — | 900 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Adjusted net income before income tax effect |
61,049 | 1,845 | 85,996 | 11,127 | 98,968 | |||||||||||||||||||
Less: Income tax effect (f) |
16,117 | 474 | 22,101 | 2,860 | 25,435 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Adjusted Net Income |
$ |
44,932 |
$ |
1,371 |
$ |
63,895 |
$ |
8,267 |
$ |
73,533 |
||||||||||||||
|
|
|
|
|
|
|
|
|
|
(a) | Represents the loss on extinguishment of debt and non-cash interest expense related to the amortization of debt issuance costs for the financing for the Silver Lake Transaction. |
(b) | Represents the depreciation and amortization expense related to intangible assets and developed technology assets recorded due to the application of ASC 805, Business Combinations |
(c) | Represents charges incurred related to acquisitions and similar transactions, primarily consisting of change in control-related costs, professional service fees, and other third-party costs. Additionally, the nine months ended September 30, 2021 includes incremental professional service fees incurred related to the IPO. |
(d) | Represents charges from organizational restructuring and integration activities outside of the ordinary course of business. |
(e) | Represents non-cash and other charges primarily related to legal exposures inherited from legacy acquisitions, foreign currency (gains) losses, and (gains) losses on the sale of assets. |
(f) | Effective tax rates of 26.4%, 25.7%, and 25.9% have been used to compute Adjusted Net Income for the 2019, 2020, and 2021 periods, respectively. As of December 31, 2020, we had net operating loss carryforwards of approximately $197.6 million, $166.2 million, and $36.0 million for federal, state and foreign income tax purposes, respectively, available to reduce future income subject to income taxes. As a result, the amount of actual cash taxes we pay for federal, state and foreign income taxes differs significantly from the effective income tax rate computed in accordance with GAAP, and from the normalized rate shown above. |
Predecessor |
Successor |
Pro Forma Adjustments for the Nine Months Ended September 30, 2020 |
Pro Forma Nine Months Ended September 30, 2020 |
Pro Forma Adjustments for the Nine Months Ended September 30, 2021 |
Pro Forma Nine Months Ended September 30, 2021 |
|||||||||||||||||||||||||||||||
Period from January 1 through January 31, 2020 |
Period from February 1, 2020 through September 30, 2020 |
Nine Months Ended September 30, 2021 |
||||||||||||||||||||||||||||||||||
Diluted net (loss) income per share (GAAP) |
$ | (0.24 | ) | $ | (0.32 | ) | $ | 0.00 | $ | 0.13 | $ | (0.39 | ) | $ | 0.03 | $ | 0.03 | |||||||||||||||||||
Adjusted Net Income adjustments per share |
||||||||||||||||||||||||||||||||||||
Income taxes |
(0.01 | ) | (0.09 | ) | 0.01 | 0.04 | (0.04 | ) | 0.01 | 0.02 | ||||||||||||||||||||||||||
Debt-related costs (a) |
0.07 | 0.02 | 0.14 | (0.03 | ) | 0.06 | (0.00 | ) | 0.13 | |||||||||||||||||||||||||||
Acquisition-related depreciation and amortization (b) |
0.01 | 0.70 | 0.69 | 0.06 | 0.67 | — | 0.63 | |||||||||||||||||||||||||||||
Share-based compensation |
0.03 | 0.01 | 0.03 | 0.02 | 0.05 | 0.00 | 0.03 | |||||||||||||||||||||||||||||
Transaction and acquisition related charges (c) |
0.15 | 0.07 | 0.05 | (0.15 | ) | 0.07 | — | 0.04 | ||||||||||||||||||||||||||||
Integration and restructuring charges (d) |
0.00 | 0.00 | 0.00 | — | 0.00 | — | 0.00 | |||||||||||||||||||||||||||||
Other (e) |
0.00 | 0.01 | 0.00 | — | 0.01 | — | 0.00 | |||||||||||||||||||||||||||||
Adjusted income tax effect (f) |
(0.00 | ) | (0.10 | ) | (0.24 | ) | (0.02 | ) | (0.11 | ) | (0.01 | ) | (0.23 | ) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Adjusted Diluted Earnings Per Share (Non-GAAP) |
$ | 0.01 | $ | 0.30 | $ | 0.69 | $ | 0.05 | $ | 0.32 | $ | 0.03 | $ | 0.66 | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Weighted average number of shares outstanding used in computation of Adjusted Diluted Earnings Per Share: |
||||||||||||||||||||||||||||||||||||
Weighted average number of shares outstanding—diluted (GAAP) |
149,686,460 | 130,000,000 | 138,170,488 | 149,938,166 | 149,938,166 | 150,878,330 | 150,878,330 | |||||||||||||||||||||||||||||
Options and restricted stock not included in weighted average number of shares outstanding—diluted (GAAP) (using treasury stock method) |
— | — | — | — | — | — | — | |||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Adjusted weighted average number of shares outstanding—diluted (Non-GAAP) |
149,686,460 | 130,000,000 | 138,170,488 | 149,938,166 | 149,938,166 | 150,878,330 | 150,878,330 | |||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor |
Successor |
Pro Forma Adjustments for the Year Ended December 31, 2020, |
Pro Forma Twelve Months Ended December 31, 2020 |
|||||||||||||||||||||
Year Ended December 31, 2019 |
Period from January 1 through January 31, 2020 |
Period from February 1 through December 31, 2020 |
||||||||||||||||||||||
Diluted net income (loss) per share (GAAP) |
$ | 0.21 | $ | (0.24 | ) | $ | (0.37 | ) | $ | 0.14 | $ | (0.42 | ) | |||||||||||
Adjusted Net Income adjustments per share |
||||||||||||||||||||||||
Income taxes |
0.04 |
(0.01 |
) |
(0.09 |
) |
0.05 |
(0.03 |
) | ||||||||||||||||
Debt-related costs (a) |
0.02 | 0.07 | 0.02 | (0.03 | ) | 0.06 | ||||||||||||||||||
Acquisition-related depreciation and amortization (b) |
0.07 | 0.01 | 0.96 | 0.04 | 0.88 | |||||||||||||||||||
Share-based compensation |
0.01 |
0.03 |
0.01 |
0.02 |
0.06 |
|||||||||||||||||||
Transaction and acquisition related charges (c) |
0.01 | 0.15 | 0.08 | (0.15 | ) | 0.07 | ||||||||||||||||||
Integration and restructuring charges (d) |
— | 0.00 | 0.03 | — | 0.02 | |||||||||||||||||||
Other (e) |
0.02 | 0.00 | 0.01 | — | 0.01 | |||||||||||||||||||
Adjusted income tax effect (f) |
(0.10 | ) | (0.00 | ) | (0.17 | ) | (0.02 | ) | (0.17 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Adjusted Diluted Earnings Per Share (Non-GAAP) |
$ | 0.27 | $ | 0.01 | $ | 0.49 | $ | 0.06 | $ | 0.49 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Weighted average number of shares outstanding used in computation of Adjusted Diluted Earnings Per Share: |
||||||||||||||||||||||||
Weighted average number of shares outstanding—diluted (GAAP) |
163,879,766 | 149,686,460 | 130,000,000 | 149,938,166 | 149,938,166 | |||||||||||||||||||
Options and restricted stock not included in weighted average number of shares outstanding—diluted (GAAP) (using treasury stock method) |
— | — | — | — | — | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Adjusted weighted average number of shares outstanding—diluted (Non-GAAP) |
163,879,766 | 149,686,460 | 130,000,000 | 149,938,166 | 149,938,166 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
(a) | Represents the loss on extinguishment of debt and non-cash interest expense related to the amortization of debt issuance costs for the financing for the Silver Lake Transaction. |
(b) | Represents the depreciation and amortization expense related to intangible assets and developed technology assets recorded due to the application of ASC 805, Business Combinations |
(c) | Represents charges incurred related to acquisitions and similar transactions, primarily consisting of change in control-related costs, professional service fees, and other third-party costs. Additionally, the nine months ended September 30, 2021 includes incremental professional service fees incurred related to the IPO. |
(d) | Represents charges from organizational restructuring and integration activities outside of the ordinary course of business. |
(e) | Represents non-cash and other charges primarily related to legal exposures inherited from legacy acquisitions, foreign currency (gains) losses, and (gains) losses on the sale of assets. |
(f) | Effective tax rates of 26.4%, 25.7%, and 25.9% have been used to compute Adjusted Diluted Earnings Per Share for the 2019, 2020, and 2021 periods, respectively. As of December 31, 2020, we had net operating loss carryforwards of approximately $197.6 million, $166.2 million, and $36.0 million for federal, state and foreign income tax purposes, respectively, available to reduce future income subject to income taxes. As a result, the amount of actual cash taxes we pay for federal, state and foreign income taxes differs significantly from the effective income tax rate computed in accordance with GAAP, and from the normalized rate shown above. |
Predecessor |
Successor |
|||||||||||||||||||||||||||||||||||||||||||||||||||
For the Quarters Ended |
Period Ended |
Period Ended |
For the Quarters Ended |
|||||||||||||||||||||||||||||||||||||||||||||||||
Mar. 31, 2019 |
Jun. 30, 2019 |
Sep. 30, 2019 |
Dec. 31, 2019 |
Jan. 31, 2020 |
Mar. 31, 2020 |
Jun. 30, 2020 |
Sep. 30, 2020 |
Dec. 31, 2020 |
Mar. 31, 2021 |
June 30, 2021 |
Sep. 30, 2021 |
|||||||||||||||||||||||||||||||||||||||||
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
Q3 |
|||||||||||||||||||||||||||||||||||||||||
(In thousands) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenues |
$ | 109,687 | $ | 121,621 | $ | 123,769 | $ | 126,690 | $ | 36,785 | $ | 74,054 | $ | 104,993 | $ | 136,778 | $ | 156,544 | $ | 132,070 | $ | 174,826 | $ | 192,867 | ||||||||||||||||||||||||||||
Operating expenses |
92,566 | 95,888 | 97,252 | 103,894 | 36,794 | 78,535 | 111,195 | 131,489 | 153,190 | 135,239 | $ | 157,541 | 168,479 | |||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Income (loss) from operations |
17,121 | 25,733 | 26,517 | 22,796 | (9 | ) | (4,481 | ) | (6,202 | ) | 5,289 | 3,354 | (3,169 | ) | 17,285 | 24,388 | ||||||||||||||||||||||||||||||||||||
Other expense (income) |
13,023 | 12,829 | 12,758 | 12,409 | 37,392 | 22,253 | 13,663 | 11,630 | 9,261 | 20,655 | 10,452 | 4,706 | ||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Income (loss) before provision for income taxes |
4,098 | 12,904 | 13,759 | 10,387 | (37,401 | ) | (26,734 | ) | (19,865 | ) | (6,341 | ) | (5,907 | ) | (23,824 | ) | 6,833 | 19,682 | ||||||||||||||||||||||||||||||||||
Provision (benefit) for income taxes |
902 | 2,184 | 2,172 | 1,640 | (871 | ) | (4,920 | ) | (3,499 | ) | (2,889 | ) | (47 | ) | (4,435 | ) | 3,063 | 3,397 | ||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Net income (loss) |
$ | 3,196 | $ | 10,720 | $ | 11,587 | $ | 8,747 | $ | (36,530 | ) | $ | (21,814 | ) | $ | (16,366 | ) | $ | (3,452 | ) | $ | (5,860 | ) | $ | (19,389 | ) | $ | 3,770 | $ | 16,285 | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Net cash provided by (used in) operating activities |
$ | 16,776 | $ | 17,144 | $ | 13,055 | $ | 24,608 | $ | (19,216 | ) | $ | 1,698 | $ | 21,711 | $ | 14,217 | $ | 35,225 | $ | 23,713 | $ | 32,385 | $ | 27,762 |
Predecessor |
Successor |
|||||||||||||||||||||||||||||||||||||||||||||||||||
For the Quarters Ended |
Period Ended |
Period Ended |
For the Quarters Ended |
|||||||||||||||||||||||||||||||||||||||||||||||||
Mar. 31, 2019 |
Jun. 30, 2019 |
Sep. 30, 2019 |
Dec. 31, 2019 |
Jan. 31, 2020 |
Mar. 31, 2020 |
Jun. 30, 2020 |
Sep. 30, 2020 |
Dec. 31, 2020 |
Mar. 31, 2021 |
June 30, 2021 |
Sep. 30, 2021 |
|||||||||||||||||||||||||||||||||||||||||
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
Q3 |
|||||||||||||||||||||||||||||||||||||||||
(In thousands) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) |
$ | 3,196 | $ | 10,720 | $ | 11,587 | $ | 8,747 | $ | (36,530 | ) | $ | (21,814 | ) | $ | (16,366 | ) | $ | (3,452 | ) | $ | (5,860 | ) | $ | (19,389 | ) | $ | 3,770 | $ | 16,285 | ||||||||||||||||||||||
Interest expense, net |
13,023 | 12,829 | 12,757 | 12,410 | 4,489 | 12,830 | 13,663 | 11,630 | 9,261 | 6,717 | 10,452 | 4,706 | ||||||||||||||||||||||||||||||||||||||||
Provision (benefit) for income taxes |
902 | 2,184 | 2,172 | 1,640 | (871 | ) | (4,920 | ) | (3,499 | ) | (2,889 | ) | (47 | ) | (4,435 | ) | 3,063 | 3,397 | ||||||||||||||||||||||||||||||||||
Depreciation and amortization |
6,268 | 6,545 | 6,552 | 6,588 | 2,105 | 24,487 | 36,572 | 36,756 | 37,242 | 34,763 | 35,918 | 35,812 | ||||||||||||||||||||||||||||||||||||||||
Loss on extinguishment of debt |
— | — | — | — | 10,533 | — | — | — | — | 13,938 | — | — | ||||||||||||||||||||||||||||||||||||||||
Share-based compensation |
354 | 324 | 274 | 264 | 3,976 | 281 | 520 | 530 | 545 | 562 | 2,664 | 1,343 | ||||||||||||||||||||||||||||||||||||||||
Transaction and acquisition-related charges (a) |
— | — | 349 | 849 | 22,840 | 9,446 | 76 | 56 | 568 | 3,984 | 382 | 2,144 | ||||||||||||||||||||||||||||||||||||||||
Integration and restructuring charges (b) |
— | — | — | — | 327 | — | 262 | 26 | 3,125 | 448 | 73 | 63 | ||||||||||||||||||||||||||||||||||||||||
Other (c) |
1,349 | 760 | (200 | ) | 1,330 | 153 | (121 | ) | 427 | 630 | (189 | ) | 2 | — | 194 | |||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Adjusted EBITDA |
$ | 25,092 | $ | 33,362 | $ | 33,491 | $ | 31,828 | $ | 7,022 | $ | 20,189 | $ | 31,655 | $ | 43,287 | $ | 44,645 | $ | 36,590 | $ | 56,322 | $ | 63,944 | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Represents charges incurred related to acquisitions and similar transactions, primarily consisting of change in control-related costs, professional service fees, and other third-party costs. Additionally, the nine months ended September 30, 2021 includes incremental professional service fees incurred related to the IPO. |
(b) | Represents charges from organizational restructuring and integration activities outside of the ordinary course of business. |
(c) | Represents non-cash and other charges primarily related to legal exposures inherited from legacy acquisitions, foreign currency (gains) losses, and (gains) losses on the sale of assets. |
Predecessor |
Successor |
|||||||||||||||||||||||||||||||||||||||||||||||||||
For the Quarters Ended |
Period Ended |
Period Ended |
For the Quarters Ended |
|||||||||||||||||||||||||||||||||||||||||||||||||
Mar. 31, 2019 |
Jun. 30, 2019 |
Sep. 30, 2019 |
Dec. 31, 2019 |
Jan. 31, 2020 |
Mar. 31, 2020 |
Jun. 30, 2020 |
Sep. 30, 2020 |
Dec. 31, 2020 |
Mar. 31, 2021 |
June 30, 2021 |
Sep. 30, 2021 |
|||||||||||||||||||||||||||||||||||||||||
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
Q3 |
|||||||||||||||||||||||||||||||||||||||||
(In thousands) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) |
$ | 3,196 | $ | 10,720 | $ | 11,587 | $ | 8,747 | $ | (36,530 | ) | $ | (21,814 | ) | $ | (16,366 | ) | $ | (3,452 | ) | $ | (5,860 | ) | $ | (19,389 | ) | $ | 3,770 | $ | 16,285 | ||||||||||||||||||||||
Provision (benefit) for income taxes |
902 | 2,184 | 2,172 | 1,640 | (871 | ) | (4,920 | ) | (3,499 | ) | (2,889 | ) | (47 | ) | (4,435 | ) | 3,063 | 3,397 | ||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Income (loss) before provision for income taxes |
4,098 | 12,904 | 13,759 | 10,387 | (37,401 | ) | (26,734 | ) | (19,865 | ) | (6,341 | ) | (5,907 | ) | (23,824 | ) | 6,833 | 19,682 | ||||||||||||||||||||||||||||||||||
Adjustments: |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt-related costs (a) |
768 | 785 | 802 | 819 | 11,102 | 578 | 877 | 889 | 898 | 14,911 | 4,355 | 437 | ||||||||||||||||||||||||||||||||||||||||
Acquisition-related depreciation and amortization (b) |
2,758 | 2,800 | 2,758 | 2,758 | 848 | 22,791 | 34,135 | 34,223 | 34,270 | 31,512 | 31,786 | 31,749 | ||||||||||||||||||||||||||||||||||||||||
Share-based compensation |
354 | 324 | 274 | 264 | 3,976 | 281 | 520 | 530 | 545 | 562 | 2,664 | 1,343 | ||||||||||||||||||||||||||||||||||||||||
Transaction and acquisition related charges (c) |
— | — | 349 | 849 | 22,840 | 9,446 | 76 | 56 | 568 | 3,984 | 382 | 2,144 | ||||||||||||||||||||||||||||||||||||||||
Integration and restructuring charges (d) |
— | — | — | — | 327 | — | 262 | 26 | 3,125 | 448 | 73 | 63 | ||||||||||||||||||||||||||||||||||||||||
Other (e) |
1,349 | 760 | (200 | ) | 1,330 | 153 | (121 | ) | 427 | 630 | (189 | ) | 2 | — | 194 | |||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Adjusted net income before income tax effect |
9,327 | 17,573 | 17,742 | 16,407 | 1,845 | 6,241 | 16,432 | 30,013 | 33,310 | 27,595 | 46,093 | 55,612 | ||||||||||||||||||||||||||||||||||||||||
Less: Income tax effect (f) |
2,462 | 4,639 | 4,684 | 4,332 | 474 | 1,604 | 4,223 | 7,713 | 8,561 | 7,092 | 12,896 | 13,443 | ||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Adjusted Net Income |
$ | 6,865 | $ | 12,934 | $ | 13,058 | $ | 12,075 | $ | 1,371 | $ | 4,637 | $ | 12,209 | $ | 22,300 | $ | 24,749 | $ | 20,503 | $ | 33,197 | $ | 42,169 | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Represents the loss on extinguishment of debt and non-cash interest expense related to the amortization of debt issuance costs for the financing for the Silver Lake Transaction. |
(b) | Represents the depreciation and amortization expense related to intangible assets and developed technology assets recorded due to the application of ASC 805, Business Combinations |
(c) | Represents charges incurred related to acquisitions and similar transactions, primarily consisting of change in control-related costs, professional service fees, and other third-party costs. Additionally, the nine months ended September 30, 2021 includes incremental professional service fees incurred related to the IPO. |
(d) | Represents charges from organizational restructuring and integration activities outside of the ordinary course of business. |
(e) | Represents non-cash and other charges primarily related to legal exposures inherited from legacy acquisitions, foreign currency (gains) losses, and (gains) losses on the sale of assets. |
(f) | Effective tax rates of 26.4%, 25.7%, 25.7%, 28.0%, and 24.2% have been used to compute Adjusted Net Income for the 2019 periods, the 2020 periods, the three months ended March 31, 2021, the three months ended June 30, 2021, and the three months ended September 30, 2021, respectively. As of December 31, 2020, we had net operating loss carryforwards of approximately $197.6 million, $166.2 million, and $36.0 million for federal, state, and foreign income tax purposes, respectively, available to reduce future income subject to income taxes. As a result, the amount of actual cash taxes we pay for federal, state, and foreign income taxes differs significantly from the effective income tax rate computed in accordance with GAAP, and from the normalized rate shown above. |
Predecessor |
Successor |
|||||||||||||||
(in thousands) |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through September 30, 2020 |
Nine Months Ended September 30, 2021 |
|||||||||||||
Net cash (used in) provided by operating activities |
$ | (19,216 | ) | $ | 37,626 | $ | 83,860 | |||||||||
Net cash used in investing activities |
(2,043 | ) | (10,798 | ) | (24,992 | ) | ||||||||||
Net cash (used in) provided by financing activities |
(11,122 | ) | 50,356 | 64,372 |
Predecessor |
Successor |
|||||||||||||||
(in thousands) |
For the Year Ended December 31, 2019 |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through December 31, 2020 |
|||||||||||||
Net cash provided (used in) by operating activities |
$ | 71,583 | $ | (19,216) | $ | 72,851 | ||||||||||
Net cash used in investing activities |
(17,789 | ) | (2,043 | ) | (15,569 | ) | ||||||||||
Net cash (used in) provided by financing activities |
(3,176 | ) | (11,122 | ) | 46,404 |
(in thousands) |
2021 | 2022 | 2023 | 2024 | 2025 | Thereafter | Total | |||||||||||||||||||||
Debt principal (1) |
$ | 6,700 | $ | 6,700 | $ | 6,700 | $ | 6,700 | $ | 6,700 | $ | 778,150 | $ | 811,650 | ||||||||||||||
Interest payments (1) |
38,095 | 37,528 | 37,254 | 36,170 | 35,757 | 50,994 | 235,798 | |||||||||||||||||||||
Operating leases |
5,666 | 3,620 | 2,010 | 1,725 | 519 | 476 | 14,016 | |||||||||||||||||||||
Capital leases (2) |
1,777 | 916 | 106 | — | — | — | 2,799 | |||||||||||||||||||||
Purchase obligations (3) |
— | — | — | — | — | — | — | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total contractual cash obligations (4) |
$ | 52,238 | $ | 48,764 | $ | 46,070 | $ | 44,595 | $ | 42,976 | $ | 829,620 | $ | 1,064,263 |
(1) | Debt principal consists of short-term and long-term debt obligations, and excludes debt discounts and deferred financing costs. The estimated interest payments are based on rates on individual debt and our interest rate collar agreements outstanding at December 31, 2020. Actual interest rates on our variable rate debt and interest rate collars and the actual amount of our variable indebtedness could vary from the amounts used to compute the amounts shown here. |
(in thousands) |
2021 | 2022 | 2023 | 2024 | 2025 | Thereafter | Total | |||||||||||||||||||||
Debt principal |
$ | — | $ | — | $ | — | $ | — | $ | — | $ | 564,724 | $ | 564,724 | ||||||||||||||
Interest payments |
17,864 | 17,502 | 17,469 | 16,575 | 16,342 | 17,730 | 103,482 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total |
$ | 17,864 | $ | 17,502 | $ | 17,469 | $ | 16,575 | $ | 16,342 | $ | 582,454 | $ | 668,206 |
(2) | Capital leases reflect the principal amount of capital lease obligations, including related interest. |
(3) | We had no material purchase obligations as of December 31, 2020. In February 2021, we entered into a one-year contract with a third-party service provider which contains a minimum volume commitment. The Company expects to exceed the stipulated minimum volume of purchases in the ordinary course of business. |
(4) | Total contractual cash obligations in the table above exclude income taxes as we are unable to make a reasonably reliable estimate of the timing for the remaining payments in future years. As of December 31, 2020, we had unrecognized tax benefits of $1.3 million, including $0.5 million of accrued interest. Accrued penalties related to the unrecognized tax benefits were not material. Payments or receipts from tax authorities are not expected to have a significant impact on liquidity in the next year. See Note 9 to the consolidated financial statements included elsewhere in this prospectus for further information. |
• | our current and historical operating performance; |
• | our expected future operating performance; |
• | our financial condition at the grant date; |
• | the liquidation rights and preferences of our equity; |
• | any recent privately negotiated sales of our securities to independent third parties; |
• | input from management; |
• | the amount of debt on our balance sheet; |
• | the business risks inherent in our business and industry generally; and |
• | the market performance of comparable public companies. |
• | Our large, Enterprise customers have increased from 122 companies at the beginning of 2018 to 141 at the end of 2020. |
• | From 2018 to 2020 and despite the impact of COVID-19 on the macroeconomic environment, our revenues grew at a CAGR of 7%, all of which was organic growth from new customer wins or growth within our existing customer base. Our gross retention rate averaged approximately 95% over those three years. |
• | We generated net income of $34 million for the year ended December 31, 2019, and a net loss of $(62) million for the year ended December 31, 2020, on a pro forma basis. We generated a net loss of $(59) million for the nine months ended September 30, 2020 and net income of $5 million for the nine months ended September 30, 2021, in each case, on a pro forma basis. |
• | Our Adjusted EBITDA was $124 million for the year ended December 31, 2019. Our Adjusted EBITDA for the year ended December 31, 2020, on a pro forma basis, was $147 million. Our Adjusted EBITDA was $102 million for the nine months ended September 30, 2020, and $157 million for the nine months ended September 30, 2021, in each case, on a pro forma basis. |
• | Driven by scale, automation, and operational discipline, our Adjusted EBITDA Margins expanded, resulting in an Adjusted EBITDA CAGR 21% from 2018 to 2020, on a pro forma basis. |
• | Increased Workforce Mobility and Job Turnover: one-third of the U.S. workforce in 2020 and are three times as likely to change jobs as other generations in pursuit of earning higher wages, faster career development, and better workplace culture fit. In addition, as the economy evolves and resource needs differ significantly by sector, geography, and skill set, this is driving dynamism in the hiring environment. |
• | Increasing Use of Contingent and Flexible Workforces: 25-30% of the U.S. workforce are contingent workers, including freelancers, independent contractors, consultants, or other outsourced and non-permanent workers, and a majority of large corporations plan to substantially increase their use of a flexible workforce. When independent contractors, external consultants, and temporary workers have access to sensitive information, company facilities, or directly interact with customers, it is important for companies to screen such flexible workforce personnel diligently. |
• | C-Suite Focus on Safety and Reputational Risks: |
• | Heightened Regulatory and Compliance Scrutiny: |
• | Growth in Post-Onboarding Monitoring: “one-and-done” pre-onboarding measure, which has historically been the norm in markets like the U.S. and U.K. We have invested in and continue to innovate our post-onboarding products and solutions and believe we are well-positioned to capture share in this growing market. |
• | Development of International Markets: |
policies, screening procedures, and providers globally, driving greater demand and a shift towards high-quality, compliant, and global screening providers. In addition, many non-U.S.-based companies are initiating screening programs for the first time and are seeking reliable, compliant, and high quality providers. |
• | Investment in Enterprise Software: software-as-a-service |
• | Proliferation of Relevant Data Sources: |
• | Advances in Analytics to Increase Value of Data: |
• | Market Leadership Built on Outstanding Customer Experience. end-to-end 12-year tenure of our top 100 customers. |
• | Verticalized Go-to-Market e-commerce, essential retail, transportation and home delivery, warehousing, healthcare, technology, and staffing. |
• | Leading Technology & Analytics Drive Customer Value Proposition AI-powered applicant |
experience, Profile Advantage, offers an intuitive user interface with chatbots, digital camera-enabled document uploads, and embedded machine learning to reduce missing information dramatically and compress the timeframe of the entire application process. One business day is saved on average when applicants can submit requisite information anytime via mobile device. Since Profile Advantage manages a critical interaction between our customers and their applicants, we offer our customers the option to white-label the product as an extension of their own brand, enhancing applicant engagement and satisfaction during the onboarding process. We also deliver value to customers through robust analytics solutions that allow them to aggregate, analyze, and act on recruitment and screening data in real-time. This allows our customers to derive actionable insights and make critical and informed decisions to improve the performance of their organization’s recruitment, onboarding, safety, and screening programs. |
• | Product and Compliance Strength Across Geographies right-to-work |
• | Technology-Driven Operational Excellence and Profitability end-to-end front-end technology creates a superior applicant experience. Our back-end technology drives operational excellence, with more than 2,750 active intelligent bots yielding significant improvements in speed, accuracy, and cost savings. The intelligent bots have enabled us to improve the average turnaround time for criminal searches in the U.S. by over 10% from 2019 to 2020. Driven by these efficiency gains, we achieved more than 600 basis points of Adjusted EBITDA Margin expansion from 2018 to 2020. We expect our investments in technology and automation will help drive further improvement in our long-term margin profile. |
• | Experienced and Visionary Management Team with Complementary Skills. |
• | Continue to Win New Customers. e-commerce, essential retail, and transportation and home delivery, and sectors that are increasingly requiring deeper, more frequent checks with high compliance standards such as healthcare and technology. We are also prioritizing new verticals that align with positive secular macroeconomic trends. We focus on large Enterprise customers, which we believe are well-positioned for durable, long-term growth, have complex and diverse global operations, and, |
as a result, have the highest demand for our products and solutions. We believe our innovative and differentiated solutions, high-performing Sales and Customer Success teams, operational excellence, and industry-leading reputation and brand will enable us to expand our customer base successfully. |
• | Growth within Our Existing Customer Base through Upselling and Cross-selling. pre-onboarding products. We also cross-sell additional risk mitigation and compliance solutions such as post-onboarding screening, hiring tax credits, and fleet solutions. Our Sales and Customer Success teams frequently engage with our existing customers and identify areas where we can provide additional value and products. Our deeply entrenched, dedicated Customer Success teams work closely with our customers to develop robust and rigorous compliance and risk management programs within their organizations. We believe that our total revenue opportunity with current customers is twice the size of our current revenue base when taking into account cross-selling and upselling opportunities. Revenues from cross-sell and upsell added approximately 5 and 4 percentage points to our revenue growth rate in 2019 and 2020, respectively. We will continue to hone our sales and marketing engine to increase product penetration within our existing customer base. |
• | Continue to Innovate Our Product Offerings. |
• | Expand Internationally. |
• | Selectively Pursue Complementary Acquisitions and Strategic Partnerships. |
• | Criminal background checks: |
• | Drug / Health screening |
• | Extended workforce screening: |
• | FBI channeling: |
• | Identity checks and biometric fraud mitigation tools: |
• | Education / Work history verification: |
• | Driver records and compliance: |
• | Healthcare credentials: |
• | Executive screening: in-depth investigative reports to confirm various aspects of credentials not typically covered by most background checks, such as civil litigation and bankruptcies, negative media searches, controversies and inconsistencies in business dealings, corporate and regulatory history, and potential conflicts of interest. |
• | Others: I-9 verification. |
• | Criminal records monitoring: |
• | Healthcare sanctions: |
• | Motor vehicle records: |
• | Social media: |
• | Global sanctions and licenses: |
• | Fleet / Vehicle compliance: |
• | Hiring tax credits and incentives: |
• | Resident! Tenant screening: |
• | Investigative research: in-depth investigative reports, similar to our Executive Screening products, used in performing due diligence of alternative investment managers and senior executives before a major investment commitment or M&A transaction. |
• | Profile Advantage : easy-to-use time-to-hire. |
• | Enterprise Advantage : end-to-end |
• | Insight Advantage : best-in-class time-to-hire |
• | accuracy of screening results; |
• | turnaround time of screening results; |
• | product pricing; |
• | applicant and enterprise user experience, ease of use, level of functionality, scalability, and efficiency; |
• | breadth and depth of screening solutions; |
• | geographical reach; |
• | sales and marketing relationship history with the key decision-makers; |
• | compliance and regulation; |
• | industry vertical support that meets the needs of a customers’ specific requirements; |
• | technical and systems performance, including the ability to integrate with customer and third-party systems and applications; and |
• | cybersecurity, privacy, and data protection. |
• | Fair Credit Reporting Act, which regulates the use of consumer report information and governs the accuracy, fairness, and privacy of such information; |
• | Dodd-Frank Act, which prohibits unfair, deceptive, or abusive acts or practices with respect to consumer financial services practices; |
• | Gramm-Leach-Bliley Act, which regulates the use of non-public personal financial information held by financial institutions; |
• | Health Insurance Portability and Accountability Act, which restricts the public disclosure of patient information and applies indirectly to companies that provide services to healthcare-related businesses; |
• | Drivers’ Privacy Protection Act, which restricts the public disclosure, use, and resale of personal data contained in state department of motor vehicle records; |
• | U.K. and E.U. GDPR; |
• | Various U.S. federal, state, and local data protection and consumer reporting agency laws at the state level, state data breach laws, and state privacy laws, such as the California Consumer Privacy Act and the Illinois Biometric Information Privacy Act; |
• | International data protection, data localization, and state secret laws impacting our data suppliers, such as the E.U. GDPR, or us; and |
• | Oversight by regulatory authorities for engaging in consumer reporting, including the FTC and CFPB in the United States. |
Name |
Age |
Position | ||||
Scott Staples |
55 | Chief Executive Officer & Director | ||||
David L. Gamsey |
64 | Executive Vice President & Chief Financial Officer | ||||
Bret T. Jardine |
55 | Executive Vice President, General Counsel & Secretary | ||||
Joseph Jaeger |
62 | President, Americas | ||||
Joseph Osnoss |
43 | Chairman | ||||
Susan R. Bell |
58 | Director | ||||
James L. Clark |
60 | Director | ||||
John Rudella |
50 | Director | ||||
Judith Sim |
53 | Director | ||||
Bianca Stoica |
28 | Director |
• | selecting and hiring our independent auditors, and approving the audit and non-audit services to be performed by our independent auditors; |
• | assisting the board of directors in evaluating the qualifications, performance and independence of our independent auditors; |
• | assisting the board of directors in monitoring the quality and integrity of our financial statements and our accounting and financial reporting; |
• | assisting the board of directors in monitoring our compliance with legal and regulatory requirements; |
• | reviewing the adequacy and effectiveness of our internal control over financial reporting processes; |
• | assisting the board of directors in monitoring the performance of our internal audit function; |
• | reviewing with management and our independent auditors our annual and quarterly financial statements; |
• | overseeing our technology security and data privacy programs; |
• | establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or auditing matters and the confidential, anonymous submission by our employees of concerns regarding questionable accounting or auditing matters; and |
• | preparing the audit committee report that the rules and regulations of the SEC require to be included in our annual proxy statement. |
• | reviewing and approving corporate goals and objectives relevant to the compensation of our Chief Executive Officer, evaluating our Chief Executive Officer’s performance in light of those goals and objectives, and, either as a committee or together with the other independent directors (as directed by the board of directors), determining and approving, or making recommendations to the board of directors with respect to, our Chief Executive Officer’s compensation level based on such evaluation; |
• | reviewing and approving, or making recommendations to the board of directors with respect to, the compensation of our other executive officers, including annual base salary, bonus and equity-based incentives and other benefits; |
• | reviewing and recommending the compensation of our directors; |
• | reviewing and discussing annually with management our “Compensation Discussion and Analysis” disclosure required by SEC rules; |
• | preparing the compensation committee report required by the SEC to be included in our annual proxy statement; and |
• | reviewing and making recommendations with respect to our equity compensation plans. |
• | assisting our board of directors in identifying prospective director nominees and recommending nominees to the board of directors; |
• | overseeing the evaluation of the board of directors and management; |
• | developing and recommending a set of corporate governance guidelines; |
• | recommending members for each committee of our board of directors; and |
• | otherwise taking a leadership role in shaping our corporate governance and overseeing our strategy as it relates to environmental and social matters. |
NAME AND PRINCIPAL POSITION |
YEAR |
SALARY ($)(1) |
BONUS ($)(2) |
EQUITY AWARDS ($)(3) |
NON-EQUITY INCENTIVE PLAN COMPENSATION ($)(4) |
ALL OTHER COMPENSATION ($)(5) |
TOTAL ($) |
|||||||||||||||||||||
Scott Staples | 2020 | 450,007 | 750,000 | 4,192,412 | 277,300 | 4,275 | 5,673,994 | |||||||||||||||||||||
Chief Executive Officer |
||||||||||||||||||||||||||||
Joseph Jaeger | 2020 | 499,995 | 750,000 | 1,222,787 | 432,100 | 4,275 | 2,909,157 | |||||||||||||||||||||
President, Americas(6) |
||||||||||||||||||||||||||||
David L. Gamsey | 2020 | 400,006 | 750,000 | 873,419 | 172,800 | 4,275 | 2,200,500 | |||||||||||||||||||||
Chief Financial Officer & Executive Vice President |
(1) | The amounts reported in this column represent each Named Executive Officer’s base salary earned during 2020. |
(2) | Each of the Named Executive Officers received a one-time transaction bonus paid upon the January 31, 2020 close of the Silver Lake Transaction. |
(3) | We granted Class C LP Units, which are intended to qualify as profits interests, to each of our Named Executive Officers pursuant to a form of grant agreement (the “Unit Grant Agreement”). 50% of the Class C LP Units are subject solely to time-based vesting criteria, and the other 50% of the Class C LP Units are subject to both time and performance-based vesting criteria. The performance-vesting Class C LP Units are subject to market conditions and an implied performance condition as defined under applicable accounting standards. The grant date fair value of performance-vesting Class C LP Units was computed based upon the probable outcome of the performance conditions as of the grant date in accordance with FASB ASC Topic 718. Achievement of the performance conditions for the performance-vesting Class C LP Units was not deemed probable on the grant date and, accordingly, no value is included in the table for these awards pursuant to the SEC’s disclosure rules. Assuming achievement of the performance conditions, the aggregate grant date fair values of the performance-vesting Class C LP Units would have been: $4,192,412 for Mr. Staples, $1,222,787 for Mr. Jaeger, and $873,419 for Mr. Gamsey. See Note 11 to our audited consolidated financial statements included elsewhere in this prospectus for a discussion of the valuation of our equity-based awards. In connection with the IPO, all outstanding Class C LP Units, including those held by our Named Executive Officers, were exchanged with newly issued shares of our common stock. |
(4) | The amounts reported in this column represent the annual incentive bonus amounts earned by each Named Executive Officer pursuant to our Management Incentive Compensation Plan (the “MICP” and as described below under “—Management Incentive Compensation Plan”). |
(5) | The amounts reported in this column represent the discretionary employer matching contribution under the 401(k) Plan for each Named Executive Officer. |
(6) | In 2020, Mr. Jaeger served as our Chief Revenue Officer and was promoted to President, Americas effective 2021. |
Name |
2020 Base Salary ($) |
Target MICP Bonus Amount ($) |
Actual MICP Bonus Paid ($) (1) |
|||||||||
Scott Staples |
450,000 | 350,000 | 277,300 | |||||||||
Joseph Jaeger |
500,000 | 500,000 | 432,100 | |||||||||
David L. Gamsey |
400,000 | 200,000 | 172,800 |
(1) | In 2020, Mr. Staples’s bonus payment under the MICP was a fixed dollar target pursuant to the Staples Employment Agreement, tied to Company financial performance only. The bonus payment under the MICP in 2020 for each of Messrs. Jaeger and Gamsey was calculated by multiplying each Named Executive Officer’s base salary by the target bonus opportunity provided in the executive’s employment agreement, which amount was then adjusted by an overall achievement factor based on the level of achievement of the applicable performance metrics (with the following allocation: one-third Company financial performance, one-third business unit financial performance, and one-third individual performance). |
NUMBER OF SHARES OR UNITS OF STOCK THAT HAVE NOT VESTED |
MARKET VALUE OF SHARES OR UNITS OF STOCK THAT HAVE NOT VESTED |
EQUITY INCENTIVE PLAN AWARDS: NUMBER OF UNEARNED SHARES, UNITS OR OTHER RIGHTS THAT HAVE NOT VESTED |
EQUITY INCENTIVE PLAN AWARDS: MARKET VALUE OF UNEARNED SHARES, UNITS OR OTHER RIGHTS THAT HAVE NOT VESTED |
|||||||||||||||||
NAME |
GRANT DATE |
(#) (1) |
($) (2) |
(#) (3) |
($) (4) |
|||||||||||||||
Scott Staples |
||||||||||||||||||||
Class C LP Unit Award |
2/9/2020 | 1,286,016 | 4,771,119 | 1,286,016 | 4,771,119 | |||||||||||||||
Joseph Jaeger |
||||||||||||||||||||
Class C LP Unit Award |
2/9/2020 | 375,088 | 1,391,576 | 375,088 | 1,391,576 | |||||||||||||||
David L. Gamsey |
||||||||||||||||||||
Class C LP Unit Award |
2/9/2020 | 267,920 | 993,983 | 267,920 | 993,983 |
1) | Amounts in this column represent the number of time-based vesting Class C LP Units (“Time Units”) that have not vested prior to December 31, 2020. The Class C LP Units were issued pursuant to the Unit Grant Agreement, described under “—Long-Term Equity Incentive Compensation,” which provides that subject to the executive’s continued employment through the applicable vesting date, 20% of the Time Units become time vested on each of the first five anniversaries of the vesting commencement date (January 31, 2020). |
2) | Amounts in this column represent the appreciation in the value of each Class C LP Unit over its threshold value from the date of grant through December 31, 2020, based on the Company’s valuation as of December 31, 2020. |
3) | Amounts in this column represent the number of performance-based vesting Class C LP Units (“Performance Units”) that have not vested prior to December 31, 2020. The Class C LP Units were issued pursuant to the Unit Grant Agreement, described under “—Long-Term Equity Incentive Compensation,” which provides that subject to the executive’s continued employment through the applicable potential vesting date, upon each occurrence of a Realization Event (as defined in the Unit Grant Agreement), the number of Performance Units that vest will equal the excess, if any, of (i) the total number of Performance Units as of such Realization Event over (ii) the number of Performance Units that had vested prior to such Realization Event; provided that, as of any time, the percentage of the Performance Units that are vested may not exceed the product of (A) the percentage of the Time Units that are vested as of such time (after giving effect to any accelerated vesting contemplated by the Unit Grant Agreement), and (B) the MOM Percentage (as defined in the Unit Grant Agreement) as of such time. Performance Units that would have vested pursuant to the preceding sentence but for the proviso thereof will vest at such time as doing so would not violate such proviso. |
4) | Amounts in this column represent the appreciation in the value of each performance-vesting Class C LP Unit over its threshold value from the date of grant through December 31, 2020, based on the Company’s valuation as of December 31, 2020. |
• | 50% of the Class C LP Units are Time Units, subject solely to time-based vesting criteria. Subject to the executive’s continued employment through the applicable vesting date, 20% of the Time Units become time vested on each of the first five anniversaries of the vesting commencement date (January 31, 2020). |
• | The other 50% of the Class C LP Units are Performance Units, subject to both time and performance-based vesting criteria. Subject to the executive’s continued employment through the applicable potential vesting date, upon each occurrence of a Realization Event (as defined in the Unit Grant Agreement), the number of Performance Units that vest will equal the excess, if any, of (i) the total number of Performance Units as of such Realization Event over (ii) the number of Performance Units that had vested prior to such Realization Event; provided that, as of any time, the percentage of the Performance Units that are vested may not exceed the product of (A) the percentage of the Time Units that are vested as of such time (after giving effect to any accelerated vesting contemplated by the Unit Grant Agreement), and (B) the MOM Percentage (as defined in the Unit Grant Agreement) as of such time. Performance Units that would have vested pursuant to the preceding sentence but for the proviso thereof will vest at such time as doing so would not violate such proviso. |
• | all unvested Time Units and all Performance Units that have not satisfied the time vesting condition will be immediately forfeited for no consideration (even if such Performance Units have satisfied the performance vesting condition prior to such termination), and |
• | any Performance Units that have satisfied the time vesting condition but not the performance vesting condition will (x) if such termination of employment is for any reason other than without Cause (as defined in the Unit Grant Agreement), be immediately forfeited for no consideration upon the date of such termination, and (y) solely if such termination of employment is without Cause (and other than due to death or permanent disability), remain outstanding and be eligible to satisfy the performance vesting condition upon future Realization Events, subject to a restrictive covenant violation not having occurred. |
Name |
Shares of Common Stock Received Upon Exchange of Vested Class C LP Units |
Unvested Shares of Restricted Stock Received Upon Replacement of Unvested Class C LP Units |
||||||||||||||
# |
$ |
# |
$ |
|||||||||||||
Scott Staples |
230,500 | 3,457,500 | 1,947,297 | 29,209,455 | ||||||||||||
Joseph Jaeger |
67,229 | 1,008,435 | 567,961 | 8,519,415 | ||||||||||||
David L. Gamsey |
48,020 | 720,300 | 405,688 | 6,085,320 |
Name |
Number of Performance-Vesting Class C LP Units |
|||
Scott Staples |
15,025 | |||
Joseph Jaeger |
4,382 | |||
David L. Gamsey |
3,130 |
Name |
Number of Options |
|||
Scott Staples |
2,146,004 | |||
Joseph Jaeger |
628,756 | |||
David L. Gamsey |
448,030 |
Name |
Number of Performance-Vesting Restricted Shares |
Number of Performance-Vesting “Top-Up” Options |
||||||
Scott Staples |
197,707 | 194,821 | ||||||
Joseph Jaeger |
57,664 | 57,080 | ||||||
David L. Gamsey |
41,189 | 40,673 |
Name |
Fees Earned or Paid in Cash ($)(1) |
Equity Awards ($)(2) |
Total ($) |
|||||||||
Dann Adams |
4,167 | 0 | 4,167 | |||||||||
Ronald Domanico |
4,167 | 0 | 4,167 | |||||||||
Robert Schriesheim |
2,500 | 0 | 2,500 |
(1) | Amounts reflect the aggregate amount of cash retainers paid during 2020. |
(2) | The above described non-employee directors did not receive any equity award from us in 2020 and on January 31, 2020 forfeited all of their outstanding options such that they did not hold any options or equity awards in the Company on December 31, 2020. |
• | selling stockholders; |
• | each individual or entity known by us to beneficially own more than 5% of our outstanding common stock; |
• | each named executive officer; |
• | each of our directors; and |
• | all of our directors and executive officers as a group. |
Name of Beneficial Owner |
Shares beneficially owned prior to the offering |
Shares to be sold in the offering |
Shares beneficially owned after the offering and the SLP Distribution |
|||||||||||||||||||||||||||||
Excluding exercise of the underwriters’ option to purchase additional shares |
Including exercise of the underwriters’ option to purchase additional shares |
Excluding exercise of the underwriters’ option to purchase additional shares |
Including exercise of the underwriters’ option to purchase additional shares |
|||||||||||||||||||||||||||||
Number |
Percent |
Number |
Number |
Number |
Percent |
Number |
Percent |
|||||||||||||||||||||||||
Greater than 5% Stockholders: |
||||||||||||||||||||||||||||||||
SLP Fastball Aggregator, L.P. and affiliated entities (1) |
110,734,013 | 72.4 | % | 13,726,648 | 15,786,333 | 92,749,615 | 60.7 | % | 90,051,054 | 58.9 | % | |||||||||||||||||||||
Named Executive Officers and Directors: |
||||||||||||||||||||||||||||||||
Scott Staples (2) |
4,373,370 | 2.9 | % | 300,973 | 346,134 | 4,267,218 | 2.8 | % | 4,232,863 | 2.8 | % | |||||||||||||||||||||
David L. Gamsey (3) |
639,805 | * | 29,070 | 33,432 | 651,408 | * | 649,300 | * | ||||||||||||||||||||||||
Joseph Jaeger (4) |
806,001 | * | 29,576 | 34,013 | 833,505 | * | 832,228 | * | ||||||||||||||||||||||||
Joseph Osnoss (5) |
— | — | — | — | 99,759 | (9) |
|
* |
|
|
114,727 |
(9) |
|
* |
| |||||||||||||||||
Susan R. Bell |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||
James L. Clark |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||
John Rudella (5) |
— | — | — | — | |
13,095 |
(9) |
|
* |
|
|
15,060 |
(9) |
|
* |
| ||||||||||||||||
Judith Sim |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||
Bianca Stoica (5) |
— | — | — | — | |
6,720 |
(9) |
|
* |
|
|
7,728 |
(9) |
|
* |
| ||||||||||||||||
All executive officers and directors as a group (10 persons) (6) |
5,844,089 | 3.8 | % | 362,707 | 417,130 | 5,908,253 | 3.9 | % | 5,888,397 | 3.9 | % | |||||||||||||||||||||
Other selling stockholders: |
||||||||||||||||||||||||||||||||
Workday, Inc. (7) |
7,190,520 | 4.7 | % | 891,340 | 1,025,086 | 6,299,180 | 4.1 | % | 6,165,434 | 4.0 | % | |||||||||||||||||||||
Other selling stockholders as a group (8) |
175,762 | * | 19,305 | 21,451 | 224,670 | * | 224,404 | * |
* | Less than 1% |
(1) | Shares beneficially owned prior to the offering represents shares held of record by SLP Fastball Aggregator, L.P. SLP V Aggregator GP, L.L.C. is the general partner of SLP Fastball Aggregator, L.P. Silver Lake Technology Associates V, L.P. is the managing member of SLP V Aggregator GP, L.L.C. SLTA V (GP), L.L.C. is the general partner of Silver Lake Technology Associates V, L.P. Silver Lake Group, L.L.C., is the managing member of SLTA V (GP), L.L.C. The managing members of Silver Lake Group, L.L.C. are Egon Durban, Kenneth Hao, Gregory Mondre, and Joseph Osnoss. The principal business address for each of the entities identified in this paragraph is c/o Silver Lake Group, L.L.C., 2775 Sand Hill Road, Suite 100 Menlo Park, CA 94025. Shares beneficially owned after the offering reflects the consummation of the SLP Distribution and includes shares to be received by affiliated entities of SLP Fastball Aggregator, L.P. in connection with the SLP Distribution. |
(2) | Includes 1,945,389 shares of unvested restricted stock and 229,016 shares underlying vested options. Shares beneficially owned after completion of the offering also includes (i) an estimated 152,014 shares of performance-based restricted stock and 149,795 shares underlying performance-based options that will vest as a result of this offering, (ii) an estimated 45,693 shares of performance-based restricted stock and 45,026 shares underlying performance-based options that will vest as a result of the SLP Distribution (assuming no exercise of the underwriters’ option to purchase additional shares), in each case, assuming an offering price of $21.05 per share based on the closing sales price of our common stock as reported on Nasdaq on November 5, 2021 for the Follow-On Offering, and (iii) if the underwriters’ option to purchase |
additional shares is exercised in full, an estimated 5,443 shares of performance-based restricted stock and 5,363 shares underlying performance-based options that will vest as a result of this offering. For purposes of the SLP Distribution, performance-based vesting is based on $20.15, the average daily closing price of our common stock as reported on Nasdaq for the ten trading day period ended November 5, 2021. |
(3) | Includes 405,291 shares of unvested restricted stock and 47,812 shares underlying vested options. Shares beneficially owned after completion of the offering also includes (i) an estimated 31,669 shares of performance-based restricted stock and 31,273 shares underlying performance-based options that will vest as a result of this offering, (ii) an estimated 9,520 shares of performance-based restricted stock and 9,400 shares underlying performance-based options that will vest as a result of the SLP Distribution (assuming no exercise of the underwriters’ option to purchase additional shares), in each case, assuming an offering price of $21.05 per share based on the closing sales price of our common stock as reported on Nasdaq on November 5, 2021 for the Follow-On Offering, and (iii) if the underwriters’ option to purchase additional shares is exercised in full, an estimated 1,134 shares of performance-based restricted stock and 1,120 shares underlying performance-based options that will vest as a result of this offering. For purposes of the SLP Distribution, performance-based vesting is based on $20.15, the average daily closing price of our common stock as reported on Nasdaq for the ten trading day period ended November 5, 2021. |
(4) | Includes 567,404 shares of unvested restricted stock and 67,098 shares underlying vested options. Shares beneficially owned after completion of the offering also includes (i) an estimated 44,337 shares of performance-based restricted stock and 43,888 shares underlying performance-based options that will vest as a result of this offering, (ii) an estimated 13,327 shares of performance-based restricted stock and 13,192 shares underlying performance-based options that will vest as a result of the SLP Distribution (assuming no exercise of the underwriters’ option to purchase additional shares), in each case, assuming an offering price of $21.05 per share based on the closing sales price of our common stock as reported on Nasdaq on November 5, 2021 for the Follow-On Offering, and (iii) if the underwriters’ option to purchase additional shares is exercised in full, an estimated 1,588 shares of performance-based restricted stock and 1,572 shares underlying performance-based options that will vest as a result of this offering. For purposes of the SLP Distribution, performance-based vesting is based on $20.15, the average daily closing price of our common stock as reported on Nasdaq for the ten trading day period ended November 5, 2021. |
(5) | Mr. Osnoss is a Managing Partner and Managing Member of Silver Lake, Mr. Rudella is a Director of Silver Lake, and Ms. Stoica is a Principal of Silver Lake. The address of each of such persons is c/o Silver Lake Group, L.L.C., 2775 Sand Hill Road, Suite 100 Menlo Park, CA 94025. |
(6) | Includes 2,918,084 shares of unvested restricted stock and 361,233 shares underlying vested options. Shares beneficially owned after completion of the offering also includes (i) an estimated 228,020 shares of performance-based restricted stock and 236,276 shares underlying performance-based options that will vest as a result of this offering, (ii) an estimated 68,540 shares of performance-based restricted stock and 71,021 shares underlying performance-based options that will vest as a result of the SLP Distribution (assuming no exercise of the underwriters’ option to purchase additional shares), in each case, assuming an offering price of $21.05 per share based on the closing sales price of our common stock as reported on Nasdaq on November 5, 2021 for the Follow-On Offering, and (iii) if the underwriters’ option to purchase additional shares is exercised in full, an estimated 8,165 shares of performance-based restricted stock and 8,461 shares underlying performance-based options that will vest as a result of this offering. For purposes of the SLP Distribution, performance-based vesting is based on $20.15, the average daily closing price of our common stock as reported on Nasdaq for the ten trading day period ended November 5, 2021. |
(7) | The address of Workday, Inc. is 6110 Stoneridge Mall Road, Pleasanton, CA 94588. |
(8) | Shares shown in the table include shares owned by the selling stockholders other than those named in the table that in the aggregate beneficially own less than 1% of our common stock as of November 5, 2021. Shares beneficially owned after completion of the offering also includes (i) an estimated 52,447 shares underlying performance-based options that will vest as a result of this offering, (ii) an estimated 15,766 shares underlying performance-based options that will vest as a result of the SLP Distribution (assuming no exercise of the underwriters’ option to purchase additional shares), in each case, assuming an offering price of $21.05 per share based on the closing sales price of our common stock as reported on Nasdaq on November 5, 2021 for the Follow-On Offering, and (iii) if the underwriters’ option to purchase additional shares is exercised in full, an estimated 1,880 shares underlying performance-based options that will vest as a result of this offering. For purposes of the SLP Distribution, performance-based vesting is based on $20.15, the average daily closing price of our common stock as reported on Nasdaq for the ten trading day period ended November 5, 2021. |
(9) | Reflects the shares received from SLP Fastball Aggregator, L.P. in connection with the SLP Distribution. |
1) | the designation of the series; |
2) | the number of shares of the series, which our board of directors may, except where otherwise provided in the preferred stock designation, increase (but not above the total number of authorized shares of the class) or decrease (but not below the number of shares then outstanding); |
3) | whether dividends, if any, will be cumulative or non-cumulative and the dividend rate of the series; |
4) | the dates at which dividends, if any, will be payable; |
5) | the redemption rights and price or prices, if any, for shares of the series; |
6) | the terms and amounts of any sinking fund provided for the purchase or redemption of shares of the series; |
7) | the amounts payable on shares of the series in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the affairs of the Company; |
8) | whether the shares of the series will be convertible into shares of any other class or series, or any other security, of the Company or any other corporation and, if so, the specification of the other class or |
series or other security, the conversion price or prices or rate or rates, any rate adjustments, the date or dates as of which the shares will be convertible and all other terms and conditions upon which the conversion may be made; |
9) | restrictions on the issuance of shares of the same series or of any other class or series; and |
10) | the voting rights, if any, of the holders of the series. |
• | prior to such time, our board of directors approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder; |
• | upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of our voting stock outstanding at the time the transaction commenced, excluding certain shares; or |
• | at or subsequent to that time, the business combination is approved by our board of directors and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of holders of at least 66 2 /3 % of the outstanding voting stock that is not owned by the interested stockholder. |
• | the provision requiring a 66 2/3 % supermajority vote for stockholders to amend our amended and restated bylaws; |
• | the provisions providing for a classified board of directors (the election and term of our directors); |
• | the provisions regarding resignation and removal of directors; |
• | the provisions regarding competition and corporate opportunities; |
• | the provisions regarding entering into business combinations with interested stockholders; |
• | the provisions regarding stockholder action by written consent; |
• | the provisions regarding calling special meetings of stockholders; |
• | the provisions regarding filling vacancies on our board of directors and newly created directorships; |
• | the provisions eliminating monetary damages for breaches of fiduciary duty by a director; and |
• | the amendment provision requiring that the above provisions be amended only with a 66 2 /3 % supermajority vote. |
• | 1% of the number of shares of our common stock then outstanding, which will equal approximately 1,528,751 shares immediately after this offering; or |
• | the average reported weekly trading volume of our common stock on Nasdaq during the four calendar weeks preceding the filing of a notice on Form 144 with respect to such sale. |
• | an individual who is a citizen or resident of the United States; |
• | a corporation (or any other entity treated as a corporation for United States federal income tax purposes) created or organized in or under the laws of the United States, any state thereof or the District of Columbia; |
• | an estate the income of which is subject to United States federal income taxation regardless of its source; or |
• | a trust if it (1) is subject to the primary supervision of a court within the United States and one or more United States persons have the authority to control all substantial decisions of the trust or (2) has a valid election in effect under applicable United States Treasury regulations to be treated as a United States person. |
• | the gain is effectively connected with a trade or business of the non-U.S. holder in the United States (and, if required by an applicable income tax treaty, is attributable to a United States permanent establishment of the non-U.S. holder); |
• | the non-U.S. holder is an individual who is present in the United States for 183 days or more in the taxable year of that disposition, and certain other conditions are met; or |
• | we are or have been a “United States real property holding corporation” for United States federal income tax purposes and certain other conditions are met. |
Name |
Number of Shares |
|||
Barclays Capital Inc. |
||||
BofA Securities, Inc. |
||||
Citigroup Global Markets Inc. |
||||
Evercore Group L.L.C. |
||||
Jefferies LLC |
||||
RBC Capital Markets, LLC. |
||||
Stifel, Nicolaus & Company, Incorporated. |
||||
HSBC Securities (USA) Inc. |
||||
Citizens Capital Markets, Inc. |
||||
KKR Capital Markets LLC |
||||
MUFG Securities Americas Inc. |
||||
Loop Capital Markets LLC |
||||
R. Seelaus & Co., LLC |
||||
Samuel A. Ramirez & Company, Inc. |
||||
Roberts & Ryan Investments, Inc. |
||||
|
|
|||
Total |
15,000,000 |
Per Share |
Without option |
With option |
||||||||||
Public offering price |
$ | $ | $ | |||||||||
Underwriting discount |
$ | $ | $ | |||||||||
Proceeds before expenses, to the selling stockholders |
$ | $ | $ |
Audited Consolidated Financial Statements: |
||||
F-2 |
||||
F-3 |
||||
F-5 |
||||
F-6 |
||||
F-8 |
||||
F-10 |
Unaudited Interim Consolidated Financial Statements: |
||||
F-40 |
||||
F-41 |
||||
F-42 |
||||
F-44 |
||||
F-45 |
||||
F-46 |
Predecessor |
Successor |
|||||||||||
December 31, 2019 |
December 31, 2020 |
|||||||||||
ASSETS |
||||||||||||
CURRENT ASSETS: |
||||||||||||
Cash and cash equivalents |
$ | $ | ||||||||||
Restricted cash |
||||||||||||
Short-term investments |
||||||||||||
Accounts receivable (net of allowance for doubtful accounts of $ |
||||||||||||
Prepaid expenses and other current assets |
||||||||||||
Income tax receivable |
||||||||||||
|
|
|
|
|||||||||
Total current assets |
||||||||||||
Property and equipment, net |
||||||||||||
Goodwill |
||||||||||||
Trade name, net |
||||||||||||
Customer lists, net |
||||||||||||
Deferred tax asset, net |
||||||||||||
Other assets |
||||||||||||
|
|
|
|
|||||||||
TOTAL ASSETS |
$ | $ | ||||||||||
|
|
|
|
|||||||||
LIABILITIES AND (DEFICIT) EQUITY |
||||||||||||
CURRENT LIABILITIES: |
||||||||||||
Accounts payable |
$ | $ | ||||||||||
Accrued compensation |
||||||||||||
Accrued liabilities |
||||||||||||
Current portion of long-term debt |
||||||||||||
Income tax payable |
||||||||||||
Deferred revenue |
||||||||||||
|
|
|
|
|||||||||
Total current liabilities |
||||||||||||
Long-term debt (net of deferred financing costs of $ December 31, 2020 (Successor), respectively) |
||||||||||||
Deferred tax liability, net |
||||||||||||
Other liabilities |
||||||||||||
|
|
|
|
|||||||||
Total liabilities |
||||||||||||
COMMITMENTS AND CONTINGENCIES (Note 13) |
||||||||||||
EQUITY: |
||||||||||||
Common stock—$ as of December 31, 2020 |
||||||||||||
Additional paid-in-capital |
||||||||||||
Class A units— |
Class B units— |
||||||||||||
Class C units— |
||||||||||||
Accumulated deficit |
( |
) | ( |
) | ||||||||
Accumulated other comprehensive (loss) income |
( |
) | ||||||||||
|
|
|
|
|||||||||
Total (deficit) equity |
( |
) | ||||||||||
|
|
|
|
|||||||||
TOTAL LIABILITIES AND (DEFICIT) EQUITY |
$ | $ | ||||||||||
|
|
|
|
Predecessor |
Successor |
|||||||||||||||
Year Ended December 31, 2019 |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through December 31, 2020 |
||||||||||||||
REVENUES |
$ | $ | $ | |||||||||||||
OPERATING EXPENSES: |
||||||||||||||||
Cost of services (exclusive of depreciation and amortization below) |
||||||||||||||||
Product and technology expense |
||||||||||||||||
Selling, general, and administrative expense |
||||||||||||||||
Depreciation and amortization |
||||||||||||||||
|
|
|
|
|
|
|||||||||||
Total operating expenses |
||||||||||||||||
|
|
|
|
|
|
|||||||||||
INCOME (LOSS) FROM OPERATIONS |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|||||||||||
OTHER EXPENSE (INCOME): |
||||||||||||||||
Interest expense |
||||||||||||||||
Interest income |
( |
) | ( |
) | ( |
) | ||||||||||
Loss on extinguishment of Predecessor debt |
||||||||||||||||
Transaction expenses, change in control |
||||||||||||||||
|
|
|
|
|
|
|||||||||||
Total other expense |
||||||||||||||||
|
|
|
|
|
|
|||||||||||
INCOME (LOSS) BEFORE PROVISION FOR INCOME TAXES |
( |
) | ( |
) | ||||||||||||
Provision for income taxes |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|||||||||||
NET INCOME (LOSS) |
$ | $ | ( |
) | $ | ( |
) | |||||||||
|
|
|
|
|
|
|||||||||||
Foreign currency translation (loss) income |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|||||||||||
COMPREHENSIVE INCOME (LOSS) |
$ | $ | ( |
) | $ | ( |
) | |||||||||
|
|
|
|
|
|
|||||||||||
NET INCOME (LOSS) |
$ | $ | ( |
) | $ | ( |
) | |||||||||
Basic and diluted net (loss) per share |
$ | ( |
) | |||||||||||||
Weighted average number of shares outstanding—basic and diluted |
||||||||||||||||
Basic net income (loss) per unit |
$ | $ | ( |
) | ||||||||||||
Diluted net income (loss) per unit |
$ | $ | ( |
) | ||||||||||||
Weighted average number of units outstanding—basic |
||||||||||||||||
Weighted average number of units outstanding—diluted |
Predecessor |
Successor |
|||||||||||||||
Year Ended December 31, 2019 |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through December 31, 2020 |
||||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: |
||||||||||||||||
Net income (loss) |
$ | $ | ( |
) | $ | ( |
) | |||||||||
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: |
||||||||||||||||
Depreciation and amortization |
||||||||||||||||
Loss on extinguishment of Predecessor debt |
||||||||||||||||
Amortization of deferred financing costs |
||||||||||||||||
Bad debt expense |
||||||||||||||||
Deferred taxes |
( |
) | ( |
) | ||||||||||||
Share-based compensation |
||||||||||||||||
(Gain) on foreign currency exchange rates |
( |
) | ( |
) | ( |
) | ||||||||||
(Gain) loss on disposal of fixed assets |
( |
) | ||||||||||||||
Change in fair value of interest rate swaps |
||||||||||||||||
Changes in operating assets and liabilities: |
||||||||||||||||
Accounts receivable |
( |
) | ( |
) | ||||||||||||
Prepaid expenses and other current assets |
( |
) | ||||||||||||||
Other assets |
( |
) | ||||||||||||||
Accounts payable |
( |
) | ||||||||||||||
Accrued compensation and accrued liabilities |
( |
) | ||||||||||||||
Deferred revenue |
( |
) | ( |
) | ||||||||||||
Other liabilities |
||||||||||||||||
Income tax receivable and payable, net |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|||||||||||
Net cash provided by (used in) operating activities |
( |
) | ||||||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES: |
||||||||||||||||
Changes in short-term investments |
( |
) | ( |
) | ||||||||||||
Proceeds from sale of property and equipment |
||||||||||||||||
Purchases of property and equipment |
( |
) | ( |
) | ( |
) | ||||||||||
Capitalized software development costs |
( |
) | ( |
) | ( |
) | ||||||||||
|
|
|
|
|
|
|||||||||||
Net cash used in investing activities |
( |
) | ( |
) | ( |
) | ||||||||||
CASH FLOWS FROM FINANCING ACTIVITIES: |
||||||||||||||||
Payments on capital lease obligations |
( |
) | ( |
) | ( |
) | ||||||||||
Repayment of Predecessor First Lien Credit Facility |
( |
) | ||||||||||||||
Repayment of Successor First Lien Credit Facility |
( |
) | ||||||||||||||
Capital contributions |
||||||||||||||||
Distributions to Predecessor Members and Optionholders |
( |
) | ( |
) |
Payments of debt issuance costs |
( |
) | ||||||||||||||
Borrowings on Successor Revolver |
||||||||||||||||
Repayments of Successor Revolver |
( |
) | ||||||||||||||
|
|
|
|
|
|
|||||||||||
Net cash (used in) provided by financing activities |
( |
) | ( |
) | ||||||||||||
EFFECT OF EXCHANGE RATES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH |
( |
) | ( |
) | ||||||||||||
INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH |
( |
) | ||||||||||||||
CASH, CASH EQUIVALENTS AND RESTRICTED CASH: |
||||||||||||||||
Beginning of period |
||||||||||||||||
|
|
|
|
|
|
|||||||||||
Cash, cash equivalents and restricted cash at period end |
$ | $ | $ | |||||||||||||
|
|
|
|
|
|
|||||||||||
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: |
||||||||||||||||
Cash paid for income taxes |
$ | $ | $ | |||||||||||||
Cash paid for interest |
||||||||||||||||
NON-CASH FINANCING ACTIVITIES: |
||||||||||||||||
Capital lease obligations |
$ | $ | $ | |||||||||||||
Non-cash property and equipment additions |
||||||||||||||||
Distributions declared to Optionholders but not paid |
Class A Units Additional Paid-In Capital |
Class B Units Additional Paid-In Capital |
Class C Units Additional Paid-In Capital |
Accumulated Deficit |
Accumulated Other Comprehensive Loss |
Total Members’ Equity (Deficit) |
|||||||||||||||||||
Predecessor: |
||||||||||||||||||||||||
BALANCE—December 31, 2018 |
$ | $ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||||||||||
Share-based compensation |
— | — | — | |||||||||||||||||||||
Foreign currency translation |
— | — | — | — | ( |
) | ( |
) | ||||||||||||||||
Net income |
— | — | — | — | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
BALANCE—December 31, 2019 |
$ | $ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||||||||||
Share-based compensation |
— | — | — | |||||||||||||||||||||
Capital contribution |
— | — | ||||||||||||||||||||||
Distribution to Optionholders |
— | ( |
) | ( |
) | — | — | ( |
) | |||||||||||||||
Foreign currency translation |
— | — | — | — | ( |
) | ( |
) | ||||||||||||||||
Net (loss) |
— | — | — | ( |
) | — | ( |
) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
BALANCE—January 31, 2020 |
$ | $ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock |
Additional Paid-In-Capital |
Accumulated Deficit |
Accumulated Other Comprehensive Loss |
Total Stockholders’ Equity |
||||||||||||||||
Successor: |
||||||||||||||||||||
BALANCE – February 1, 2020 |
$ | $ | $ | $ | $ | |||||||||||||||
Share-based compensation |
— | — | — | |||||||||||||||||
Capital contribution |
— | — | — | |||||||||||||||||
Shareholder distribution |
— | ( |
) | — | — | ( |
) | |||||||||||||
Foreign currency translation |
— | — | — | |||||||||||||||||
Net (loss) |
— | — | ( |
) | — | ( |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
BALANCE—December 31, 2020 |
$ | $ | $ | ( |
) | $ | $ | |||||||||||||
|
|
|
|
|
|
|
|
|
|
1. |
ORGANIZATION, NATURE OF BUSINESS, AND BASIS OF PRESENTATION |
2. |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
Level 1 |
Level 2 |
Level 3 |
||||||||||
Liabilities |
||||||||||||
Interest rate swaps |
$ | $ | $ |
a. | Identify the contract with a customer |
b. | Identify the performance obligations in the contract |
c. | Determine the transaction price |
d. | Allocate the transaction price to the performance obligations in the contract |
e. | Recognize revenue when (or as) the entity satisfies a performance obligation |
3. |
SILVER LAKE TRANSACTION |
Consideration |
||||
Cash, net of cash acquired |
$ | |||
Rollover management equity interests |
||||
Total fair value of consideration transferred |
$ | |||
Current assets |
$ | |||
Property and equipment, including software developed for internal use |
||||
Trade name |
||||
Customer lists |
||||
Deferred tax asset |
||||
Other assets |
||||
Current liabilities |
( |
) | ||
Deferred tax liability |
( |
) | ||
Other liabilities |
( |
) | ||
Total identifiable net assets |
$ | |||
Goodwill |
$ | |||
Years ended December 31, |
||||||||
(in thousands) |
2019 (Unaudited) |
2020 (Unaudited) |
||||||
Revenue |
$ | $ | ||||||
Net (loss) |
$ | ( |
) | $ | ( |
) |
4. |
ALLOWANCE FOR DOUBTFUL ACCOUNTS |
Predecessor: |
||||
Balance – December 31, 2018 |
$ | |
||
Additions |
||||
Write-offs, net of recoveries |
( |
) | ||
Foreign currency translation |
( |
) | ||
Balance – December 31, 2019 |
$ | |||
Additions |
||||
Write-offs, net of recoveries |
( |
) | ||
Foreign currency translation |
||||
Balance – January 31, 2020 |
$ | |||
Successor: |
||||
Balance – February 1, 2020 |
$ | |||
Additions |
||||
Write-offs, net of recoveries |
( |
) | ||
Foreign currency translation |
( |
) | ||
Balance – December 31, 2020 |
$ | |||
5. |
PROPERTY AND EQUIPMENT, NET |
Predecessor |
Successor |
|||||||||||
December 31, 2019 |
December 31, 2020 |
|||||||||||
Furniture and equipment |
$ | $ | ||||||||||
Capitalized software for internal use, acquired by business combination |
||||||||||||
Capitalized software for internal use, developed internally or otherwise purchased |
||||||||||||
Leasehold improvements |
||||||||||||
|
|
|
|
|||||||||
Total property and equipment |
||||||||||||
Less: accumulated depreciation and amortization |
( |
) | ( |
) | ||||||||
|
|
|
|
|||||||||
Property and equipment, net |
$ | $ | ||||||||||
|
|
|
|
6. |
GOODWILL, TRADE NAME, AND CUSTOMER LISTS |
Predecessor: |
||||
Balance – December 31, 2018 |
$ | |||
Foreign currency translation |
||||
|
|
|||
Balance – December 31, 2019 |
$ | |||
Foreign currency translation |
( |
) | ||
|
|
|||
Balance – January 31, 2020 |
$ | |||
|
|
|||
Successor: |
||||
Balance – February 1, 2020 |
$ | |||
Foreign currency translation |
||||
|
|
|||
Balance – December 31, 2020 |
$ | |||
|
|
2019 (Predecessor) |
||||||||||||||||
Gross Carrying Value |
Accumulated Amortization |
Net Carrying Value |
Useful Life (in years) |
|||||||||||||
Trade name |
$ | $ | — | $ | Indefinite | |||||||||||
Customer lists |
( |
) | ||||||||||||||
|
|
|
|
|
|
|||||||||||
Total |
$ | $ | ( |
) | $ | |||||||||||
|
|
|
|
|
|
|||||||||||
2020 (Successor) |
||||||||||||||||
Gross Carrying Value |
Accumulated Amortization |
Net Carrying Value |
Useful Life (in years) |
|||||||||||||
Trade name |
$ | $ | ( |
) | $ | |||||||||||
Customer lists |
( |
) | ||||||||||||||
|
|
|
|
|
|
|||||||||||
Total |
$ | $ | ( |
) | $ | |||||||||||
|
|
|
|
|
|
Years Ending December 31, |
||||
2021 |
$ | |||
2022 |
||||
2023 |
||||
2024 |
||||
2025 |
||||
Thereafter |
||||
|
|
|||
$ | ||||
|
|
|
|
7. |
LONG-TERM DEBT |
Predecessor |
||||
December 31, 2019 |
||||
Predecessor First Lien Facility |
$ | |||
Predecessor Second Lien Facility |
||||
|
|
|||
Total debt |
||||
Less: Current portion of long-term debt |
||||
|
|
|||
Total long-term debt |
||||
Less: Deferred financing costs |
( |
) | ||
|
|
|||
Long-term debt, net |
$ | |||
|
|
Successor |
||||
December 31, 2020 |
||||
Successor First Lien Facility |
$ | |||
Successor Second Lien Facility |
||||
|
|
|||
Total debt |
||||
Less: Current portion of long-term debt |
( |
) | ||
|
|
|||
Total long-term debt |
||||
Less: Deferred financing costs |
( |
) | ||
|
|
|||
Long-term debt, net |
$ | |||
|
|
Years Ending December 31, |
||||
2021 |
$ | |||
2022 |
||||
2023 |
||||
2024 |
||||
2025 |
||||
Thereafter |
||||
|
|
|||
$ | ||||
|
|
8. |
DERIVATIVES |
Fair Value |
Gain/(Loss) | |||||||||
Derivatives not designated as hedging instruments |
Balance Sheet Location |
As of December 31, 2020 |
Income Statement Location |
Period from February 1, 2020 through December 31, 2020 (Successor) | ||||||
Interest rate swaps |
Other Liabilities | $ | Interest expense, net |
$ ( |
9. |
INCOME TAXES |
Predecessor |
Successor |
|||||||||||||||
Year Ended December 31, 2019 |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through December 31, 2020 |
||||||||||||||
Income (loss) before provision for income taxes from United States operations |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||
Income before provision for income taxes from foreign operations |
||||||||||||||||
|
|
|
|
|
|
|||||||||||
Net income (loss) before provision for income taxes |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||
|
|
|
|
|
|
Predecessor |
Successor |
|||||||||||||||
Year Ended December 31, 2019 |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through December 31, 2020 |
||||||||||||||
Current: |
||||||||||||||||
Federal |
$ |
( |
) |
$ |
( |
) |
$ |
|||||||||
State |
( |
) |
||||||||||||||
Foreign |
||||||||||||||||
|
|
|
|
|
|
|||||||||||
Total Current |
$ |
$ |
$ |
|||||||||||||
|
|
|
|
|
|
|||||||||||
Deferred: |
||||||||||||||||
Federal |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||
State |
( |
) |
( |
) | ||||||||||||
Foreign |
( |
) |
( |
) |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||||||
Total Deferred |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||
|
|
|
|
|
|
|||||||||||
Total |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||
|
|
|
|
|
|
Predecessor |
Successor |
|||||||||||||||
Year Ended December 31, 2019 |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through December 31, 2020 |
||||||||||||||
U.S. federal statutory rate |
% |
% |
% | |||||||||||||
State and local income taxes – net of federal tax benefits |
( |
) |
( |
) | ||||||||||||
Foreign rate difference |
( |
) | ||||||||||||||
Change in valuation allowance |
( |
) |
( |
) |
||||||||||||
GILTI inclusion |
( |
) |
||||||||||||||
Transaction cost |
( |
) |
( |
) | ||||||||||||
Share-based compensation |
( |
) |
( |
) | ||||||||||||
Rate change impact |
||||||||||||||||
US research and development credit |
( |
) |
||||||||||||||
Withholding tax |
( |
) | ||||||||||||||
Other nondeductible items |
( |
) |
( |
) |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||||||
Effective rate |
% |
% |
% | |||||||||||||
|
|
|
|
|
|
Predecessor |
Successor |
|||||||||||
December 31, 2019 |
December 31, 2020 |
|||||||||||
Deferred tax assets: |
||||||||||||
Federal net operating loss carryforwards |
$ |
$ |
||||||||||
State net operating loss carryforwards |
||||||||||||
Foreign net operating loss carryforwards |
||||||||||||
Deferred revenue |
||||||||||||
Bad debt reserves |
||||||||||||
Employee benefits |
||||||||||||
Share-based compensation |
||||||||||||
Accrued expenses and loss reserves |
||||||||||||
Interest subject to IRC Section 163(j) |
||||||||||||
Other deferred tax assets |
||||||||||||
Depreciable and other amortizable assets |
||||||||||||
Less: Valuation allowance |
( |
) |
( |
) | ||||||||
|
|
|
|
|||||||||
Total deferred tax asset |
$ |
$ |
||||||||||
Deferred tax liabilities: |
||||||||||||
Trade name |
$ |
( |
) |
$ |
( |
) | ||||||
Goodwill |
( |
) |
( |
) | ||||||||
Depreciable and other amortizable assets |
( |
) | ||||||||||
Other deferred liabilities |
( |
) |
( |
) | ||||||||
|
|
|
|
|||||||||
Total deferred tax liability |
$ |
( |
) |
$ |
( |
) | ||||||
|
|
|
|
|||||||||
Net deferred tax liability |
$ |
( |
) |
$ |
( |
) | ||||||
|
|
|
|
Predecessor |
Successor |
|||||||||||
December 31, 2019 |
December 31, 2020 |
|||||||||||
Federal |
$ |
$ |
||||||||||
State |
||||||||||||
Foreign |
||||||||||||
|
|
|
|
|||||||||
$ |
$ |
Predecessor |
Successor |
|||||||||||||||
Year Ended December 31, 2019 |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through December 31, 2020 |
||||||||||||||
Balance, beginning of period |
$ |
$ |
$ |
|||||||||||||
Increases for tax positions related to prior years |
||||||||||||||||
Decreases for tax positions related to prior years |
( |
) |
( |
) |
||||||||||||
|
|
|
|
|
|
|||||||||||
Balance, end of period |
$ |
$ |
$ |
|||||||||||||
|
|
|
|
|
|
10. |
REVENUES |
Predecessor |
Successor |
|||||||||||||||
(in thousands) |
Year Ended December 31, 2019 |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through December 31, 2020 |
|||||||||||||
Revenues |
||||||||||||||||
North America |
$ | $ | $ | |||||||||||||
International |
||||||||||||||||
Eliminations |
( |
) | ( |
) | ( |
) | ||||||||||
|
|
|
|
|
|
|||||||||||
Total revenues |
$ | $ | $ | |||||||||||||
|
|
|
|
|
|
11. |
SHARE-BASED COMPENSATION |
Class B |
Class C |
|||||||||||||||||
Units |
Weighted Average Exercise Price |
Units |
Weighted Average Exercise Price |
|||||||||||||||
December 31, 2018 |
Grants outstanding | $ | $ | |||||||||||||||
Forfeited | $ | ( |
) | $ | ||||||||||||||
December 31, 2019 |
Grants outstanding | $ | $ | |||||||||||||||
Forfeited | $ | ( |
) | $ | ||||||||||||||
January 31, 2020 |
Grants outstanding | $ | $ | |||||||||||||||
January 31, 2020 |
Grants vested | $ | $ | |||||||||||||||
January 31, 2020 |
Grants unvested | $ | $ |
2020 Class B |
2020 Class C |
|||||||
Expected volatility |
% | % | ||||||
Risk-free interest rate |
% | % | ||||||
Expected term (in years) |
||||||||
Estimated fair-value of the underlying unit |
$ | $ |
Class C |
||||||
Units |
||||||
February 1, 2020 |
Grants outstanding |
|||||
Issued |
||||||
Forfeited |
( |
) | ||||
December 31, 2020 |
Grants outstanding |
|||||
December 31, 2020 |
Grants vested |
|||||
December 31, 2020 |
Grants unvested |
Class B |
||||||||||
Units |
Weighted Average Exercise Price |
|||||||||
February 1, 2020 |
Grants outstanding |
$ | ||||||||
Issued |
$ | |||||||||
Forfeited |
( |
) | $ | |||||||
December 31, 2020 |
Grants outstanding |
$ | ||||||||
December 31, 2020 |
Grants vested |
$ | ||||||||
December 31, 2020 |
Grants unvested |
$ |
12. |
EQUITY |
13. |
COMMITMENTS AND CONTINGENCIES |
Predecessor |
Successor |
|||||||||||||||
Year Ended December 31, 2019 |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through December 31, 2020 |
||||||||||||||
Depreciation and amortization |
$ | $ | $ | |||||||||||||
Interest expense |
$ | $ | $ |
Years Ending December 31, |
||||||||
Operating Leases |
Capital Leases |
|||||||
2021 |
$ | $ | ||||||
2022 |
||||||||
2023 |
||||||||
2024 |
||||||||
2025 |
||||||||
Thereafter |
||||||||
Total minimum lease payments |
$ | |||||||
Less: Imputed interest |
( |
) | ||||||
Present value of minimum lease payments under capital leases |
||||||||
Less: Current portion of capital lease liability |
( |
) | ||||||
Total long-term capital lease liability |
$ | |||||||
14. |
RELATED PARTY TRANSACTIONS |
15. |
NET INCOME (LOSS) PER SHARE |
Predecessor |
Successor |
|||||||||||||||
For the Year Ended December 31, 2019 |
Period from January 1, 2020 through January 31, 2020 |
Period from February 1, 2020 through December 31, 2020 |
||||||||||||||
Basic and diluted net income (loss) per share |
$ | n/a | $ | n/a | $ | ( |
) | |||||||||
Numerator: |
||||||||||||||||
Net income (loss) |
$ | n/a | $ | n/a | $ | ( |
) | |||||||||
Denominator: |
||||||||||||||||
Weighted-average common shares outstanding used in computing basic and diluted net income (loss) per share |
n/a | n/a | ||||||||||||||
Basic net income (loss) per unit |
$ | $ | ( |
) | $ | n/a | ||||||||||
Diluted net income (loss) per unit |
$ | $ | ( |
) | $ | n/a | ||||||||||
Numerator: |
||||||||||||||||
Net income (loss) |
$ | $ | ( |
) | $ | n/a | ||||||||||
Denominator |
||||||||||||||||
Weighted-average common shares outstanding used in computing basic net income (loss) per unit |
n/a | |||||||||||||||
Add options and restricted stock units to purchase units |
n/a | |||||||||||||||
Weighted-average shares used in computing diluted net income (loss) per unit |
n/a | |||||||||||||||
16. |
ENTITY-WIDE DISCLOSURES |
Predecessor |
Successor |
|||||||||||
December 31, 2019 |
December 31, 2020 |
|||||||||||
Long-lived assets, net |
||||||||||||
United States, country of domicile |
$ | $ | ||||||||||
International |
||||||||||||
Total long-lived assets, net |
$ | $ | ||||||||||
17. |
SUBSEQUENT EVENTS |
18. |
CONDENSED FINANCIAL INFORMATION OF REGISTRANT |
As of December 31, |
||||||||
2019 |
2020 |
|||||||
ASSETS |
||||||||
Investment in subsidiaries |
$ |
$ |
||||||
LIABILITIES AND EQUITY |
||||||||
Liabilities |
$ |
$ |
||||||
EQUITY |
||||||||
Common stock—$ |
||||||||
Additional paid-in-capital |
||||||||
Accumulated deficit |
( |
) | ||||||
Accumulated other comprehensive income |
||||||||
Total equity |
||||||||
TOTAL LIABILITIES AND EQUITY |
$ |
$ |
||||||
For the Period from November 15, 2019 through December 31, 2019 |
For the Year Ended December 31, 2020 |
|||||||
Equity in net (loss) of subsidiaries |
$ |
$ |
( |
) | ||||
NET (LOSS) |
( |
) | ||||||
Foreign currency translation adjustments |
||||||||
COMPREHENSIVE (LOSS) |
$ |
$ |
( |
) | ||||
NET (LOSS) |
$ |
$ |
( |
) | ||||
Basic and diluted net (loss) per share |
$ |
$ |
( |
) | ||||
Weighted average number of shares outstanding – basic and diluted |
Successor |
Successor |
|||||||
September 30, 2021 |
December 31, 2020 |
|||||||
ASSETS |
||||||||
CURRENT ASSETS |
||||||||
Cash and cash equivalents |
$ | $ |
||||||
Restricted cash |
||||||||
Short-term investments |
||||||||
Accounts receivable (net of allowance for doubtful accounts of $ and $ at September 30, 2021 and December 31, 2020, respectively) |
||||||||
Prepaid expenses and other current assets |
||||||||
Income tax receivable |
||||||||
Total current assets |
||||||||
Property and equipment, net |
||||||||
Goodwill |
||||||||
Trade name, net |
||||||||
Customer lists, net |
||||||||
Deferred tax asset, net |
||||||||
Other assets |
||||||||
TOTAL ASSETS |
$ | $ |
||||||
LIABILITIES AND EQUITY |
||||||||
CURRENT LIABILITIES |
||||||||
Accounts payable |
$ | $ | ||||||
Accrued compensation |
||||||||
Accrued liabilities |
||||||||
Current portion of long-term debt |
||||||||
Income tax payable |
||||||||
Deferred revenue |
||||||||
Total current liabilities |
||||||||
Long-term debt (net of deferred financing costs of $ September 30, 2021 and December 31, 2020, respectively) |
||||||||
Deferred tax liability, net |
||||||||
Other liabilities |
||||||||
Total liabilities |
||||||||
C OMMITMENTS AND CONTINGENCIES (Note 12) |
||||||||
EQUITY |
||||||||
Common stock—$ par value; shares authorized, and shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively |
||||||||
Additional paid-in-capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
Accumulated other comprehensive income |
||||||||
Total equity |
||||||||
TOTAL LIABILITIES AND EQUITY |
$ | $ | ||||||
Three-Month Period (1) |
Nine-Month Period (1) |
|||||||||||||||||||
Successor |
Predecessor |
|||||||||||||||||||
|
|
|
|
|||||||||||||||||
Three Months Ended September 30, 2021 |
Three Months Ended September 30, 2020 |
Nine Months Ended September 30, 2021 |
Period from February 1, 2020 through September 30, 2020 |
Period from January 1, 2020 through January 31, 2020 |
||||||||||||||||
REVENUES |
$ | $ | $ | $ | $ | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING EXPENSES: |
||||||||||||||||||||
Cost of services (exclusive of depreciation and amortization below) |
||||||||||||||||||||
Product and technology expense |
||||||||||||||||||||
Selling, general, and administrative expense |
||||||||||||||||||||
Depreciation and amortization |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total operating expenses |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
INCOME (LOSS) FROM OPERATIONS |
( |
) | ( |
) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
OTHER EXPENSE (INCOME): |
||||||||||||||||||||
Interest expense |
||||||||||||||||||||
Interest income |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||
Loss on extinguishment of debt |
||||||||||||||||||||
Transaction expenses, change in control |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total other expense |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
INCOME (LOSS) BEFORE PROVISION FOR INCOME TAXES |
( |
) | ( |
) | ( |
) | ||||||||||||||
Provision (benefit) for income taxes |
( |
) | ( |
) | ( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
NET INCOME (LOSS) |
$ | $ | ( |
) | $ | $ | ( |
) | $ | ( |
) | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Foreign currency translation (loss) income |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
COMPREHENSIVE INCOME (LOSS) |
$ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
NET INCOME (LOSS) |
$ | $ | ( |
) | $ | $ | ( |
) | $ | ( |
) | |||||||||
Basic net income (loss) per share |
$ | $ | ( |
) | $ | $ | ( |
) | n/a | |||||||||||
Diluted net income (loss) per share |
$ | $ | ( |
) | $ | $ | ( |
) | n/a | |||||||||||
Weighted average number of shares outstanding—basic |
n/a | |||||||||||||||||||
Weighted average number of shares outstanding—diluted |
n/a | |||||||||||||||||||
Basic net (loss) per unit |
n/a | n/a | n/a | n/a | $ | ( |
) | |||||||||||||
Diluted net (loss) per unit |
n/a | n/a | n/a | n/a | $ | ( |
) | |||||||||||||
Weighted average units outstanding—basic |
n/a | n/a | n/a | n/a | ||||||||||||||||
Weighted average units outstanding— diluted |
n/a | n/a | n/a | n/a |
(1) | See Note 1 “Organization, Nature of Business, and Basis of Presentation” for further discussion. |
Successor |
Predecessor |
|||||||||||
Nine Months Ended September 30, 2021 |
Period from February 1, through September ,2020 |
Period from January 1, through January 31, 2020 |
||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES |
||||||||||||
Net income (loss) |
$ | $ | ( |
) | $ | ( |
) | |||||
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: |
||||||||||||
Depreciation and amortization |
||||||||||||
Loss on extinguishment of debt |
||||||||||||
Amortization of deferred financing costs |
||||||||||||
Bad debt (recovery) expense |
( |
) | ||||||||||
Deferred taxes |
( |
) | ( |
) | ( |
) | ||||||
Share-based compensation |
||||||||||||
(Gain) on foreign currency exchange rates |
( |
) | ( |
) | ( |
) | ||||||
Loss on disposal of fixed assets |
||||||||||||
Change in fair value of interest rate swaps |
( |
) | ||||||||||
Changes in operating assets and liabilities: |
||||||||||||
Accounts receivable |
( |
) | ( |
) | ||||||||
Prepaid expenses and other current assets |
( |
) | ( |
) | ||||||||
Other assets |
( |
) | ( |
) | ( |
) | ||||||
Accounts payable |
( |
) | ||||||||||
Accrued compensation and accrued liabilities |
( |
) | ||||||||||
Deferred revenue |
( |
) | ||||||||||
Other liabilities |
||||||||||||
Income taxes receivable and payable, net |
( |
) | ||||||||||
Net cash provided by (used in) operating activities |
( |
) | ||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES |
||||||||||||
Changes in short-term investments |
( |
) | ||||||||||
Acquisition of business |
( |
) | ||||||||||
Purchase of property and equipment |
( |
) | ( |
) | ( |
) | ||||||
Capitalized software development costs |
( |
) | ( |
) | ( |
) | ||||||
Net cash used in investing activities |
( |
) | ( |
) | ( |
) | ||||||
Successor |
Predecessor |
|||||||||||
Nine Months Ended September 30, 2021 |
Period from February 1, 2020 through September 30, 2020 |
Period from January 1, 2020 through January 31, 2020 |
||||||||||
CASH FLOWS FROM FINANCING ACTIVITIES |
||||||||||||
Proceeds from issuance of common stock in initial public offering, net of underwriting discounts and commissions |
||||||||||||
Payments of initial public offering issuance costs |
( |
) | ||||||||||
Shareholder distribution |
( |
) | ||||||||||
Capital contributions |
||||||||||||
Distributions to Predecessor Members and Optionholders |
( |
) | ( |
) | ||||||||
Borrowings from Successor First Lien Credit Facility |
||||||||||||
Repayments of Successor First Lien Credit Facility |
( |
) | ( |
) | ||||||||
Repayment of Successor Second Lien Credit Facility |
( |
) | ||||||||||
Borrowings on Successor Revolver |
||||||||||||
Repayments on Successor Revolver |
( |
) | ||||||||||
Repayment of Predecessor First Lien Credit Facility |
( |
) | ||||||||||
Payments of debt issuance costs |
( |
) | ( |
) | ||||||||
Payments on capital lease obligations |
( |
) | ( |
) | ( |
) | ||||||
Payments on deferred purchase agreements |
( |
) | ||||||||||
Proceeds from stock option exercises |
— |
— |
||||||||||
Net settlement of stock option exercises |
( |
) |
— |
— |
||||||||
Net cash provided by (used in) financing activities |
( |
) | ||||||||||
Effect of exchange rate on cash. cash equivalents, and restricted cash |
( |
) | ( |
) | ( |
) | ||||||
Increase (decrease) in cash, cash equivalents, and restricted cash |
( |
) | ||||||||||
Cash, cash equivalents, and restricted cash at beginning of period |
||||||||||||
Cash, cash equivalents, and restricted cash at end of period |
$ | $ | $ | |||||||||
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: |
||||||||||||
Cash paid for income taxes, net of refunds received |
$ | $ | $ | |||||||||
Cash paid for interest |
$ | $ | $ | |||||||||
NON-CASH INVESTING AND FINANCING ACTIVITIES: |
||||||||||||
Offering costs included in accounts payable and accrued liabilities |
$ | $ | $ | |||||||||
Non-cash property and equipment additions |
$ | $ | $ | |||||||||
Distributions declared to Optionholders but not paid |
$ | $ | $ |
Common Stock |
Additional Paid-In-Capital |
Accumulated Deficit |
Accumulated Other Comprehensive Income |
Total Stockholders’ Equity |
||||||||||||||||
Successor: |
||||||||||||||||||||
For the period from January 1, 2021 to September 30, 2021 |
||||||||||||||||||||
BALANCE – December 31, 2020 |
$ |
$ |
$ |
( |
) |
$ |
$ |
|||||||||||||
Share-based compensation |
— |
— |
— |
|||||||||||||||||
Foreign currency translation |
— |
— |
— |
|||||||||||||||||
Net (loss) |
— |
— |
( |
) |
— |
( |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
BALANCE – March 31, 2021 |
$ |
$ |
$ |
( |
) |
$ |
$ |
|||||||||||||
Share-based compensation |
— |
— |
— |
|||||||||||||||||
Capital contributions |
— |
— |
— |
|||||||||||||||||
Issuance of common stock in connection with initial public offering, net of offering costs, underwriting discounts and commissions |
— |
— |
||||||||||||||||||
Shareholder distribution |
— |
( |
) |
— |
— |
( |
) | |||||||||||||
Foreign currency translation |
— |
— |
— |
( |
) |
( |
) | |||||||||||||
Net income |
— |
— |
— |
|||||||||||||||||
BALANCE – June 30, 2021 |
$ |
$ |
$ |
( |
) |
$ |
$ |
|||||||||||||
Share-based compensation |
— |
— |
— |
|||||||||||||||||
Exercise of stock options |
— |
— |
— |
|||||||||||||||||
Common stock withheld for tax obligations and net settlement of stock option exercise |
— |
( |
) |
— |
— |
( |
) | |||||||||||||
Foreign currency translation |
— |
— |
— |
( |
) |
( |
) | |||||||||||||
Net income |
— |
— |
— |
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
BALANCE – September 30, 2021 |
$ |
$ |
$ |
( |
) |
$ |
$ |
|||||||||||||
|
|
|
|
|
|
|
|
|
|
(in thousands) |
Common Stock |
Additional Paid-In-Capital |
Accumulated Deficit |
Accumulated Other Comprehensive (Loss) |
Total Stockholders’ Equity |
|||||||||||||||
Successor: |
||||||||||||||||||||
For the period from February 1, 2020 to September 30, 2020 |
||||||||||||||||||||
BALANCE – February 1, 2020 |
$ |
$ |
$ |
— |
$ |
— |
$ |
|||||||||||||
Share-based compensation |
— |
— |
— |
|||||||||||||||||
Capital contributions |
— |
— |
— |
|||||||||||||||||
Foreign currency translation |
— |
— |
— |
( |
) |
( |
) | |||||||||||||
Net (loss) |
— |
— |
( |
) |
— |
( |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
BALANCE – March 31, 2020 |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
|||||||||||
Share-based compensation |
— |
— |
— |
|||||||||||||||||
Foreign currency translation |
— |
— |
— |
|||||||||||||||||
Net (loss) |
— |
— |
( |
) |
— |
( |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
BALANCE – June 30, 2020 |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
|||||||||||
Share-based compensation |
— |
— |
— |
|||||||||||||||||
Foreign currency translation |
— |
— |
— |
|||||||||||||||||
Net (loss) |
— |
— |
( |
) |
— |
( |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
BALANCE – September 30, 2020 |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
|||||||||||
|
|
|
|
|
|
|
|
|
|
Class A Units Additional Paid-In Capital |
Class B Units Additional Paid-In Capital |
Class C Units Additional Paid-In Capital |
Accumulated Deficit |
Accumulated Other Comprehensive (Loss) |
Total Members’ (Deficit) Equity |
|||||||||||||||||||
Predecessor: |
||||||||||||||||||||||||
For the period January 1, 2020 to January 31, 2020 |
||||||||||||||||||||||||
BALANCE—December 31, 2019 |
$ | $ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||||||||||
Share-based compensation |
— | — | — | |||||||||||||||||||||
Capital contributions |
— | — | ||||||||||||||||||||||
Distribution to Optionholders |
— | ( |
) | ( |
) | — | — | ( |
) | |||||||||||||||
Foreign currency translation |
— | — | — | — | ( |
) | ( |
) | ||||||||||||||||
Net (loss) |
— | — | — | ( |
) | — | ( |
) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
BALANCE— January 31, 2020 |
$ | $ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Level 1 |
Level 2 |
Level 3 |
||||||||||
Liabilities |
||||||||||||
Interest rate swaps |
$ | $ | $ |
a) | Identify the contract with a customer |
b) | Identify the performance obligations in the contract |
c) | Determine the transaction price |
d) | Allocate the transaction price to the performance obligations in the contract |
e) | Recognize revenue when (or as) the entity satisfies a performance obligation |
Consideration |
||||
Cash, net of cash acquired |
$ | |||
Rollover management equity interests |
||||
Total fair value of consideration transferred |
$ | |||
Current assets |
$ | |||
Property and equipment, including software developed for internal use |
||||
Trade name |
||||
Customer lists |
||||
Deferred tax asset |
||||
Other assets |
||||
Current liabilities |
( |
) | ||
Deferred tax liability |
( |
) | ||
Other liabilities |
( |
) | ||
Total identifiable net assets |
$ | |||
Goodwill |
$ | |||
(in thousands) |
Three Months Ended September 30, 2020 |
Nine Months Ended September 30, 2020 |
||||||
Revenue |
$ | $ | ||||||
Net income (loss) |
$ | $ | ( |
) |
Consideration |
||||
Cash |
$ |
|||
Property and equipment, including software developed for internal use |
$ |
|||
Customer lists |
||||
Deferred tax liability |
( |
) | ||
Total identifiable net assets |
$ |
|||
Goodwill |
$ |
|||
Successor |
Successor |
|||||||
September 30,2021 |
December 31, 2020 |
|||||||
Furniture and equipment |
$ | $ | ||||||
Capitalized software for internal use, acquired by business combination |
||||||||
Capitalized software for internal use, developed internally or otherwise purchased |
||||||||
Leasehold improvements |
||||||||
Total property and equipment |
||||||||
Less: accumulated depreciation and amortization |
( |
) | ( |
) | ||||
Property and equipment, net |
$ |
$ |
||||||
Successor: |
||||
Balance – December 31, 2020 |
$ | |||
Acquisitions |
||||
Foreign currency translation |
( |
) | ||
Balance – September 30, 2021 |
$ | |||
September 30, 2021 (Successor) |
||||||||||||||||
Gross Carrying Value |
Accumulated Amortization |
Net Carrying Value |
Useful Life (in years) |
|||||||||||||
Trade name |
$ | $ | ( |
) | $ | |||||||||||
Customer lists |
( |
) | ||||||||||||||
Total |
$ | $ | ( |
) | $ | |||||||||||
December 31, 2020 (Successor) |
||||||||||||||||
Gross Carrying Value |
Accumulated Amortization |
Net Carrying Value |
Useful Life (in years) |
|||||||||||||
Trade name |
$ | $ | ( |
) | $ | |||||||||||
Customer lists |
( |
) | ||||||||||||||
Total |
$ | $ | ( |
) | $ | |||||||||||
Successor |
Successor |
|||||||
September 30, 2021 |
December 31, 2020 |
|||||||
Successor First Lien Credit Facility |
$ | $ | ||||||
Successor Second Lien Credit Facility |
||||||||
Total debt |
||||||||
Less: Current portion of long-term debt |
( |
) | ||||||
Total long-term debt |
||||||||
Less: Deferred financing costs |
( |
) | ( |
) | ||||
Long-term debt, net |
$ | $ | ||||||
Fair Value |
Gain/(Loss) |
|||||||||||||||||||||||||||
Derivatives not designated as hedging instruments |
Balance Sheet Location |
As of September 30, 2021 (Successor) |
As of December 31, 2020 (Successor) |
Income Statement Location |
Three Months Ended September 30, 2021 (Successor) |
Three Months Ended September 30, 2020 (Successor) |
Nine Months Ended September 30, 2021 (Successor) |
Period from February 1, 2020 through September 30, 2020 (Successor) |
||||||||||||||||||||
Interest rate swaps |
Other liabilities | $ | $ | Interest expense | $ | ( |
) | $ | $ | $ | ( |
) |
Three-Month Period |
Nine-Month Period |
|||||||||||||||||||||||
Successor |
Predecessor |
|||||||||||||||||||||||
Three Months Ended September 30, 2021 |
Three Months Ended September 30, 2020 |
Nine Months Ended September 30, 2021 |
Period from February 1, 2020 through September 30, 2020 |
Period from January 1, 2020 through January 31, 2020 |
||||||||||||||||||||
Revenues |
||||||||||||||||||||||||
North America |
$ | $ | $ | $ | $ | |||||||||||||||||||
International |
||||||||||||||||||||||||
Eliminations |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
Total revenues |
$ | $ | $ | $ | $ | |||||||||||||||||||
Three-Month Period |
Nine-Month Period |
|||||||||||||||||||||||
Successor |
Predecessor |
|||||||||||||||||||||||
Three Months Ended September 30, 2021 |
Three Months Ended September 30, 2020 |
Nine Months Ended September 30, 2021 |
Period from February 1, 2020 through September 30, 2020 |
Period from January 1, 2020 through January 31, 2020 |
||||||||||||||||||||
Share-based compensation expense |
||||||||||||||||||||||||
Cost of services |
$ | $ | $ | $ | $ | |||||||||||||||||||
Product and technology expense |
||||||||||||||||||||||||
Selling, general, and administrative expense |
||||||||||||||||||||||||
Total share-based compensation expense |
$ | $ | $ | $ | $ | |||||||||||||||||||
2020 Class B |
2020 Class C |
|||||||
Expected stock price volatility |
% | % | ||||||
Risk-free interest rate |
% | % | ||||||
Expected term (in years) |
||||||||
Estimated fair-value of the underlying unit |
$ | $ |
Class C |
||||||
Units |
||||||
December 31, 2020 |
Grants outstanding | |||||
Exchanged for common stock in the Company | ( |
) | ||||
Exchanged for restricted stock in the Company | ( |
) | ||||
|
|
|||||
September 30 , 2021 |
Grants outstanding | |||||
|
|
|
|
|
|
|
Options |
Weighted Average Exercise Price |
|||||||||
December 31, 2020 |
Grants outstanding | $ | ||||||||
Exercised | ( |
) | $ | |||||||
Forfeited | ( |
) | $ | |||||||
Exchanged for options in the Company | ( |
) | $ | |||||||
|
|
|||||||||
September 30 , 2021 |
Grants outstanding | |||||||||
|
|
|
|
|
|
|
|
|
|
|
• |
All vested outstanding profits interest grants issued by the Company’s parent were converted to common stock in the Company and all unvested outstanding profits interest grants issued by the Company’s parent were converted to restricted stock in the Company under the 2021 Omnibus Incentive Plan (the “2021 Equity Plan”). The number of common stock and restricted stock shares issued to each profits interest holder was ratably adjusted to preserve the fair value of the awards. Additionally, the vesting conditions and equity classification of the awards remained unchanged as a result of the conversion. |
• |
All outstanding stock option grants issued by the Company’s parent were converted into stock options issued by the Company under the terms of the individual grant agreements. The number of options granted and the strike price of the options was ratably adjusted using an exchange ratio calculated to preserve the fair value of the awards. Additionally, the vesting, vesting conditions, and equity classification of the awards remained unchanged as a result of the conversion. |
Options |
Weighted Average Price |
|||||||||
December 31, 2020 |
Grants outstanding | $ | ||||||||
Grants issued in exchange for options in the Company’s Parent | $ | |||||||||
|
|
Grants exercised |
|
|
( |
) |
|
$ |
|
|
|
|
Grants cancelled/forfeited |
|
|
( |
) |
|
$ |
|
|
|
|
|||||||||
September 30 , 2021 |
Grants outstanding | $ |
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30 , 2021 |
Grants vested | $ | ||||||||
September 30 , 2021 |
Grants unvested | $ |
Options |
Weighted Average Exercise Price |
|||||||||
June 21, 2021 |
Grants outstanding | $ | ||||||||
Grants issued | $ | |||||||||
|
|
|||||||||
September 30 , 2021 |
Grants outstanding | $ | ||||||||
|
|
|
|
|
|
|
|
|
|
|
September 30 , 2021 |
Grants vested | $ | ||||||||
September 30 , 2021 |
Grants unvested | $ |
Options |
||||
Expected stock price volatility |
% | |||
Risk-free interest rate |
% | |||
Expected term (in years) |
||||
Estimated fair-value of the underlying unit |
$ |
Shares |
||||||
June 21, 2021 |
Nonvested RSUs | |||||
Granted | ||||||
Vested | ||||||
|
|
|||||
September 30, 2021 |
Nonvested RSUs | |||||
|
|
|
|
|
|
|
|
Shares |
||||||
June 21, 2021 |
|
Nonvested restricted stock | |||||
|
Grants issued in exchange for unvested profits interests in the Company’s Parent | ||||||
|
Vested | ||||||
|
|
|
|||||
September 30, 2021 |
|
Nonvested restricted stock | |||||
|
|
|
|
|
|
|
|
Three-Month Period |
Nine-Month Period |
|||||||||||||||||||||||
Successor |
|
Predecessor |
||||||||||||||||||||||
Three Months Ended September 30, 2021 |
Three Months Ended September 30, 2020 |
Nine Months Ended September 30, 2021 |
Period from February 1, 2020 through September 30, 2020 |
|
Period from January 1, 2020 through January 31, 2020 |
|||||||||||||||||||
Basic net income (loss) per share |
$ | $ | ( |
) | $ | $ | ( |
) | n/a | |||||||||||||||
Diluted net income (loss) per share |
$ | $ | ( |
) | $ | $ | ( |
) | n/a | |||||||||||||||
Numerator: |
||||||||||||||||||||||||
Net income (loss) (in thousands) |
$ | $ | ( |
) | $ | $ | ( |
) | n/a | |||||||||||||||
Denominator: |
||||||||||||||||||||||||
Weighted average number of shares outstanding - basic |
n/a | |||||||||||||||||||||||
Add options and restricted stock units to purchase units |
n/a |
Three-Month Period |
Nine-Month Period |
|||||||||||||||||||||||
Successor |
Predecessor |
|||||||||||||||||||||||
Three Months Ended September 30, 2021 |
Three Months Ended September 30, 2020 |
Nine Months Ended September 30, 2021 |
Period from February 1, 2020 through September 30, 2020 |
Period from January 1, 2020 through January 31, 2020 |
||||||||||||||||||||
Weighted average number of shares outstanding - diluted |
n/a |
|||||||||||||||||||||||
Basic net (loss) per unit |
n/a | n/a | n/a | n/a | $ | ( |
) | |||||||||||||||||
Diluted net (loss) per unit |
n/a | n/a | n/a | n/a | $ | ( |
) | |||||||||||||||||
Numerator: |
||||||||||||||||||||||||
Net (loss) |
n/a | n/a | n/a | n/a | $ | ( |
) | |||||||||||||||||
Denominator: |
n/a |
|||||||||||||||||||||||
Weighted units outstanding - basic |
n/a | n/a | n/a | n/a | ||||||||||||||||||||
Add options and restricted stock units to purchase units |
n/a | n/a | n/a | n/a | ||||||||||||||||||||
Weighted average units outstanding - diluted |
n/a | n/a | n/a | n/a |
(dollars in thousands) |
||||
SEC registration fee |
$ |
30,379 |
| |
FINRA filing fee |
49,656 | |||
Printing fees and expenses |
150,000 | |||
Legal fees and expenses |
1,000,000 | |||
Accounting fees and expenses |
400,000 | |||
Blue Sky fees and expenses (including legal fees) |
50,000 | |||
Transfer agent and registrar fees and expenses |
15,000 | |||
Miscellaneous |
204,965 | |||
|
|
|||
Total |
$ | 1,900,000 | ||
|
|
(a) | Exhibits. |
(b) | Financial Statement Schedules. |
* | Filed herewith. |
† | Compensatory arrangements for director(s) and/or executive officer(s). |
FIRST ADVANTAGE CORPORATION | ||
By: |
/S/ SCOTT STAPLES | |
Name: Scott Staples | ||
Title: Chief Executive Officer |
Signatures |
Title | |
/S/ SCOTT STAPLES SCOTT STAPLES |
Chief Executive Officer & Director (principal executive officer) | |
/S/ DAVID L. GAMSEY DAVID L. GAMSEY |
Executive Vice President & Chief Financial Officer (principal financial officer and principal accounting officer) | |
/S/ JOSEPH OSNOSS JOSEPH OSNOSS |
Director | |
/S/ SUSAN R. BELL SUSAN R. BELL |
Director | |
/S/ JAMES L. CLARK JAMES L. CLARK |
Director | |
/S/ JOHN RUDELLA JOHN RUDELLA |
Director | |
/S/ JUDITH SIM JUDITH SIM |
Director | |
/S/ BIANCA STOICA BIANCA STOICA |
Director |
Exhibit 1.1
[ ] shares
First Advantage Corporation
Common Stock
UNDERWRITING AGREEMENT
November [ ], 2021
BARCLAYS CAPITAL INC.
BOFA SECURITIES, INC.
As Representatives of the several
Underwriters named in Schedule I attached hereto (the Representatives)
c/o Barclays Capital Inc.
745 Seventh Avenue
New York, New York 10019
BofA Securities, Inc.
One Bryant Park
New York, New York 10036
Ladies and Gentlemen:
Certain stockholders of First Advantage Corporation, a Delaware corporation (the Company), named in Schedule II attached hereto (the Selling Stockholders) propose to sell an aggregate of [ ] shares (the Firm Stock) of the Companys common stock, par value $0.001 per share (the Common Stock). In addition, the Selling Stockholders propose to grant to the underwriters named in Schedule I (the Underwriters) attached to this agreement (this Agreement) an option to purchase up to an aggregate of [ ] additional shares of the Common Stock on the terms set forth in Section 3 (the Option Stock). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the Stock. This Agreement is to confirm the agreement concerning the purchase of the Stock from the Selling Stockholders by the Underwriters.
1. Representations, Warranties and Agreements of the Company. The Company represents, warrants and agrees that:
(a) A registration statement on Form S-1 (File No. 333-[ ]) relating to the Stock has (i) been prepared by the Company in conformity with the requirements of the Securities Act of 1933, as amended (the Securities Act), and the rules and regulations of the Securities and Exchange Commission (the Commission) thereunder; (ii) been filed with the Commission under the Securities Act; and (iii) become effective under the Securities Act. Copies of such registration statement and any amendment thereto have been delivered by the Company to you as the representatives (the Representatives) of the Underwriters. As used in this Agreement:
(i) Applicable Time means [ ] P.M. (New York City time) on November [ ], 2021;
(ii) Effective Date means the date and time as of which such registration statement was declared effective by the Commission;
(iii) Issuer Free Writing Prospectus means each issuer free writing prospectus (as defined in Rule 433 under the Securities Act) relating to the Stock;
(iv) Preliminary Prospectus means any preliminary prospectus relating to the Stock included in such registration statement or filed with the Commission pursuant to Rule 424(b) under the Securities Act;
(v) Pricing Disclosure Package means, as of the Applicable Time, the most recent Preliminary Prospectus, together with the information included in Schedule IV hereto, if any, and each Issuer Free Writing Prospectus filed or used by the Company at or before the Applicable Time, other than a road show that is an Issuer Free Writing Prospectus but is not required to be filed under Rule 433 under the Securities Act;
(vi) Prospectus means the final prospectus relating to the Stock as filed with the Commission pursuant to Rule 424(b) under the Securities Act;
(vii) Registration Statement means, collectively, the various parts of such registration statement, each as amended as of the Effective Date for such part, including any Preliminary Prospectus or the Prospectus, all exhibits to such registration statement and including the information deemed by virtue of Rule 430A under the Securities Act to be part of such registration statement as of the Effective Date;
(viii) Testing-the-Waters Communication means any oral or written communication with potential investors undertaken in reliance on Section 5(d) of the Securities Act; and
(ix) Written Testing-the-Waters Communication means any Testing-the-Waters Communication that is a written communication within the meaning of Rule 405 under the Securities Act.
Any reference to the most recent Preliminary Prospectus shall be deemed to refer to the latest Preliminary Prospectus included in the Registration Statement or filed pursuant to Rule 424(b) under the Securities Act prior to or on the date hereof. The Commission has not issued any order preventing or suspending the use of any Preliminary Prospectus or the Prospectus or suspending the effectiveness of the Registration Statement, and no proceeding or examination for such purpose has been instituted or, to the Companys knowledge, threatened by the Commission.
(b) From the time of initial confidential submission of the Registration Statement to the Commission (or, if earlier, the first date on which the Company engaged directly or through any person authorized to act on its behalf in any Testing-the-Waters Communication) through the date hereof, the Company has been an emerging growth company, as defined in Section 2(a) of the Securities Act (an Emerging Growth Company).
(c) The Company has not engaged in any Testing-the-Waters Communication, other than Testing-the-Waters Communications with the consent of the Representatives, with entities that are reasonably believed to be qualified institutional buyers within the meaning of Rule 144A under the Securities Act, or with institutions that are reasonably believed to be accredited investors within the meaning of Rule 501 under the Securities Act. The Company reconfirms that the Representatives have been authorized to act on its behalf in undertaking Testing-the-Waters Communications. The Company has not distributed or approved for distribution any Written Testing-the-Waters Communications other than those listed on Schedule VI hereto.
(d) The Company was not at the time of the initial filing of the Registration Statement and at the earliest time thereafter that the Company or another offering participant made a bona fide offer (within the meaning of Rule 164(h)(2) under the Securities Act) of the Stock, is not on the date hereof and will not be on the applicable Delivery Date (as defined below), an ineligible issuer (as defined in Rule 405 under the Securities Act).
(e) The Registration Statement conformed and will conform in all material respects on the Effective Date and on the applicable Delivery Date, and any amendment to the Registration Statement filed after the date hereof will conform in all material respects when filed, to the requirements of the Securities Act and the rules and regulations thereunder. The most recent Preliminary Prospectus conformed, and the Prospectus will conform, in all material respects when filed with the Commission pursuant to Rule 424(b) under the Securities Act and on the applicable Delivery Date to the requirements of the Securities Act and the rules and regulations thereunder.
(f) The Registration Statement did not, as of the Effective Date, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, not misleading; provided that no representation or warranty is made as to information contained in or omitted from the Registration Statement in reliance upon and in conformity with written information furnished to the Company through the Representatives by or on behalf of any Underwriter specifically for inclusion therein, which information is specified in Section 10(f).
(g) The Prospectus will not, as of its date or as of the applicable Delivery Date, contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided that no representation or warranty is made as to information contained in or omitted from the Prospectus in reliance upon and in conformity with written information furnished to the Company through the Representatives by or on behalf of any Underwriter specifically for inclusion therein, which information is specified in Section 10(f).
(h) The Pricing Disclosure Package did not, as of the Applicable Time, contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided that no representation or warranty is made as to information contained in or omitted from the Pricing Disclosure Package made in reliance upon and in conformity with written information furnished to the Company through the Representatives by or on behalf of any Underwriter specifically for inclusion therein, which information is specified in Section 10(f).
(i) Each Issuer Free Writing Prospectus listed in Schedule V hereto, when taken together with the Pricing Disclosure Package, did not, as of the Applicable Time, contain an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided that no representation or warranty is made as to information contained in or omitted from such Issuer Free Writing Prospectus listed in Schedule V hereto in reliance upon and in conformity with written information furnished to the Company through the Representatives by or on behalf of any Underwriter specifically for inclusion therein, which information is specified in Section 10(f).
(j) No Written Testing-the-Waters Communication, as of the Applicable Time, when taken together with the Pricing Disclosure Package, contained an untrue statement of a material fact or omitted to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided that no representation or warranty is made as to information contained in or omitted from such Written Testing-the-Waters Communication listed on Schedule VI hereto in reliance upon and in conformity with written information furnished to the Company through the Representatives by or on behalf of any Underwriter specifically for inclusion therein, which information is specified in Section 10(f).
(k) Each Issuer Free Writing Prospectus conformed or will conform in all material respects to the requirements of the Securities Act and the rules and regulations thereunder on the date of first use, and the Company has complied with all prospectus delivery and any filing requirements applicable to such Issuer Free Writing Prospectus pursuant to the Securities Act and rules and regulations thereunder. The Company has not made any offer relating to the Stock that would constitute an Issuer Free Writing Prospectus without the prior written consent of the Representatives.
(l) The Company and each of its significant subsidiaries (as such term is defined in Rule 1-02 of Regulation S-X promulgated by the Commission) (each, a Significant Subsidiary) have been duly organized, is validly existing and in good standing as a corporation or other business entity under the laws of its jurisdiction of organization and is duly qualified to do business and in good standing as a foreign corporation or other business entity in each jurisdiction in which its ownership or lease of property or the conduct of its businesses requires such qualification, except where the failure to be so qualified or in good standing would not, in the aggregate, reasonably be expected to have a material adverse effect on the condition (financial or otherwise), results of operations, stockholders equity, properties or business of the Company and its subsidiaries taken as a whole (a Material Adverse Effect). The Company and each of its subsidiaries have all power and authority necessary to own or hold its properties and to conduct the businesses in which it is engaged.
(m) The authorized capital stock of the Company conforms as to legal matters to the description thereof contained in each of the most recent Preliminary Prospectus and the Prospectus as of the date or dates set forth therein, and all of the issued shares of capital stock of the Company have been duly authorized and validly issued, are fully paid and non-assessable and were issued
in compliance with federal and state securities laws and not in violation of any preemptive right, resale right, right of first refusal or similar right other than those that have been waived. All of the issued shares of capital stock or other ownership interest of each Significant Subsidiary have been duly authorized and validly issued, are fully paid and non-assessable (to the extent such concepts are applicable under relevant law) and are owned directly or indirectly by the Company, free and clear of all liens, encumbrances, equities or claims, except for such liens, encumbrances, equities or claims as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(n) The shares of Stock to be sold by the Selling Stockholders to the Underwriters hereunder will be sold in compliance with federal and state securities laws.
(o) The Company has all requisite corporate power and authority to execute, deliver and perform its obligations under this Agreement. This Agreement has been duly and validly authorized, executed and delivered by the Company.
(p) The execution, delivery and performance of this Agreement by the Company and the consummation of the transactions contemplated hereby will not (i) conflict with or result in a breach or violation of any of the terms or provisions of, impose any lien, charge or encumbrance upon any property or assets of the Company and its subsidiaries, or constitute a default under, any indenture, mortgage, deed of trust, loan agreement, license, lease or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound; (ii) result in any violation of the provisions of the charter or by-laws (or similar organizational documents) of the Company or any of its subsidiaries; or (iii) result in any violation of any statute or any judgment, order, decree, rule or regulation of any court or governmental agency or body having jurisdiction over the Company or any of its subsidiaries, except, with respect to clauses (i) and (iii), conflicts or violations that would not reasonably be expected to have a Material Adverse Effect.
(q) No consent, approval, authorization or order of, or filing, registration or qualification with, any court or governmental agency or body having jurisdiction over the Company or any of its subsidiaries or any of their properties or assets is required for the execution, delivery and performance of this Agreement by the Company or the consummation of the transactions contemplated hereby, except (i) such consents, approvals, authorizations, orders, filings, registrations or qualifications as have previously been obtained, (ii) the registration of the Stock under the Securities Act, and (iii) such consents, approvals, authorizations, orders, filings, registrations or qualifications as may be required under the Securities Exchange Act of 1934, as amended (the Exchange Act), and applicable state securities laws and/or the bylaws and rules of the Financial Industry Regulatory Authority, Inc. (the FINRA) in connection with the purchase and sale of the Stock by the Underwriters, and (iv) as would not reasonably be expected to have a Material Adverse Effect or would not, in the aggregate, reasonably be expected to have a Material Adverse Effect on the performance of this Agreement or the consummation of the transactions contemplated hereby.
(r) The historical financial statements (including the related notes and any supporting schedules) included in the most recent Preliminary Prospectus comply as to form in all material respects with the requirements of Regulation S-X under the Securities Act and present fairly the financial condition, results of operations and cash flows of the entities purported to be shown thereby at the dates and for the periods indicated and have been prepared in conformity with U.S. generally accepted accounting principles (GAAP) applied on a consistent basis throughout the periods involved.
(s) The pro forma financial statements included in the most recent Preliminary Prospectus include assumptions that provide a reasonable basis for presenting the significant effects directly attributable to the transactions and events described therein, the related pro forma adjustments give appropriate effect to those assumptions, and the pro forma adjustments reflect the proper application of those adjustments to the historical financial statement amounts in the pro forma financial statements included in the most recent Preliminary Prospectus. The pro forma financial statements included in the most recent Preliminary Prospectus comply as to form in all material respects with the applicable requirements of Regulation S-X under the Securities Act.
(t) Deloitte & Touche LLP, who have certified certain financial statements of the Company and its consolidated subsidiaries, whose report appears in the most recent Preliminary Prospectus and who have delivered the initial letter referred to in Section 9(h) hereof, are independent public accountants as required by the Securities Act and the rules and regulations thereunder.
(u) The Company and each of its subsidiaries, taken as a whole, maintain internal accounting controls sufficient to provide reasonable assurances regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States, including, but not limited to, internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with managements general or specific authorization, (ii) transactions are recorded as necessary to permit preparation of the Companys financial statements in conformity with GAAP and to maintain accountability for its assets, (iii) access to the Companys assets is permitted only in accordance with managements general or specific authorization, (iv) the recorded accountability for the Companys assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences and (v) the interactive data in eXtensible Business Reporting Language included in the Pricing Disclosure Package and the Prospectus fairly present the information called for in all material respects and are prepared in accordance with the Commissions rules and guidelines applicable thereto. As of the date of the most recent balance sheet of the Company and its consolidated subsidiaries reviewed or audited by Deloitte & Touche LLP and the Audit Committee of the board of directors of the Company, the Company is not aware of any material weaknesses in the Companys internal controls.
(v) The Company, on a consolidated basis, maintains an effective system of disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) that complies with the requirements of the Exchange Act applicable to the Company and that has been designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commissions rules and forms, including controls and procedures designed to provide reasonable assurances that such information is accumulated and communicated to the Companys management as appropriate to allow timely decisions regarding required disclosure.
(w) Since the date of the most recent balance sheet of the Company and its consolidated subsidiaries reviewed or audited by Deloitte & Touche LLP and the Audit Committee, (i) the Company has not been advised of or become aware of (A) any significant deficiencies in the design or operation of internal controls that would adversely affect the ability of the Company or any of its subsidiaries to record, process, summarize and report financial data, or any material weaknesses in internal controls, or (B) any fraud, whether or not material, that involves management or other employees who have a significant role in the internal controls of the Company and each of its subsidiaries; and (ii) there have been no significant changes in internal controls or in other factors that would significantly affect internal controls, including any corrective actions with regard to significant deficiencies and material weaknesses.
(x) To the extent applicable to the Company on the date hereof, there is and has been no failure on the part of the Company and any of the Companys directors or officers, in their capacities as such, to comply with any provision of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated in connection therewith (it being understood that this subsection shall not require the Company to comply with any provision of the Sarbanes-Oxley Act of 2002 or the rules and regulations promulgated in connection therewith as of an earlier date than it would otherwise be required to so comply under applicable law).
(y) Except as described in the most recent Preliminary Prospectus, since the date of the latest audited financial statements included in the most recent Preliminary Prospectus, neither the Company nor any of its subsidiaries, taken as a whole, has (i) sustained any loss or interference with its business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree (whether domestic or foreign), (ii) incurred any material liability or obligation, direct or contingent, other than liabilities and obligations that were incurred in the ordinary course of business, (iii) entered into any material transaction not in the ordinary course of business, or (iv) declared or paid any dividend on its capital stock, and since such date, there has not been any material change in the capital stock or long-term debt of the Company or any of its subsidiaries or any material adverse change, or any development involving a prospective material adverse change, in or affecting the properties, management, financial position or results of operations, or business of the Company and its subsidiaries taken as a whole.
(z) The Company and each of its subsidiaries have, and are operating in compliance with, such permits, licenses, franchises, certificates of need and other approvals or authorizations of governmental or regulatory authorities (Permits) as are necessary under applicable law to own their properties and conduct their businesses in the manner described in the most recent Preliminary Prospectus, except for any of the foregoing that would not, in the aggregate, reasonably be expected to have a Material Adverse Effect or except as described in the most recent Preliminary Prospectus. The Company and each of its subsidiaries have fulfilled and performed all of their respective obligations with respect to the Permits, and no event has occurred that allows, or after notice or lapse of time would allow, revocation or termination thereof or results in any other impairment of the rights of the holder or any such Permits, except for any of the foregoing that would not reasonably be expected to have a Material Adverse Effect or except as described in the most recent Preliminary Prospectus. Neither the Company nor any of its subsidiaries has received notice of any revocation, non-renewal or modification of any such Permits or has any reason to believe that any such Permits will not be renewed in the ordinary course, in each case which, singly or in the aggregate, as a result of an unfavorable decision, ruling or finding, would reasonably be expected to result in a Material Adverse Effect.
(aa) Except as would not reasonably be expected to have a Material Adverse Effect, the Company and each of its subsidiaries have good and marketable title in fee simple or good and valid leasehold title, as applicable, to all real property owned or leased by the Company and good and marketable title to all personal property owned by them, in each case free and clear of all liens, encumbrances and defects, except such liens, encumbrances and defects as are described in the most recent Preliminary Prospectus or such as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and its subsidiaries, taken as a whole. All assets held under lease by the Company and its subsidiaries are held by them under valid, subsisting and enforceable leases, with such exceptions as do not materially interfere with the use made and proposed to be made of such assets by the Company and its subsidiaries.
(bb) Except as described in the most recent Preliminary Prospectus, there are no legal or governmental proceedings pending or, to the Companys knowledge, threatened, to which the Company or any of its subsidiaries is a party or of which any property or assets of the Company or any of its subsidiaries is the subject that would, in the aggregate, reasonably be expected to have a Material Adverse Effect or would, in the aggregate, reasonably be expected to have a Material Adverse Effect on the performance of this Agreement or the consummation of the transactions contemplated hereby.
(cc) There are no contracts or other documents required under the Securities Act to be described in the Registration Statement or the most recent Preliminary Prospectus or filed as exhibits to the Registration Statement that are not described in all material respects and filed as required. The statements made in the most recent Preliminary Prospectus, insofar as they purport to constitute summaries of the terms of the contracts and other documents described and filed, constitute accurate summaries of the terms of such contracts and documents in all material respects.
(dd) The Company and each of its subsidiaries, taken as a whole, are insured against such losses and risks and in such amounts as are, in the reasonable judgment of the Company, prudent and customary in the businesses in which they are engaged. (A) All policies of insurance of the Company and its subsidiaries are in full force and effect; (B) the Company and each of its subsidiaries are in compliance with the terms of such policies in all material respects; and (C) (i) neither the Company nor any of its subsidiaries has received written notice from any insurer or agent of such insurer that capital improvements or other expenditures are required or necessary to be made in order to continue such insurance; there are no claims by the Company or any of its subsidiaries under any such policy or instrument as to which any insurance company is denying liability or defending under a reservation of rights clause; and (ii) neither the Company nor any such subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business, except, with respect to clauses (A), (C)(i) and (C)(ii), as would not reasonably be expected to have a Material Adverse Effect.
(ee) Except as described in the most recent Preliminary Prospectus, no material relationship, direct or indirect, exists between or among the Company, on the one hand, and the directors, officers, stockholders, customers or suppliers of the Company, on the other hand, that is required to be described under the Securities Act in the most recent Preliminary Prospectus which is not so described.
(ff) No labor disturbance by or dispute with the employees of the Company or any of its subsidiaries exists or, to the knowledge of the Company, is imminent that would reasonably be expected to have a Material Adverse Effect.
(gg) Neither the Company nor any of its subsidiaries (i) is in violation of its charter or by laws (or similar organizational documents), (ii) is in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or observance of any term, covenant, condition or other obligation contained in any indenture, mortgage, deed of trust, loan agreement, license or other agreement or instrument to which it is a party or by which it is bound or to which any of its properties or assets is subject, (iii) is in violation of any law, statute or any order, rule or regulation of any court or governmental agency or body having jurisdiction over it or its property or assets or (iv) has failed to obtain any license, permit, certificate, franchise or other governmental authorization or permit necessary to the ownership of its property or to the conduct of its business, except in the case of clauses (ii), (iii), and (iv) above, for such defaults or violations as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(hh) Except as described in the most recent Preliminary Prospectus, (i) there are no proceedings that are pending, or, to the knowledge of the Company, contemplated, against the Company or any of its subsidiaries under any laws, regulations, ordinances, rules, orders, judgments, decrees, permits or other legal requirements of any governmental authority, including without limitation any international, foreign, national, state, provincial, regional, or local authority, relating to pollution, the protection of the environment, or natural resources, or to use, handling, storage, manufacturing, transportation, treatment, discharge, disposal or release of hazardous or toxic substances or wastes, pollutants or contaminants (Environmental Laws) in which a governmental authority is also a party, other than such proceedings regarding which it is reasonably believed no monetary sanctions of $300,000 or more will be imposed, (ii) neither the Company nor any of its subsidiaries is aware of any issues regarding compliance with Environmental Laws, including any pending or proposed Environmental Laws, or liabilities or other obligations under Environmental Laws or concerning hazardous or toxic substances or wastes, pollutants or contaminants, that would reasonably be expected to have a material effect on the capital expenditures, earnings or competitive position of the Company and its subsidiaries or a Material Adverse Effect, and (iii) neither the Company nor any of its subsidiaries anticipates material capital expenditures relating to Environmental Laws.
(ii) Except where any failure to file or pay any tax deficiencies that would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect, the Company and each of its subsidiaries have filed all federal, state, local and foreign tax returns required to be filed through the date hereof, subject to permitted extensions, and have paid all taxes due, and no tax deficiency has been determined adversely to the Company or any of its subsidiaries, nor does the Company have any knowledge of any tax deficiencies that have been, or would reasonably be expected to be asserted against the Company.
(jj) (i) Each employee benefit plan (within the meaning of Section 3(3) of the Employee Retirement Security Act of 1974, as amended (ERISA)) for which the Company or any member of its Controlled Group (defined as any organization which is a member of a controlled group of corporations within the meaning of Section 414 of the Internal Revenue Code of 1986, as amended (the Code)) would have any liability (each a Plan) has been maintained in compliance with its terms and with the requirements of all applicable statutes, rules and regulations including ERISA and the Code; (ii) no prohibited transaction, within the meaning of Section 406 of ERISA or Section 4975 of the Code, has occurred with respect to any Plan excluding transactions effected pursuant to a statutory or administrative exemption; (iii) with respect to each Plan subject to Title IV of ERISA (A) no reportable event (within the meaning of Section 4043(c) of ERISA) has occurred or is reasonably expected to occur, (B) no failure to meet the minimum funding standard set forth in Sections 412 of the Code and 303 of ERISA, whether or not waived, has occurred or is reasonably expected to occur, (C) no Plan is or is reasonably expected to be in at risk status (within the meaning of Section 430 of the Code or Section 303 of ERISA), (D) there has been no filing pursuant to Section 412(c) of the Code or Section 302(c) of ERISA of an application for a waiver of the minimum funding standard with respect to any Plan or the receipt by the Company or any member of its Controlled Group from the PBGC or the Plan administrator of the notice relating to the intention to terminate any Plan or Plans or to appoint a trustee to administer any Plan, (E) no conditions contained in Section 303(k)(1)(A) of ERISA for the imposition of a lien shall have been met with respect to any Plan, (F) the fair market value of the assets under each Plan exceeds the present value of all benefits accrued under such Plan (determined based on those assumptions used to fund such Plan) and (G) neither the Company or any member of its Controlled Group has incurred, or reasonably expects to incur, any liability under Title IV of ERISA (other than contributions to the Plan or premiums to the Pension Benefit Guaranty Corporation in the ordinary course and without default) in respect of a Plan (including a multiemployer plan, within the meaning of Section 4001(c)(3) of ERISA) (Multiemployer Plan); (iv) no Multiemployer Plan is, or is expected to be, insolvent (within the meaning of Section 4245 of ERISA), or in endangered or critical status (within the meaning of Section 432 of the Code or Section 304 of ERISA); and (v) each Plan that is intended to be qualified under Section 401(a) of the Code has received a favorable determination letter from the Internal Revenue Service that it is so qualified and nothing has occurred, whether by action or by failure to act, which would cause the loss of such qualification, except in each case with respect to the events or conditions set forth in (i) through (v) hereof, as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(kk) The statistical and market-related data included in the most recent Preliminary Prospectus are based on or derived from sources that the Company believes to be reliable in all material respects.
(ll) Neither the Company nor any of its subsidiaries is, and as of the applicable Delivery Date none of them will be, (i) an investment company or a company controlled by an investment company within the meaning of the Investment Company Act of 1940, as amended (the Investment Company Act), and the rules and regulations of the Commission thereunder, or (ii) a business development company (as defined in Section 2(a)(48) of the Investment Company Act).
(mm) The statements set forth in each of the most recent Preliminary Prospectus and the Prospectus under the caption Description of Capital Stock, insofar as they purport to summarize the provisions of the laws and documents referred to therein, are accurate summaries in all material respects.
(nn) Except as described in the most recent Preliminary Prospectus, there are no contracts, agreements or understandings between the Company and any person granting such person the right to require the Company to file a registration statement under the Securities Act with respect to any securities of the Company owned or to be owned by such person or to require the Company to include such securities in the securities registered pursuant to the Registration Statement or in any securities being registered pursuant to any other registration statement filed by the Company under the Securities Act.
(oo) Neither the Company nor any of its subsidiaries is a party to any contract, agreement or understanding with any person (other than this Agreement) that would give rise to a valid claim against any of them or the Underwriters for a brokerage commission, finders fee or like payment in connection with the offering and sale of the Stock.
(pp) The Company has not sold or issued any securities that would be integrated with the offering of the Stock contemplated by this Agreement pursuant to the Securities Act, the rules and regulations thereunder or the interpretations thereof by the Commission.
(qq) The Company and its controlled affiliates have not taken, directly or indirectly, any action designed to constitute, or that has constituted, or that would reasonably be expected to cause or result in the stabilization or manipulation of the price of any security of the Company in connection with the offering of the shares of the Stock.
(rr) The Stock has been approved for listing on The Nasdaq Global Select Market.
(ss) The Company has not distributed and, prior to the later to occur of any Delivery Date and completion of the distribution of the Stock by the Selling Stockholders, will not distribute any offering material in connection with the offering and sale of the Stock by the Selling Stockholders other than any Preliminary Prospectus, the Prospectus, and any Issuer Free Writing Prospectus to which the Representatives have consented in accordance with Section 1(k) or 6(a)(vi).
(tt) Neither the Company nor any of its subsidiaries, any director or officer, nor, to the knowledge of the Company, any controlled affiliates, agent, employee or other person acting on behalf of the Company or any of its subsidiaries, has in the course of its actions for, or on behalf of, the Company or any of its subsidiaries: (i) made any unlawful contribution, gift, or other unlawful expense relating to political activity; (ii) made any direct or indirect unlawful bribe, kickback, rebate, payoff, influence payment, or otherwise unlawfully provided anything of value, to any foreign official (as defined in the U.S. Foreign Corrupt Practices Act of 1977, as amended (collectively, the FCPA)) or domestic government official; or (iii) violated or is in violation of any provision of the FCPA, the Bribery Act 2010 of the United Kingdom, as amended (the
Bribery Act 2010), or any other applicable anti-corruption or anti-bribery statute or regulation. The Company and its subsidiaries have conducted their respective businesses in compliance with the FCPA, Bribery Act 2010 and all other applicable anti-corruption and anti-bribery statutes or regulations, and have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to ensure, continued compliance therewith.
(uu) The operations of the Company and its subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, that have been issued, administered or enforced by any governmental agency (collectively, the Money Laundering Laws) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator or non-governmental authority involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.
(vv) Neither the Company nor any of its subsidiaries, any director or officer, nor, to the knowledge of the Company, any controlled affiliate, agent or employee of the Company or any of its subsidiaries is: (i) currently the subject or the target of any sanctions administered or enforced by the Office of Foreign Assets Control of the U.S. Treasury Department, the U.S. Department of State, the United Nations Security Council, the European Union, Her Majestys Treasury, or other relevant sanctions authority (collectively, Sanctions); or (ii) located, organized or resident in a country or territory that is the subject or target of Sanctions (currently, Cuba, Iran, North Korea, Syria and Crimea). The Company and its subsidiaries have not knowingly engaged in for the past five years, are not now knowingly engaged in, and will not engage in, any dealings or transactions in violation of Sanctions with any individual or entity, or in any country or territory, that at the time of the dealing or transaction, is or was the subject or target of Sanctions.
(ww) Except as would not reasonably be expected to have a Material Adverse Effect, (i) the Company and its subsidiaries respective information technology assets and equipment, computers, systems, servers, networks, hardware, software, websites, applications, and databases used in connection with the operation of their business (collectively, IT Systems) are adequate for, and the Company and its subsidiaries have taken all technical and organizational measures necessary to protect the IT Systems and Personal Data (as defined below) used in connection with, and the operation of the business of the Company and each of its subsidiaries as currently conducted, and to the knowledge of the Company, the IT Systems are free and clear of all bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants; (ii) the Company and its subsidiaries have implemented and maintain reasonable controls, policies, procedures, and safeguards designed to comply with all Privacy Laws, Obligations and Policies (as defined below) and to protect their confidential information and preserve the integrity, confidentiality, continuous operation, redundancy and security of all IT Systems and data (including personal data as defined by the EU General Data Protection Regulations (GDPR) (EU 2016 679) and any personal, personally identifiable, household, sensitive, confidential or regulated data (Personal Data)) used in connection with their respective businesses; (iii) there have been no data breaches or other security incidents related to any IT Systems, including any that resulted in any unauthorized acquisition, access, use, misappropriation, exfiltration, disclosure, modification or corruption of any data, including Personal Data, stored or contained therein or transmitted thereby,
or that resulted in the exertion of third-party control over any of the IT Systems; and (iv) the Company and its subsidiaries have been, and are presently in compliance with all applicable laws and statutes, all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, all internal and external-facing policies and all contractual obligations, in each case, relating to the privacy or security of IT Systems or Personal Data or to the use, transfer, export, storage, protection, disposal or other processing of such IT Systems or Personal Data (collectively, Privacy Laws, Obligations and Policies) from unauthorized use, acquisition, misappropriation, access, exfiltration, disclosure, corruption or modification.
(xx) Except as would not reasonably be expected to have a Material Adverse Effect, (i) to the knowledge of the Company, the execution, delivery and performance of this Agreement will not result in a breach of or violation of, any Privacy Laws, Obligations and Policies; (ii) neither the Company nor any subsidiary (A) has received written notice of any actual or potential liability under or relating to, or actual or potential violation of, any Privacy Laws, Obligations and Policies or (B) is aware of any other facts that, individually or in the aggregate, would reasonably indicate non-compliance with any Privacy Laws, Obligations and Polices; and (iii) there is no action, suit or proceeding by or before any court or governmental agency, authority or body pending or, to the Companys knowledge, threatened alleging non-compliance by the Company or any of its subsidiaries with any Privacy Laws, Obligations and Policies.
(yy) Except as would not reasonably be expected to have a Material Adverse Effect, (i) the Company and its subsidiaries own or possess valid and enforceable rights to use any and all patents, inventions, copyrights, know-how (including, without limitation, trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures), trademarks, service marks, trade names, domain names and other worldwide intellectual property and similar proprietary rights (including any and all registrations and applications for registration of, and goodwill associated with, any of the foregoing) (collectively, Intellectual Property), in each case, used or held for use in, or necessary to carry on the conduct of their respective businesses as currently conducted, (ii) to the Companys knowledge, no Intellectual Property owned or purported to be owned by the Company or any of its subsidiaries has been infringed, misappropriated or otherwise violated by any person, (iii) all Intellectual Property owned or purported to be owned by the Company or any of its subsidiaries is solely and exclusively owned by the Company or one of its subsidiaries, in each case, free and clear of all liens and encumbrances (other than (x) liens securing the obligations under the credit agreement and (y) non-exclusive licenses granted in the ordinary course of business) and, to the knowledge of the Company, all registrations of Intellectual Property of the Company and its subsidiaries are valid and enforceable in all material respects, (iv) the Company and its subsidiaries have taken reasonable steps to maintain the confidentiality of all Intellectual Property, including trade secrets and confidential information, of which the value to the Company or any of its subsidiaries is contingent upon maintaining the confidentiality thereof, (v) to the Companys knowledge, neither the Company nor any of its subsidiaries has infringed, misappropriated or otherwise violated any Intellectual Property of any person and (vi) there is no pending or, to the Companys knowledge, threatened claim alleging infringement, misappropriation or other violation by the Company or any of its subsidiaries of any Intellectual Property of any person or challenging the validity, enforceability, scope or ownership of any Intellectual Property owned or purported to be owned by Company or any of its subsidiaries.
Any certificate signed by any officer of the Company and delivered to the Representatives or counsel for the Underwriters in connection with the offering of the Stock shall be deemed a representation and warranty by the Company, as to matters covered thereby, to each Underwriter.
2. Representations, Warranties and Agreements of the Selling Stockholders. Each Selling Stockholder, severally and not jointly, represents, warrants and agrees that:
(a) Such Selling Stockholder, if an entity, has been duly incorporated or formed, as applicable, and is validly existing as a corporation, limited liability company, public agency, or a limited partnership, as the case may be, in good standing in its jurisdiction of formation.
(b) Neither such Selling Stockholder nor any person acting on behalf of such Selling Stockholder (other than, if applicable, the Company and the Underwriters) has used or referred to any free writing prospectus (as defined in Rule 405 under the Securities Act) relating to the Stock.
(c) Such Selling Stockholder has, and immediately prior to any Delivery Date on which such Selling Stockholder is selling shares of Stock, such Selling Stockholder will have, good and marketable title to the shares of Stock to be sold by such Selling Stockholder hereunder on such Delivery Date and any security entitlement within the meaning of Section 8-501 of the New York Uniform Commercial Code (the UCC) in respect thereof, free and clear of all liens, encumbrances, equities, community property rights, restrictions on transfer or claims.
(d) Upon payment for the Stock to be sold by such Selling Stockholder, delivery of such Stock, as directed by the Underwriters, to Cede & Co. (Cede) or such other nominee as may be designated by The Depository Trust Company (DTC), registration of such Stock in the name of Cede or such other nominee and the crediting of such Stock on the books of DTC to securities accounts of the Underwriters (i) DTC shall be a protected purchaser of such Stock within the meaning of Section 8-303 of the UCC, (ii) under Section 8-501 of the UCC, the Underwriters will acquire a valid security entitlement in respect of such Stock, and (iii) an action based on an adverse claim to such securities entitlement, whether framed in conversion, replevin, constructive trust, equitable lien or other theory may not be successfully asserted against the Underwriters with respect to such security entitlement. For purposes of this representation, such Selling Stockholder may assume that when such payment, delivery and crediting occur, (x) such Stock will have been registered in the name of Cede or another nominee designated by DTC, in each case on the Companys share registry in accordance with its certificate of incorporation, bylaws and applicable law, (y) DTC will be registered as a clearing corporation within the meaning of Section 8-102 of the UCC, and (z) appropriate entries to the accounts of the several Underwriters on the records of DTC will have been made pursuant to the UCC.
(e) Such Selling Stockholder (other than SLP Fastball Aggregator, L.P. and Workday, Inc.) (a Specified Selling Stockholder) has placed in custody under a custody agreement (the Custody Agreement and, together with all other similar agreements executed by or on behalf of the other Selling Stockholders, the Custody Agreements) with American Stock Transfer & Trust Company, LLC, as custodian (the Custodian), for delivery under this Agreement, certificates in negotiable form (with signature guaranteed by a participant in the Securities Transfer Agents Medallion Program, the New York Stock Exchange Medallion Signature Program or the Stock Exchange Medallion Program) representing the shares of Stock to be sold by the Selling Stockholder hereunder.
(f) Such Specified Selling Stockholder has duly and irrevocably executed and delivered a power of attorney (the Power of Attorney and, together with all other similar agreements executed by the other Selling Stockholders, the Powers of Attorney) appointing the Messrs. Scott Staples, David Gamsey, and Bret Jardine as attorneys-in-fact, with full power of substitution, and with full authority (exercisable by any one or more of them) to execute and deliver this Agreement and to take such other action as may be necessary or desirable to carry out the provisions hereof on behalf of the Selling Stockholder.
(g) Such Selling Stockholder has full right, power and authority, corporate or otherwise, to enter into this Agreement.
(h) This Agreement has been duly and validly authorized, executed and delivered by or on behalf of such Selling Stockholder.
(i) The Power of Attorney and the Custody Agreement have been duly and validly authorized, executed and delivered by or on behalf of such Specified Selling Stockholder and constitute valid and legally binding obligations of such Selling Stockholder enforceable against such Selling Stockholder in accordance with their terms, subject to (i) the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws relating to or affecting creditors rights generally, (ii) general equitable principles (whether considered in a proceeding in equity or at law), and (iii) an implied covenant of good faith and fair dealing.
(j) All information furnished to the Company or the Underwriters by or on behalf of such Selling Stockholder in writing expressly for use in the Registration Statement, the Pricing Disclosure Package or the Prospectus is, and on the Closing Date will be, true, correct and complete in all material respects, and did not, as of the Applicable Time, and on the Closing Date will not, contain any untrue statement of a material fact or omit to state any material fact necessary to make such information not misleading, it being understood and agreed that the only such information furnished consists of the name of such Selling Stockholder, the number of offered shares and the address and other information with respect to such Selling Stockholder (excluding percentages) which appears in the Registration Statement, the Prospectus, and the Pricing Disclosure Package in the table (and corresponding footnotes) under the caption Selling Stockholders (collectively, the Selling Stockholder Information).
(k) The sale of the Stock by such Selling Stockholder, the execution, delivery and performance of this Agreement, the Custody Agreement and the Power of Attorney by such Selling Stockholder (to the extent a party thereto) and the consummation by such Selling Stockholder of the transactions contemplated hereby do not and will not (i) conflict
with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, any indenture, mortgage, deed of trust, loan agreement, license, lease or other agreement or instrument to which such Selling Stockholder is a party or by which such Selling Stockholder is bound or to which any of the property or assets of such Selling Stockholder is subject, (ii) result in any violation of the provisions of the charter or by-laws (or similar organizational documents) of such Selling Stockholder (if an entity), or (iii) result in any violation of any statute or any judgment, order, decree, rule or regulation of any court or governmental agency or body having jurisdiction over such Selling Stockholder or the property or assets of such Selling Stockholder, except, in the case of clauses (i) and (iii), where such conflict, breach, violation or default, in the aggregate, would not reasonably be expected to have a material adverse effect on the ability of such Selling Stockholder to perform its obligations hereunder.
(l) No consent, approval, authorization or order of, or filing or registration with, any court or governmental agency or body having jurisdiction over such Selling Stockholder or the property or assets of such Selling Stockholder is required for the issue and sale of the Stock by such Selling Stockholder, the execution, delivery and performance of this Agreement, the Custody Agreement or the Power of Attorney by such Selling Stockholder (to the extent a party thereto) and the consummation by such Selling Stockholder of the transactions contemplated hereby, except (i) such consents, approvals, authorizations, orders, filings, registrations or qualifications as have already been obtained, (ii) the registration of the Stock under the Securities Act, (iii) such consents, approvals, authorizations, orders, filings, registrations or qualifications as may be required under the rules and regulations of FINRA, the Exchange Act and applicable state securities laws in connection with the purchase and sale of the Stock by the Underwriters and (iv) as would not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the ability of such Selling Stockholder to perform its obligations hereunder.
(m) Such Selling Stockholder has not taken, directly or indirectly, any action that is designed to or that has constituted or that would reasonably be expected to cause or result in the stabilization or manipulation of the price of any security of the Company in connection with the offering of the shares of Stock.
(n) Such Selling Stockholder will not directly or indirectly use the proceeds of the offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the activities of any person, or in any country or territory, that currently is the subject or target of Sanctions or in any other manner that will result in a violation by any person participating in the transaction whether as an underwriter, advisor, investor or otherwise of Sanctions.
Any certificate signed by any officer of any Selling Stockholder and delivered to the Representatives or counsel for the Underwriters in connection with the offering of the Stock shall be deemed to be a representation and warranty by such Selling Stockholder, as to matters covered thereby, to each Underwriter.
3. Purchase of the Stock by the Underwriters. On the basis of the representations, warranties and covenants contained in, and subject to the terms and conditions of, this Agreement, each Selling Stockholder agrees to sell the number of shares of the Firm Stock set forth opposite its name in Schedule II hereto, severally and not jointly, to the several Underwriters, and each of the Underwriters, severally and not jointly, agrees to purchase the number of shares of the Firm Stock set forth opposite that Underwriters name in Schedule I hereto. Each Underwriter shall be obligated to purchase from each Selling Stockholder, that number of shares of the Firm Stock that represents the same proportion of the number of shares of the Firm Stock to be sold by each Selling Stockholder as the number of shares of the Firm Stock set forth opposite the name of such Underwriter in Schedule I represents to the total number of shares of the Firm Stock to be purchased by all of the Underwriters pursuant to this Agreement. The respective purchase obligations of the Underwriters with respect to the Firm Stock shall be rounded among the Underwriters to avoid fractional shares, as the Representatives may determine.
In addition, each Selling Stockholder grants to the Underwriters an option to purchase up to the number of shares of Option Stock set forth opposite such Selling Stockholders name in Schedule II hereto, severally and not jointly. Such option is exercisable in the event that the Underwriters sell more shares of Common Stock than the number of shares of Firm Stock in the offering and as set forth in Section 5 hereof. Any such election to purchase Option Stock shall be made in proportion to the maximum number of shares of Option Stock to be sold by each Selling Stockholder as set forth in Schedule II hereto. Each Underwriter agrees, severally and not jointly, to purchase the number of shares of Option Stock (subject to such adjustments to eliminate fractional shares as the Representatives may determine) that bears the same proportion to the total number of shares of Option Stock to be sold on such Delivery Date as the number of shares of Firm Stock set forth in Schedule I hereto opposite the name of such Underwriter bears to the total number of shares of Firm Stock.
The purchase price payable by the Underwriters for both the Firm Stock and any Option Stock is $[ ] per share.
The Selling Stockholders are not obligated to deliver any of the Firm Stock or Option Stock to be delivered on the applicable Delivery Date, except upon payment for all such Stock to be purchased on such Delivery Date as provided herein.
4. Offering of Stock by the Underwriters. Upon authorization by the Representatives of the release of the Firm Stock, the several Underwriters propose to offer the Firm Stock for sale upon the terms and conditions to be set forth in the Prospectus.
5. Delivery of and Payment for the Stock. Delivery of and payment for the Firm Stock shall be made at 10:00 A.M., New York City time, on the second full business day following the date of this Agreement or at such other date or place as shall be determined by agreement between the Representatives and the Company. This date and time are sometimes referred to as the Initial Delivery Date. Delivery of the Firm Stock shall be made to the Representatives for the account of each Underwriter against payment by the several Underwriters through the Representatives and of the respective aggregate purchase prices of the Firm Stock being sold by the Selling Stockholders to or upon the order of the Selling Stockholders of the purchase price by wire transfer in immediately available funds to the accounts specified by the Selling Stockholders. Time shall be of the essence, and delivery at the time and place specified pursuant to this Agreement is a further condition of the obligation of each Underwriter hereunder. The Selling Stockholders shall deliver the Firm Stock through the facilities of DTC unless the Representatives shall otherwise instruct.
The option granted in Section 3 will expire 30 days after the date of this Agreement and may be exercised in whole or from time to time in part by written notice being given to the Company and the Selling Stockholders by the Representatives; provided that if such date falls on a day that is not a business day, the option granted in Section 3 will expire on the next succeeding business day. Such notice shall set forth the aggregate number of shares of Option Stock as to which the options are being exercised, the names in which the shares of Option Stock are to be registered, the denominations in which the shares of Option Stock are to be issued and the date and time, as determined by the Representatives, when the shares of Option Stock are to be delivered; provided, however, that this date and time shall not be earlier than the Initial Delivery Date nor earlier than the second business day after the date on which the options shall have been exercised nor later than the fifth business day after the date on which the options shall have been exercised. Each date and time the shares of Option Stock are delivered is sometimes referred to as an Option Stock Delivery Date, and the Initial Delivery Date and any Option Stock Delivery Date are sometimes each referred to as a Delivery Date.
Delivery of the Option Stock by the Selling Stockholders and payment for the Option Stock by the several Underwriters through the Representatives shall be made at 10:00 A.M., New York City time, on the date specified in the corresponding notice described in the preceding paragraph or at such other date or place as shall be determined by agreement between the Representatives and the Selling Stockholders. On each Option Stock Delivery Date, the Selling Stockholders shall deliver, or cause to be delivered, the Option Stock, to the Representatives for the account of each Underwriter, against payment by the several Underwriters through the Representatives and of the respective aggregate purchase prices of the Option Stock being sold by the Selling Stockholders to or upon the order of the Selling Stockholders of the purchase price by wire transfer in immediately available funds to the accounts specified by the Selling Stockholders. Time shall be of the essence, and delivery at the time and place specified pursuant to this Agreement is a further condition of the obligation of each Underwriter hereunder. The Selling Stockholders shall deliver the Option Stock through the facilities of DTC unless the Representatives shall otherwise instruct.
6. Further Agreements of the Company and the Underwriters. (a) The Company agrees:
(i) To prepare the Prospectus in a form approved by the Representatives and to file such Prospectus pursuant to Rule 424(b) under the Securities Act not later than the Commissions close of business on the second business day following the execution and delivery of this Agreement; except as provided herein, to make no further amendment or any supplement to the Registration Statement or the Prospectus prior to the last Delivery Date to which the Representatives reasonably object by written notice to the Company in a timely manner; to advise the Representatives, promptly after it receives notice thereof, of the time when any amendment or supplement to the Registration Statement or the Prospectus has been filed and to furnish the Representatives with copies thereof; to advise the Representatives, promptly after it receives notice thereof, of the issuance by the Commission of any stop order or of any order preventing or suspending the use of the
Prospectus or any Issuer Free Writing Prospectus, of the suspension of the qualification of the Stock for offering or sale in any jurisdiction, of the initiation or threatening of any proceeding or examination for any such purpose, or any notice from the Commission objecting to the use of the form of Registration Statement or any post-effective amendment thereto or of any request by the Commission for the amending or supplementing of the Registration Statement, the Prospectus or any Issuer Free Writing Prospectus or for additional information; and, in the event of the issuance of any stop order or of any order preventing or suspending the use of the Prospectus or any Issuer Free Writing Prospectus or suspending any such qualification, to use promptly its best efforts to obtain its withdrawal.
(ii) To furnish promptly to each of the Representatives a signed copy of the Registration Statement as originally filed with the Commission, and each amendment thereto filed with the Commission, including all consents and exhibits filed therewith.
(iii) To deliver promptly to the Representatives such number of the following documents as the Representatives shall reasonably request: (A) conformed copies of the Registration Statement as originally filed with the Commission and each amendment thereto (in each case excluding exhibits other than this Agreement), (B) each Preliminary Prospectus, the Prospectus and any amended or supplemented Prospectus, and (C) each Issuer Free Writing Prospectus; and, if the delivery of a prospectus is required at any time after the date hereof in connection with the offering or sale of the Stock or any other securities relating thereto and if at such time any events shall have occurred as a result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made when such Prospectus is delivered, not misleading, or, if for any other reason it shall be necessary to amend or supplement the Prospectus in order to comply with the Securities Act, to notify the Representatives and, upon their request, to file such document and to prepare and furnish without charge to each Underwriter and to any dealer in securities as many copies as the Representatives may from time to time reasonably request of an amended or supplemented Prospectus that will correct such statement or omission or effect such compliance.
(iv) To file promptly with the Commission any amendment or supplement to the Registration Statement or the Prospectus that may, in the judgment of the Company or the Representatives, be required by the Securities Act or requested by the Commission.
(v) Prior to filing with the Commission any amendment or supplement to the Registration Statement, or the Prospectus, to furnish a copy thereof to the Representatives and counsel for the Underwriters and obtain the consent of the Representatives to the filing.
(vi) Not to make any offer relating to the Stock that would constitute an Issuer Free Writing Prospectus without the prior written consent of the Representatives.
(vii) To comply with all applicable requirements of Rule 433 under the Securities Act with respect to any Issuer Free Writing Prospectus. If at any time after the date hereof any events shall have occurred as a result of which any Issuer Free Writing Prospectus, as then amended or supplemented, would conflict with the information in the Registration Statement, the most recent Preliminary Prospectus or the Prospectus or would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, or, if for any other reason it shall be necessary to amend or supplement any Issuer Free Writing Prospectus, to notify the Representatives and, upon their request, to file such document and to prepare and furnish without charge to each Underwriter as many copies as the Representatives may from time to time reasonably request of an amended or supplemented Issuer Free Writing Prospectus that will correct such conflict, statement or omission or effect such compliance.
(viii) To make generally available (which may be satisfied by filing with EDGAR) to the Companys security holders and to the Representatives as soon as reasonably practicable an earning statement covering a period of at least twelve months beginning with the first fiscal quarter of the Company occurring after the date of this Agreement which shall satisfy the provisions of Section 11(a) of the Securities Act and the rules and regulations of the Commission thereunder.
(ix) Promptly from time to time to take such action as the Representatives may reasonably request to qualify the Stock for offering and sale under the securities or Blue Sky laws of such jurisdictions as the Representatives may request and to comply with such laws so as to permit the continuance of sales and dealings therein in such jurisdictions for as long as may be necessary to complete the distribution of the Stock; provided, that in connection therewith the Company shall not be required to (A) qualify as a foreign corporation in any jurisdiction in which it would not otherwise be required to so qualify, (B) file a general consent to service of process in any such jurisdiction, or (C) subject itself to taxation in any jurisdiction in which it would not otherwise be subject.
(x) For a period commencing on the date hereof and ending on the 60th day after the date of the Prospectus (the Lock-Up Period), not to, directly or indirectly, (A) offer for sale, sell, pledge, or otherwise dispose of (or enter into any transaction or device that is designed to, or would be expected to, result in the disposition by any person at any time in the future of) any shares of Common Stock or securities convertible into or exercisable or exchangeable for Common Stock, or sell or grant options, rights or warrants with respect to any shares of Common Stock or securities convertible into or exchangeable for Common Stock, (B) enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership of such shares of Common Stock, whether any such transaction described in clause (A) or (B) above is to be settled by delivery of Common Stock or other securities, in cash or otherwise, (C) file, submit or cause to be submitted or filed a registration statement, including any amendments thereto, with respect to the registration of any shares of Common Stock or securities convertible, exercisable or exchangeable into Common Stock or any other securities of the Company, or (D) publicly disclose the intention to do any of the foregoing, in each case other than (i) the shares of Stock to be sold hereunder by the Selling Stockholders, (ii) shares of Common Stock issued pursuant to employee benefit plans, qualified stock option plans or other employee compensation plans described in the
Registration Statement, Prospectus, or Pricing Disclosure Package, (iii) shares of Common Stock issued upon the conversion or exchange of convertible or exchangeable securities outstanding as of the date of this Agreement described in the Registration Statement, Prospectus, or Pricing Disclosure Package, (iv) any options or other awards (including without limitation, restricted stock or restricted stock units), or the shares of Common Stock issued with respect to, or upon the exercise or settlement of, such options and other awards, existing as of the Initial Delivery Date or otherwise granted under the Companys equity plans described in the Registration Statement, Prospectus, or Pricing Disclosure Package, (v) the filing of a registration statement on Form S-8, and the issuance of securities registered thereunder, relating to any benefit plans or arrangements disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (vi) [reserved], (vii) the issuance of shares of Common Stock in connection with the acquisition of the assets of, or a majority of controlling portion of the equity of, or a business combination or a joint venture with, another entity in connection with such business combination or such acquisition by the Company or any of its subsidiaries of such entity, (viii) any issuance of shares of Common Stock (including without limitation, restricted stock or restricted stock awards) in connection with joint ventures, commercial relationships or other strategic transactions and (ix) any confidential submissions of any registration statement, including any amendments thereto; provided that the aggregate number of shares issued or issuable pursuant to clauses (vii) and (viii) does not exceed 10% of the number of shares of Common Stock outstanding immediately after the offering of the Stock pursuant to this Agreement and prior to such issuance, each recipient of any such securities shall execute and deliver to the Representatives an agreement substantially in the form of Exhibit A hereto, without the prior written consent of Barclays Capital Inc. and BofA Securities, Inc., on behalf of the Underwriters, and to cause each officer, director and stockholder of the Company set forth on Schedule III hereto to furnish to the Representatives, prior to the Initial Delivery Date, a letter or letters, substantially in the form of Exhibit A hereto (the Lock-Up Agreements).
(xi) [Reserved.]
(xii) [Reserved.]
(xiii) The Company will promptly notify the Representatives if the Company ceases to be an Emerging Growth Company at any time prior to the later of (A) the time when a prospectus relating to the offering or sale of the Stock or any other securities relating thereto is not required by the Securities Act to be delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) and (B) completion of the Lock-Up Period.
(xiv) If at any time following the distribution of any Written Testing-the-Waters Communication there occurred or occurs an event or development as a result of which such Written Testing-the-Waters Communication included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances existing at that subsequent time, not misleading, the Company will promptly notify the Representatives and will promptly amend or supplement, at its own expense, such Written Testing-the-Waters Communication to eliminate or correct such untrue statement or omission. The Company will promptly notify the Representatives of (A) any distribution by the Company of Written Testing-the-Waters Communications and (B) any request by the Commission for information concerning the Written Testing-the-Waters Communications.
(xv) The Company and its controlled affiliates will not take, directly or indirectly, any action designed to or that has constituted or that reasonably would be expected to cause or result in the stabilization or manipulation of the price of any security of the Company in connection with the offering of the Stock.
(b) Each Underwriter severally agrees that such Underwriter shall not include any issuer information (as defined in Rule 433 under the Securities Act) in any free writing prospectus (as defined in Rule 405 under the Securities Act) used or referred to by such Underwriter without the prior consent of the Company (any such issuer information with respect to whose use the Company has given its consent, Permitted Issuer Information); provided that (i) no such consent shall be required with respect to any such issuer information contained in any document filed by the Company with the Commission prior to the use of such free writing prospectus, and (ii) issuer information, as used in this Section 6(b), shall not be deemed to include information prepared by or on behalf of such Underwriter on the basis of or derived from issuer information.
7. Further Agreements of the Selling Stockholders. Each Selling Stockholder agrees, severally and not jointly:
(a) On or prior to the date of this Agreement, such Selling Stockholder shall have delivered to the Representatives a duly executed Lock-Up Agreement in the form of Exhibit A hereto.
(b) Neither such Selling Stockholder nor any person acting on behalf of such Selling Stockholder (other than, if applicable, the Company and the Underwriters) shall use or refer to any free writing prospectus (as defined in Rule 405 under the Securities Act), relating to the Stock;
(c) To deliver to the Representatives prior to the Initial Delivery Date a properly completed and executed United States Treasury Department Form W-8 (if such Selling Stockholder is a non-United States person) or Form W-9 (if such Selling Stockholder is a United States person).
(d) Such Selling Stockholder will not take, directly or indirectly, any action designed to or that has constituted or that reasonably would be expected to cause or result in the stabilization or manipulation of the price of any security of the Company in connection with the offering of the Stock.
8. Expenses. The Company agrees, whether or not the transactions contemplated by this Agreement are consummated or this Agreement is terminated, to pay all reasonable expenses, costs, fees and taxes incident to and in connection with (a) the sale and delivery of the Stock and any stamp duties or other taxes payable in that connection, and the preparation and printing of certificates for the Stock; (b) the preparation, printing and filing under
the Securities Act of the Registration Statement (including any exhibits thereto), any Preliminary Prospectus, the Prospectus, any Issuer Free Writing Prospectus, any Written Testing-the-Waters Communication, and any amendment or supplement thereto; (c) the distribution of the Registration Statement (including any exhibits thereto), any Preliminary Prospectus, the Prospectus, any Issuer Free Writing Prospectus, any Written Testing-the-Waters Communication, and any amendment or supplement thereto, all as provided in this Agreement; (d) the production and distribution of this Agreement, any supplemental agreement among Underwriters, and any other related documents in connection with the offering, purchase, sale and delivery of the Stock; (f) any required review by the FINRA of the terms of sale of the Stock (including related fees and expenses of counsel to the Underwriters in an amount that is not greater than $40,000); (g) the listing of the Stock on The Nasdaq Global Select Market; (h) the qualification of the Stock under the securities laws of the several jurisdictions as provided in Section 6(a)(ix) and the preparation, printing and distribution of a Blue Sky Memorandum in an amount not to exceed $7,500 (including related fees and expenses of counsel to the Underwriters); (i) the investor presentations on any road show or any Testing-the-Waters Communication, undertaken in connection with the marketing of the Stock, including, without limitation, expenses associated with any electronic road show, travel and lodging expenses of the representatives and officers of the Company and 50% of the cost of any aircraft chartered in connection with the road show (it being agreed that the remaining 50% of the cost of such aircraft shall be paid by the Underwriters); and (j) all other costs and expenses incident to the performance of the obligations of the Company and the Selling Stockholders under this Agreement; provided that, except as provided in this Section 8 and in Section 13, the Underwriters shall pay their own costs and expenses, including the costs and expenses of their counsel, any transfer taxes on the Stock which they may sell and the expenses of advertising any offering of the Stock made by the Underwriters. The Selling Stockholders agree to pay all underwriting discounts and commissions in connection with the sale of the Stock.
9. Conditions of Underwriters Obligations.
(a) No stop order suspending the effectiveness of the Registration Statement or preventing or suspending the use of the Prospectus or any Issuer Free Writing Prospectus shall have been issued and no proceeding or examination for such purpose shall have been initiated or threatened by the Commission; and any request of the Commission for inclusion of additional information in the Registration Statement or the Prospectus or otherwise shall have been complied with.
(b) No Underwriter shall have discovered and disclosed to the Company on or prior to such Delivery Date that the Registration Statement, the Prospectus or the Pricing Disclosure Package, including any amendment or supplement thereto, contains an untrue statement of a fact which, in the opinion of Davis Polk & Wardwell LLP, counsel for the Underwriters, is material or omits to state a fact which, in the opinion of such counsel, is material and is required to be stated therein or is necessary to make the statements therein (in the case of the Prospectus or the Pricing Disclosure Package, in light of the circumstances under which such statements were made) not misleading.
(c) All corporate proceedings and other legal matters incident to the authorization, form and validity of this Agreement, the Stock, the Registration Statement, the Prospectus and any Issuer Free Writing Prospectus, and all other legal matters relating to this Agreement and the transactions contemplated hereby shall be reasonably satisfactory in all material respects to counsel for the Underwriters, and the Company and the Selling Stockholders shall have furnished to such counsel all documents and information that they may reasonably request to enable them to pass upon such matters.
(d) Simpson Thacher & Bartlett LLP shall have furnished to the Representatives its written opinion and negative assurance letter, as counsel to the Company, addressed to the Underwriters and dated such Delivery Date, in form and substance reasonably satisfactory to the Representatives.
(e) Whalen LLP shall have furnished to the Representatives their written opinion, as counsel to each of the Selling Stockholders for whom they are acting as counsel, addressed to the Underwriters and dated such Delivery Date, in form and substance reasonably satisfactory to the Representatives.
(f) Orrick Herrington & Sutcliffe shall have furnished to the Representatives their written opinion, as counsel to Workday, Inc., addressed to the Underwriters and dated such Delivery Date, in form and substance reasonably satisfactory to the Representatives.
(g) The Representatives shall have received from Davis Polk & Wardwell, counsel for the Underwriters, such opinion and negative assurance letter, dated such Delivery Date, with respect to the sale of the Stock, the Registration Statement, the Prospectus and the Pricing Disclosure Package and other related matters as the Representatives may reasonably require, and the Company shall have furnished to such counsel such documents as they reasonably request for the purpose of enabling them to pass upon such matters.
(h) At the time of execution of this Agreement, the Representatives shall have received from Deloitte & Touche LLP a letter, in form and substance satisfactory to the Representatives, addressed to the Underwriters and dated the date hereof (i) confirming that they are independent public accountants within the meaning of the Securities Act and are in compliance with the applicable requirements relating to the qualification of accountants under Rule 2-01 of Regulation S-X of the Commission, and (ii) stating, as of the date hereof (or, with respect to matters involving changes or developments since the respective dates as of which specified financial information is given in the most recent Preliminary Prospectus, as of a date not more than two business days prior to the date hereof), the conclusions and findings of such firm with respect to the financial information and other matters ordinarily covered by accountants comfort letters to underwriters in connection with registered public offerings.
(i) With respect to the letter of Deloitte & Touche LLP referred to in the preceding paragraph and delivered to the Representatives concurrently with the execution of this Agreement (the initial letter), the Company shall have furnished to the Representatives a letter (the bring-down letter) of such accountants, addressed to the
Underwriters and dated such Delivery Date (i) confirming that they are independent public accountants within the meaning of the Securities Act and are in compliance with the applicable requirements relating to the qualification of accountants under Rule 2-01 of Regulation S-X of the Commission, (ii) stating, as of the date of the bring-down letter (or, with respect to matters involving changes or developments since the respective dates as of which specified financial information is given in the Prospectus, as of a date not more than two business days prior to the date of the bring-down letter), the conclusions and findings of such firm with respect to the financial information and other matters covered by the initial letter, and (iii) confirming in all material respects the conclusions and findings set forth in the initial letter.
(j) The Company shall have furnished to the Representatives a certificate, dated such Delivery Date, of its Chief Executive Officer and its Chief Financial Officer as to such matters as the Representatives may reasonably request, including, without limitation, a statement:
(i) That the representations, warranties and agreements of the Company in Section 1 are true and correct in all material respects (or, where such representations and warranties are already qualified as to materiality, in all respects) on and as of such Delivery Date, and the Company has complied with all its agreements contained herein and satisfied in all material respects all the conditions on its part to be performed or satisfied hereunder at or prior to such Delivery Date;
(ii) That no stop order suspending the effectiveness of the Registration Statement has been issued; and no proceedings or examination for that purpose have been instituted or, to the knowledge of such officers, threatened;
(iii) That they have examined the Registration Statement, the Prospectus and the Pricing Disclosure Package, and, in their opinion, (A) (1) the Registration Statement, as of the Effective Date, (2) the Prospectus, as of its date and on the applicable Delivery Date, and (3) the Pricing Disclosure Package, as of the Applicable Time, did not and do not contain any untrue statement of a material fact and did not and do not omit to state a material fact required to be stated therein or necessary to make the statements therein (except in the case of the Registration Statement, in the light of the circumstances under which they were made) not misleading, and (B) since the Effective Date, no event has occurred that should have been set forth in a supplement or amendment to the Registration Statement, the Prospectus or any Issuer Free Writing Prospectus that has not been so set forth; and
(iv) To the effect of Section 9(l) (provided that no representation with respect to the judgment of the Representatives need be made) and Section 9(m).
(k) Each Selling Stockholder shall have furnished to the Representatives on such Delivery Date a certificate, dated such Delivery Date, signed by, or on behalf of, the Selling Stockholder stating that the representations, warranties and agreements of the Selling Stockholder contained herein are true and correct in all material respects (or, where such representations and warranties are already qualified as to materiality, in all respects) on and as of such Delivery Date and that the Selling Stockholder has complied with all its agreements contained herein and has satisfied in all material respects all the conditions on its part to be performed or satisfied hereunder at or prior to such Delivery Date.
(l) Except as described in the most recent Preliminary Prospectus, (i) neither the Company nor any of its subsidiaries shall have sustained, since the date of the latest audited financial statements included in the most recent Preliminary Prospectus, any loss or interference with its business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree, or (ii) since such date there shall not have been any change in the capital stock or long-term debt of the Company or any of its subsidiaries or any change, or any development involving a prospective change, in or affecting the condition (financial or otherwise), results of operations, or business of the Company and its subsidiaries taken as a whole, the effect of which, in any such case described in clause (i) or (ii), is, individually or in the aggregate, in the judgment of the Representatives, so material and adverse as to make it impracticable or inadvisable to proceed with the public offering or the delivery of the Stock being delivered on such Delivery Date on the terms and in the manner contemplated in the Prospectus.
(m) Subsequent to the execution and delivery of this Agreement (i) no downgrading shall have occurred in the rating accorded the Companys securities by any nationally recognized statistical rating organization (as defined by the Commission in Section 3(a)(62) of the Exchange Act), and (ii) no such organization shall have publicly announced that it has under surveillance or review, with possible negative implications, its rating of any of the Companys securities.
(n) Subsequent to the execution and delivery of this Agreement there shall not have occurred any of the following: (i) (A) trading in securities generally on any securities exchange that has registered with the Commission under Section 6 of the Exchange Act (including the New York Stock Exchange, The Nasdaq Global Select Market, The Nasdaq Global Market or The Nasdaq Capital Market), or (B) trading in any securities of the Company on any exchange or in the over-the-counter market, shall have been suspended or materially limited or the settlement of such trading generally shall have been materially disrupted or minimum prices shall have been established on any such exchange or such market by the Commission, by such exchange or by any other regulatory body or governmental authority having jurisdiction, (ii) a general moratorium on commercial banking activities shall have been declared by federal or state authorities, (iii) the United States shall have become engaged in hostilities, there shall have been an escalation in hostilities involving the United States or there shall have been a declaration of a national emergency or war by the United States, or (iv) there shall have occurred such a material adverse change in general economic, political or financial conditions, including, without limitation, as a result of terrorist activities after the date hereof (or the effect of international conditions on the financial markets in the United States shall be such) or any other calamity or crisis, either within or outside the United States, in each case with respect to clauses (i) through (iv), as to make it, in the judgment of the Representatives, so material and adverse as to make it impracticable or inadvisable to proceed with the public offering or delivery of the Stock being delivered on such Delivery Date on the terms and in the manner contemplated in the Prospectus.
(o) [Reserved.]
(p) The Lock-Up Agreements between the Representatives and the officers, directors and Selling Stockholders of the Company set forth on Schedule III, delivered to the Representatives on or before the date of this Agreement, shall be in full force and effect on such Delivery Date.
(q) The Representatives shall have received (i) on and as of the date hereof and (ii) on and as of each Delivery Date, as the case may be, a certificate of the Chief Financial Officer of the Company in a form reasonably satisfactory to the Representatives.
(r) On or prior to each Delivery Date, the Company shall have furnished to the Underwriters such further certificates and documents as the Representatives may reasonably request.
All opinions, letters, evidence and certificates mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form and substance reasonably satisfactory to counsel for the Underwriters.
10. Indemnification and Contribution.
(a) The Company hereby agrees to indemnify and hold harmless each Underwriter, its affiliates, directors, officers and employees and each person, if any, who controls any Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against any loss, claim, damage or liability, joint or several, or any action in respect thereof (including, but not limited to, any loss, claim, damage, liability or action relating to purchases and sales of Stock), to which that Underwriter, affiliate, director, officer, employee or controlling person may become subject, under the Securities Act or otherwise, insofar as such loss, claim, damage, liability or action arises out of, or is based upon, (i) any untrue statement or alleged untrue statement of a material fact contained in (A) any Preliminary Prospectus, the Registration Statement, the Prospectus or in any amendment or supplement thereto, (B) any Issuer Free Writing Prospectus or in any amendment or supplement thereto, (C) any Permitted Issuer Information used or referred to in any free writing prospectus (as defined in Rule 405 under the Securities Act) used or referred to by any Underwriter, or (D) any materials or information provided to investors by, or with the approval of, the Company in connection with the marketing of the offering of the Stock, including any road show (as defined in Rule 433 under the Securities Act) not constituting an Issuer Free Writing Prospectus and any Written Testing-the-Waters Communication (Marketing Materials); or (ii) the omission or alleged omission to state in any Preliminary Prospectus, the Registration Statement, the Prospectus, any Issuer Free Writing Prospectus or in any amendment or supplement thereto or in any Permitted Issuer Information, any Marketing Materials, any material fact required to be stated therein or necessary to make the statements therein not misleading, and shall reimburse each Underwriter and each such affiliate, director, officer,
employee or controlling person within 45 days of demand for any legal or other expenses reasonably incurred and documented by that Underwriter, affiliate, director, officer, employee or controlling person in connection with investigating or defending or preparing to defend against any such loss, claim, damage, liability or action as such expenses are incurred; provided, however, that the Company shall not be liable in any such case to the extent that any such loss, claim, damage, liability or action arises out of, or is based upon, any untrue statement or alleged untrue statement or omission or alleged omission made in any Preliminary Prospectus, the Registration Statement, the Prospectus, any Issuer Free Writing Prospectus or in any such amendment or supplement thereto or in any Permitted Issuer Information, any Marketing Materials, in reliance upon and in conformity with written information concerning such Underwriter furnished to the Company through the Representatives by or on behalf of any Underwriter specifically for inclusion therein, which information consists solely of the information specified in Section 10(f). The foregoing indemnity agreement is in addition to any liability which the Company may otherwise have to any Underwriter or to any affiliate, director, officer, employee or controlling person of that Underwriter.
(b) The Selling Stockholders, severally and not jointly in proportion to the number of shares of Stock to be sold by each of them hereunder, shall indemnify and hold harmless each Underwriter, its affiliates, directors, officers and employees, and each person, if any, who controls any Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against any loss, claim, damage or liability, joint or several, or any action in respect thereof (including, but not limited to, any loss, claim, damage, liability or action relating to purchases and sales of Stock), to which that Underwriter, affiliate, director, officer, employee or controlling person may become subject, under the Securities Act or otherwise, insofar as such loss, claim, damage, liability or action arises out of, or is based upon, (i) any untrue statement or alleged untrue statement of a material fact contained in any Preliminary Prospectus, the Registration Statement, the Prospectus, any Issuer Free Writing Prospectus or in any amendment or supplement thereto or in any Permitted Issuer Information, any Marketing Materials or any free writing prospectus (as defined in Rule 405 under the Securities Act) or (ii) the omission or alleged omission to state in any Preliminary Prospectus, Registration Statement, the Prospectus, any Issuer Free Writing Prospectus or in any amendment or supplement thereto or in any Permitted Issuer Information, or any Marketing Materials, any material fact required to be stated therein or necessary to make the statements therein not misleading, and shall reimburse each Underwriter, its affiliates, directors, officers and employees and each such controlling person within 45 days of demand for any legal or other expenses reasonably incurred and documented by that Underwriter, its affiliates, directors, officers and employees or controlling persons in connection with investigating or defending or preparing to defend against any such loss, claim, damage, liability or action as such expenses are incurred; provided that the indemnity set forth in this paragraph 10(b) apply solely to such Selling Stockholders Selling Stockholder Information furnished to the Company in writing by such Selling Stockholder expressly for use in the Registration Statement, Prospectus, Pricing Disclosure Package, and each Issuer Free Writing Prospectus, as applicable. The liability of each Selling Stockholder under the indemnity agreement contained in this paragraph shall be limited to an amount equal to the total gross proceeds from the offering of the shares of the Stock purchased under this Agreement
received by such Selling Stockholder, net of underwriting discounts but before expenses (the Selling Stockholder Proceeds) less any amounts such Selling Stockholder is obligated to contribute under the indemnity provision in this paragraph and the contribution provisions under paragraph (e) of this Section 10. The foregoing indemnity agreement is in addition to any liability that the Selling Stockholders may otherwise have to any Underwriter or any affiliate, director, officer, employee or controlling person of that Underwriter.
(c) Each Underwriter, severally and not jointly, shall indemnify and hold harmless the Company, each Selling Stockholder, their respective directors, officers and employees, and each person, if any, who controls the Company or such Selling Stockholder within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against any loss, claim, damage or liability, joint or several, or any action in respect thereof, to which the Company, such Selling Stockholder or any such director, officer, employee or controlling person may become subject, under the Securities Act or otherwise, insofar as such loss, claim, damage, liability or action arises out of, or is based upon, (i) any untrue statement or alleged untrue statement of a material fact contained in any Preliminary Prospectus, the Registration Statement, the Prospectus, any Issuer Free Writing Prospectus or in any amendment or supplement thereto or in any Marketing Materials, or (ii) the omission or alleged omission to state in any Preliminary Prospectus, the Registration Statement, the Prospectus, any Issuer Free Writing Prospectus or in any amendment or supplement thereto or in any Marketing Materials, any material fact required to be stated therein or necessary to make the statements therein not misleading, but in each case only to the extent that the untrue statement or alleged untrue statement or omission or alleged omission was made in reliance upon and in conformity with written information concerning such Underwriter furnished to the Company through the Representatives by or on behalf of that Underwriter specifically for inclusion therein, which information is limited to the information set forth in Section 10(f). The foregoing indemnity agreement is in addition to any liability that any Underwriter may otherwise have to the Company, such Selling Stockholder or any such director, officer, employee or controlling person.
(d) Promptly after receipt by an indemnified party under this Section 10 of notice of any claim or the commencement of any action, the indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under this Section 10, notify the indemnifying party in writing of the claim or the commencement of that action; provided, however, that the failure to notify the indemnifying party shall not relieve it from any liability which it may have under this Section 10 except to the extent it has been materially prejudiced (through the forfeiture of substantive rights and defenses) by such failure and, provided, further, that the failure to notify the indemnifying party shall not relieve it from any liability which it may have to an indemnified party otherwise than under this Section 10. If any such claim or action shall be brought against an indemnified party, and it shall notify the indemnifying party thereof, the indemnifying party shall be entitled to participate therein and, to the extent that it wishes, jointly with any other similarly notified indemnifying party, to assume the defense thereof with counsel reasonably satisfactory to the indemnified party. After notice from the indemnifying party to the indemnified party of its election to assume the defense of such claim or action, the indemnifying party shall not be liable to the indemnified party under this Section 10 for
any legal or other expenses subsequently incurred by the indemnified party in connection with the defense thereof other than reasonable costs of investigation; provided, however, that the indemnified party shall have the right to employ counsel to represent jointly the indemnified party and those other indemnified parties and their respective directors, officers, employees and controlling persons who may be subject to liability arising out of any claim in respect of which indemnity may be sought under this Section 10 if (i) the indemnified party and the indemnifying party shall have so mutually agreed; (ii) the indemnifying party has failed within a reasonable time to retain counsel reasonably satisfactory to the indemnified party; (iii) the indemnified party and its directors, officers, employees and controlling persons shall have reasonably concluded, based on the advice of counsel, that there may be legal defenses available to them that are different from or in addition to those available to the indemnifying party; or (iv) the named parties in any such proceeding (including any impleaded parties) include both the indemnified parties or their respective directors, officers, employees or controlling persons, on the one hand, and the indemnifying party, on the other hand, and representation of both sets of parties by the same counsel would be inappropriate due to actual or potential differing interests between them, and in any such event the fees and expenses of such separate counsel shall be paid by the indemnifying party (it being understood, however, that the indemnifying party shall not be liable for the expenses of more than one separate counsel (together with local counsel (in each jurisdiction)), which shall be selected by the Representatives (in the case of counsel representing the Underwriters or their related persons)). No indemnifying party shall (x) without the prior written consent of the indemnified parties (which consent shall not be unreasonably withheld), settle or compromise or consent to the entry of any judgment with respect to any pending or threatened claim, action, suit or proceeding in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified parties are actual or potential parties to such claim or action) unless such settlement, compromise or consent includes an unconditional release of each indemnified party from all liability arising out of such claim, action, suit or proceeding and does not include a statement as to, or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party, or (y) be liable for any settlement of any such action effected without its written consent (which consent shall not be unreasonably withheld), but if settled with the consent of the indemnifying party or if there be a final judgment for the plaintiff in any such action, the indemnifying party agrees to indemnify and hold harmless any indemnified party from and against any loss or liability by reason of such settlement or judgment.
(e) If the indemnification provided for in this Section 10 shall for any reason be unavailable to or insufficient to hold harmless an indemnified party under Section 10(a), 10(b) or 10(c) in respect of any loss, claim, damage or liability, or any action in respect thereof, referred to therein, then each indemnifying party shall, in lieu of indemnifying such indemnified party, contribute to the amount paid or payable by such indemnified party as a result of such loss, claim, damage or liability, or action in respect thereof, (i) in such proportion as shall be appropriate to reflect the relative benefits received by the Company and the Selling Stockholders, on the one hand, and the Underwriters, on the other hand, from the offering of the Stock, or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company
and the Selling Stockholders, on the one hand, and the Underwriters, on the other hand, with respect to the statements or omissions that resulted in such loss, claim, damage or liability, or action in respect thereof, as well as any other relevant equitable considerations. The relative benefits received by the Company and the Selling Stockholders, on the one hand, and the Underwriters, on the other hand, with respect to such offering shall be deemed to be in the same proportion as the total net proceeds from the offering of the Stock purchased under this Agreement (before deducting expenses) received by the Company and the Selling Stockholders, on the one hand, and the total underwriting discounts and commissions received by the Underwriters with respect to the shares of the Stock purchased under this Agreement, on the other hand. The relative fault shall be determined by reference to whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company, the Selling Stockholders or the Underwriters, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company, the Selling Stockholders and the Underwriters agree that it would not be just and equitable if contributions pursuant to this Section 10(e) were to be determined by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation that does not take into account the equitable considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, damage or liability, or action in respect thereof, referred to above in this Section 10(e) shall be deemed to include, for purposes of this Section 10(e), any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim, subject to the provisions of Section 10(d). Notwithstanding the provisions of this Section 10(e), in no event shall an Underwriter be required to contribute any amount in excess of the amount by which the total underwriting discounts and commissions received by such Underwriter with respect to the offering of the Stock exceeds the amount of any damages that such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. Notwithstanding the provisions of this paragraph (e), each Selling Stockholders obligations to contribute any amount under this paragraph (e) is limited in the manner and to the extent set forth in paragraph 10(b) and in no event shall the aggregate liability of such Selling Stockholder under paragraph 10(b) and this paragraph (e) exceed such Selling Stockholders Selling Stockholder Proceeds limit set forth in paragraph 10(b). No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Underwriters obligations to contribute as provided in this Section 10(e) are several in proportion to their respective underwriting obligations and not joint.
(f) The Underwriters severally confirm and the Company and each Selling Stockholder acknowledges and agrees that the statements regarding delivery of shares by the Underwriters set forth on the cover page of, and the concession [and reallowance] figure[s] and the paragraph relating to stabilization by the Underwriters appearing under the caption Underwriting in, the most recent Preliminary Prospectus and the Prospectus constitute the only information concerning such Underwriters furnished in writing to the Company by or on behalf of the Underwriters specifically for inclusion in any Preliminary Prospectus, the Registration Statement, the Prospectus, any Issuer Free Writing Prospectus or in any amendment or supplement thereto or in any Marketing Materials.
11. Defaulting Underwriters.
(a) If, on any Delivery Date, any Underwriter defaults in its obligations to purchase the Stock that it has agreed to purchase under this Agreement, the remaining non-defaulting Underwriters may in their discretion arrange for the purchase of such Stock by the non-defaulting Underwriters or other persons satisfactory to the Company on the terms contained in this Agreement. If, within 36 hours after any such default by any Underwriter, the non-defaulting Underwriters do not arrange for the purchase of such Stock, then the Company shall be entitled to a further period of 36 hours within which to procure other persons satisfactory to the non-defaulting Underwriters to purchase such Stock on such terms. In the event that within the respective prescribed periods, the non-defaulting Underwriters notify the Company that they have so arranged for the purchase of such Stock, or the Company notifies the non-defaulting Underwriters that it has so arranged for the purchase of such Stock, either the non-defaulting Underwriters or the Company may postpone such Delivery Date for up to seven full business days in order to effect any changes that in the opinion of counsel for the Company or counsel for the Underwriters may be necessary in the Registration Statement, the Prospectus or in any other document or arrangement, and the Company agrees to promptly prepare any amendment or supplement to the Registration Statement, the Prospectus or in any such other document or arrangement that effects any such changes. As used in this Agreement, the term Underwriter, unless the context requires otherwise, includes any party not listed in Schedule I hereto that, pursuant to this Section 11, purchases Stock that a defaulting Underwriter agreed but failed to purchase.
(b) If, after giving effect to any arrangements for the purchase of the Stock of a defaulting Underwriter or Underwriters by the non-defaulting Underwriters and the Company as provided in paragraph (a) above, the total number of shares of the Stock that remains unpurchased does not exceed one-eleventh of the total number of shares of all the Stock, then the Company and the Selling Stockholders shall have the right to require each non-defaulting Underwriter to purchase the total number of shares of Stock that such Underwriter agreed to purchase hereunder plus such Underwriters pro rata share (based on the total number of shares of Stock that such Underwriter agreed to purchase hereunder) of the Stock of such defaulting Underwriter or Underwriters for which such arrangements have not been made; provided that the non-defaulting Underwriters shall not be obligated to purchase more than 110% of the total number of shares of Stock that it agreed to purchase on such Delivery Date pursuant to the terms of Section 3.
(c) If, after giving effect to any arrangements for the purchase of the Stock of a defaulting Underwriter or Underwriters by the non-defaulting Underwriters and the Company as provided in paragraph (a) above, the total number of shares of Stock that remains unpurchased exceeds one-eleventh of the total number of shares of all the
Stock, or if the Company shall not exercise the right described in paragraph (b) above, then this Agreement shall terminate without liability on the part of the non-defaulting Underwriters. Any termination of this Agreement pursuant to this Section 11 shall be without liability on the part of the Company or the Selling Stockholders, except that the Company will continue to be liable for the payment of expenses as set forth in Sections 8 and 13 and except that the provisions of Section 10 shall not terminate and shall remain in effect.
(d) Nothing contained herein shall relieve a defaulting Underwriter of any liability it may have to the Company, the Selling Stockholders or any non-defaulting Underwriter for damages caused by its default.
12. Recognition of the U.S. Special Resolution Regimes.
(a) In the event that any of the Underwriters that are a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States.
(b) In the event that any of the Underwriters that are a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights would be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States.
(c) For the purposes of this Section 15, a BHC Act Affiliate has the meaning assigned to the term affiliate in, and shall be interpreted in accordance with, 12 U.S.C. § 1841(k). Covered Entity means any of the following: (i) a covered entity as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b); (ii) a covered bank as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b); or (iii) a covered FSI as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b). Default Right has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as applicable. U.S. Special Resolution Regime means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.
13. Termination. The obligations of the Underwriters hereunder may be terminated by the Representatives by notice given to and received by the Company and the Selling Stockholders prior to delivery of and payment for the Firm Stock if, prior to that time, any of the events described in Sections 9(l), 9(m) and 9(n) shall have occurred or if the Underwriters shall decline to purchase the Stock for any reason permitted under this Agreement.
14. Reimbursement of Underwriters Expenses. If (a) any Selling Stockholder shall fail to tender the Stock for delivery to the Underwriters for any reason, or (b) the Underwriters shall decline to purchase the Stock for any reason permitted under this Agreement, the Company will reimburse the Underwriters for all reasonable out-of-pocket expenses (including fees and disbursements of counsel for the Underwriters) incurred by the Underwriters in connection with this Agreement and the proposed purchase of the Stock, and upon demand the Company shall pay the full amount thereof to the Representatives. If this Agreement is terminated pursuant to Section 11 by reason of the default of one or more Underwriters, neither the Company nor any Selling Stockholder shall be obligated to reimburse any defaulting Underwriter on account of those expenses.
15. Research Analyst Independence. The Company acknowledges that the Underwriters research analysts and research departments are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and that such Underwriters research analysts may hold views and make statements or investment recommendations and/or publish research reports with respect to the Company and/or the offering that differ from the views of their respective investment banking divisions. The Company and the Selling Stockholders hereby waive and release, to the fullest extent permitted by law, any claims that the Company or the Selling Stockholders may have against the Underwriters with respect to any conflict of interest that may arise from the fact that the views expressed by their independent research analysts and research departments may be different from or inconsistent with the views or advice communicated to the Company or the Selling Stockholders by such Underwriters investment banking divisions. The Company and the Selling Stockholders acknowledge that each of the Underwriters is a full service securities firm and as such from time to time, subject to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short positions in debt or equity securities of the companies that may be the subject of the transactions contemplated by this Agreement.
16. No Fiduciary Duty. The Company and the Selling Stockholders acknowledge and agree that in connection with this offering, sale of the Stock or any other services the Underwriters may be deemed to be providing hereunder, notwithstanding any preexisting relationship, advisory or otherwise, between the parties or any oral representations or assurances previously or subsequently made by the Underwriters: (a) no fiduciary or agency relationship between the Company, Selling Stockholders and any other person, on the one hand, and the Underwriters, on the other hand, exists; (b) the Underwriters are not acting as advisors, expert or otherwise and are not providing a recommendation or investment advice, to either the Company or the Selling Stockholders, including, without limitation, with respect to the determination of the public offering price of the Stock, and such relationship between the Company and the Selling Stockholders, on the one hand, and the Underwriters, on the other hand, is entirely and solely commercial, based on arms-length negotiations and, as such, not intended for use by any individual for personal, family or household purposes; (c) any duties and obligations that the Underwriters may have to the Company or Selling Stockholders shall be limited to those duties and obligations specifically stated herein; (d) the Underwriters and their respective affiliates may have interests that differ from those of the Company and the Selling Stockholders; and (e) does not constitute a
solicitation of any action by the Underwriters. The Company and the Selling Stockholders hereby (x) waive any claims that the Company or the Selling Stockholders may have against the Underwriters with respect to any breach of fiduciary duty in connection with this offering and (y) agree that none of the activities of the Underwriters in connection with the transactions contemplated herein constitutes a recommendation, investment advice or solicitation of any action by the Underwriters with respect to any entity or natural person. Each of the Company and the Selling Stockholders has consulted their own legal, accounting, financial, regulatory and tax advisors to the extent deemed appropriate.
17. Notices, etc. All statements, requests, notices and agreements hereunder shall be in writing, and:
(a) if to the Underwriters, shall be delivered or sent by mail or facsimile transmission to:
(i) Barclays Capital Inc., 745 Seventh Avenue, New York, New York 10019, Attention: Syndicate Registration (Fax: (646) 834-8133), with a copy, in the case of any notice pursuant to Section 10(d), to the Director of Litigation, Office of the General Counsel, Barclays Capital Inc., 745 Seventh Avenue, New York, New York 10019; and
(ii) BofA Securities, Inc., One Bryant Park, New York, New York 10036, Facsimile: (646) 855 3073, Attention: Syndicate Department, with a copy to: Facsimile: (212) 230-8730, Attention: ECM Legal.
(b) if to the Company or SLP Fastball Aggregator, L.P., shall be delivered or sent by mail or facsimile transmission to the address of the Company set forth in the Registration Statement, Attention: Bret T. Jardine, with a copy to Simpson Thacher & Bartlett LLP, 425 Lexington Avenue, New York, New York 10017, Attention: Ken Wallach and Hui Lin;
(c) if to WorkDay, Inc., shall be delivered or sent by mail or facsimile transmission to Orrick, Herrington & Sutcliffe at [ ]; and
(d) if to any Selling Stockholder (other than SLP Fastball Aggregator, L.P.), shall be delivered or sent by mail or facsimile transmission to each of the Attorneys-in-Fact named in the Power of Attorney, c/o the Company at the address set forth on the cover of the Registration Statement, attention of General Counsel, with a copy, which shall not constitute notice, to Whalen LLP, 1601 Dove Street, Suite 270, Newport Beach, California 92660.
Any such statements, requests, notices or agreements shall take effect at the time of receipt thereof. The Company and the Selling Stockholders shall be entitled to act and rely upon any request, consent, notice or agreement given or made on behalf of the Underwriters by Barclays Capital Inc. on behalf of the Representatives, and the Company and the Underwriters shall be entitled to act and rely upon any request, consent, notice or agreement given or made on behalf of: (i) the Specified Selling Stockholders by the Custodian, (ii) SLP Fastball Aggregator, L.P. by [ ] and (iii) Workday, Inc, by [ ].
18. Persons Entitled to Benefit of Agreement. This Agreement shall inure to the benefit of and be binding upon the Underwriters, the Company, the Selling Stockholders and their respective personal representatives and successors. This Agreement and the terms and provisions hereof are for the sole benefit of only those persons, except that (a) the representations, warranties, indemnities and agreements of the Company and the Selling Stockholders contained in this Agreement shall also be deemed to be for the benefit of the directors, officers and employees of the Underwriters and each person or persons, if any, who control any Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, and (b) the indemnity agreement of the Underwriters contained in Section 10(c) of this Agreement shall be deemed to be for the benefit of the directors of the Company, the officers of the Company who have signed the Registration Statement and any person controlling the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act. Nothing in this Agreement is intended or shall be construed to give any person, other than the persons referred to in this Section 17, any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein.
19. Survival. The respective indemnities, rights of contributions, representations, warranties and agreements of the Company, the Selling Stockholders and the Underwriters contained in this Agreement or made by or on behalf of them, respectively, pursuant to this Agreement, shall survive the delivery of and payment for the Stock and shall remain in full force and effect, regardless of any investigation made by or on behalf of any of them or any person controlling any of them.
20. Definition of the Terms Business Day, Affiliate and Subsidiary. For purposes of this Agreement, (a) business day means each Monday, Tuesday, Wednesday, Thursday or Friday that is not a day on which banking institutions in New York are generally authorized or obligated by law or executive order to close, and (b) affiliate and subsidiary have the meanings set forth in Rule 405 under the Securities Act.
21. Governing Law. This Agreement and any transaction contemplated by this Agreement shall be governed by and construed in accordance with the laws of the State of New York without regard to conflict of laws principles that would result in the application of any other law than the laws of the State of New York (other than Section 5-1401 of the General Obligations Law).
22. Waiver of Jury Trial. The Company, the Selling Stockholders and the Underwriters hereby irrevocably waive, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.
23. Counterparts. This Agreement may be executed in one or more counterparts and, if executed in more than one counterpart, the executed counterparts shall each be deemed to be an original but all such counterparts shall together constitute one and the same instrument. Delivery of an executed Agreement by one party to any other party may be made by facsimile, electronic mail (including any electronic signature complying with the New York Electronic Signatures and Records Act (N.Y. State Tech. §§ 301-309), as amended from time to time, or other applicable law) or other transmission method, and the parties hereto agree that any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.
24. Headings. The headings herein are inserted for convenience of reference only and are not intended to be part of, or to affect the meaning or interpretation of, this Agreement.
If the foregoing correctly sets forth the agreement among the Company, the Selling Stockholders and the Underwriters, please indicate your acceptance in the space provided for that purpose below.
Very truly yours, | ||
FIRST ADVANTAGE CORPORATION | ||
By: |
| |
Name: | ||
Title: |
SLP FASTBALL AGGREGATOR, L.P. | ||
By: SLP V Aggregator GP, L.L.C., its general partner | ||
By: Silver Lake Technology Associates V, L.P., its managing member | ||
By: SLTA V (GP), L.L.C., its general partner | ||
By: Silver Lake Group, L.L.C., its managing member | ||
By: |
| |
Name: | ||
Title: |
WORKDAY, INC. | ||
By: |
| |
Name: | ||
Title: |
SPECIFIED SELLING STOCKHOLDERS, acting severally | ||
By: |
| |
Name: | ||
Title: Attorney-in-Fact acting on behalf of each of the Specified Selling Stockholders named in Schedule II to this Agreement. |
Accepted:
BARCLAYS CAPITAL INC.
BOFA SECURITIES, INC.
For themselves and as Representatives
of the several Underwriters named
in Schedule I hereto
BY: BARCLAYS CAPITAL INC.
By: |
| |
Name: | ||
Title: | ||
By: | BOFA SECURITIES, INC. | |
By: |
| |
Name: | ||
Title: |
SCHEDULE I
Underwriters |
Number of Shares of Firm Stock |
Number of Shares of Option Stock | ||
Barclays Capital Inc. |
[ ] | [ ] | ||
BofA Securities, Inc. |
[ ] | [ ] | ||
Citigroup Global Markets Inc. |
[ ] | [ ] | ||
Evercore Group L.L.C. |
[ ] | [ ] | ||
Jefferies LLC |
[ ] | [ ] | ||
RBC Capital Markets, LLC. |
[ ] | [ ] | ||
Stifel, Nicolaus & Company, Incorporated. |
[ ] | [ ] | ||
HSBC Securities (USA) Inc. |
[ ] | [ ] | ||
Citizens Capital Markets, Inc. |
[ ] | [ ] | ||
KKR Capital Markets LLC |
[ ] | [ ] | ||
MUFG Securities Americas Inc. |
[ ] | [ ] | ||
Loop Capital Markets LLC |
[ ] | [ ] | ||
R. Seelaus & Co., LLC |
[ ] | [ ] | ||
Samuel A. Ramirez & Company, Inc. |
[ ] | [ ] | ||
Roberts & Ryan Investments, Inc. |
[ ] | [ ] | ||
|
| |||
Total |
||||
|
|
SCHEDULE II
Name and Address of Selling Stockholder |
Number of Shares of Firm Stock |
Number of Shares of Option Stock |
||||||
[ | ] | [ | ] | |||||
[ | ] | [ | ] | |||||
|
|
|
|
SCHEDULE III
PERSONS DELIVERING LOCK-UP AGREEMENTS
SCHEDULE IV
ORALLY CONVEYED PRICING INFORMATION
1. Public offering price: $[ ]
2. Number of Firm Shares offered: [ ]
3. Number of Option Shares offered: [ ]
SCHEDULE V
ISSUER FREE WRITING PROSPECTUSES ROAD SHOW MATERIALS
[ ]
SCHEDULE VI
TESTING THE WATERS MATERIALS
[ ]
EXHIBIT A
LOCK-UP LETTER AGREEMENT
BARCLAYS CAPITAL INC.
BOFA SECURITIES, INC.
As Representatives of the several
Underwriters named in Schedule I attached hereto,
c/o Barclays Capital Inc.
745 Seventh Avenue
New York, New York 10019
BofA Securities, Inc.
One Bryant Park
New York, New York 10036
, 2021
Ladies and Gentlemen:
The undersigned understands that you and certain other firms (the Underwriters) propose to enter into an Underwriting Agreement (the Underwriting Agreement) providing for the purchase by the Underwriters of shares (the Stock) of Common Stock, par value $0.001 per share (the Common Stock), of First Advantage Corporation, a Delaware corporation (the Company), and that the Underwriters propose to reoffer the Stock to the public (the Offering). Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Underwriting Agreement.
In consideration of the execution of the Underwriting Agreement by the Underwriters, and for other good and valuable consideration, the undersigned hereby irrevocably agrees that, without the prior written consent of Barclays Capital Inc. and BofA Securities, Inc., on behalf of the Underwriters, the undersigned will not, directly or indirectly, (1) offer for sale, sell, pledge, lend, or otherwise dispose of (or enter into any transaction or device that is designed to, or would be expected to, result in the disposition by any person at any time in the future of) any shares of Common Stock (including, without limitation, shares of Common Stock that may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and shares of Common Stock that may be issued upon exercise of any options or warrants) or securities convertible into or exercisable or exchangeable for Common Stock (other than the Stock), (2) enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership of shares of Common Stock, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of Common Stock or other securities, in cash or otherwise, (3) make any demand for or exercise any right that causes to be filed a registration statement, including any amendments thereto, with respect to the registration of any shares of Common Stock or securities convertible into or exercisable or exchangeable for Common Stock or any other securities of the Company, or (4) publicly disclose the intention to do any of the foregoing for a period commencing on the date hereof and ending on the 60th day after the date of the Prospectus relating to the Offering (such 60-day period, the Lock-Up Period).
The foregoing restrictions are expressly agreed to preclude the undersigned from engaging in any hedging or other transaction which is designed to or which reasonably would be expected to lead to or result in a sale or disposition of Common Stock or any other securities of the Company even if such Common Stock or other securities of the Company would be disposed of by someone other than the undersigned, including, without limitation, any short sale or any purchase, sale or grant of any right (including without limitation any put or call option, forward, swap or any other derivative transaction or instrument) with respect to any Common Stock, or any other security of the Company that includes, relates to, or derives any significant part of its value from Common Stock or other securities of the Company.
The foregoing restrictions, including without limitation the immediately preceding sentence, shall not apply to:
(a) | the pledge, hypothecation or other granting of a security interest in shares of Common Stock or securities convertible into or exchangeable for Common Stock to one or more lending institutions as collateral or security for any loan, advance or extension of credit and any transfer upon foreclosure upon such Common Stock or such securities; |
(b) | transactions relating to shares of Common Stock or other securities acquired in the Offering or in the open market after the completion of the Offering; |
(c) | bona fide gifts or for bona fide estate planning purposes; provided that it shall be a condition to any transfer pursuant to this clause (c) that the transferee agrees to be bound by the terms of this Lock-Up Letter Agreement (including, without limitation, the restrictions set forth in the preceding sentence) to the same extent as if the transferee were a party hereto; |
(d) | gifts, sales, distributions or other dispositions of shares of any class of the Companys capital stock, in each case (A) that are made exclusively between and among the undersigned or members of the undersigneds family or other dependents, or (B) if the undersigned is a corporation, partnership, limited liability company, trust or other business entity, (1) to another corporation, partnership, limited liability company, trust or other business entity that is an affiliate (as defined in Rule 405 promulgated under the Securities Act) of the undersigned, or to any investment fund or other entity controlling, controlled by, managing or managed by or under common control with the undersigned or affiliates of the undersigned (including, for the avoidance of doubt, where the undersigned is a partnership, to its general partner or a successor partnership or fund, or any other funds managed by such partnership), or (2) as part of a distribution, transfer or disposition to members, partners, shareholders or other equity holders of the undersigned; provided that it shall be a condition to any |
transfer pursuant to this clause (d) that any transferee agrees to be bound by the terms of this Lock-Up Letter Agreement (including, without limitation, the restrictions set forth in the preceding sentence) to the same extent as if the transferee were a party hereto, and provided further that in the case of any transfer or distribution pursuant to clause (B), it shall be a condition to such transfer that no public filing, report or announcement shall be voluntarily made and if any filing under Section 16(a) of the Exchange Act, or other public filing, report or announcement reporting a reduction in beneficial ownership of shares of Common Stock in connection with such transfer or distribution, shall be legally required during the Lock-Up Period, such filing, report or announcement shall clearly indicate in the footnotes thereto the nature and conditions of such transfer; |
(e) | transfers by will or other testamentary document, or intestacy; |
(f) | if the undersigned is a trust, transfers to the grantor or beneficiary of such trust; provided that it shall be a condition to any transfer pursuant to this clause (f) that the transferee agrees to be bound by the terms of this Lock-Up Letter Agreement (including, without limitation, the restrictions set forth in the preceding sentence) to the same extent as if the transferee were a party hereto; |
(g) | transfers to a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under clauses (b) through (e) above provided that it shall be a condition to any transfer pursuant to this clause (g) that the transferee agrees to be bound by the terms of this Lock-Up Letter Agreement (including, without limitation, the restrictions set forth in the preceding sentence) to the same extent as if the transferee were a party hereto; |
(h) | the cashless exercise or surrender of warrants, the conversion of preferred stock or the cashless exercise or surrender of stock options or settlement of restricted stock units or other equity awards granted pursuant to the Companys stock option/incentive plans or otherwise outstanding on the date hereof; provided, that the restrictions shall apply to shares of Common Stock issued upon such exercise or conversion; |
(i) | transfers to the Company to the extent necessary to fund the exercise price of options held by the undersigned and the payment of taxes due with respect to the exercise, vesting, or lapse of substantial risk of forfeiture or other similar taxable event, of restricted stock, restricted stock units, stock options or other rights to purchase or receive shares of Common Stock pursuant to the Companys stock option/equity incentive plans disclosed in the Prospectus relating to the Offering; |
(j) | transfers to the Company or its subsidiaries upon death, disability or termination of employment of the undersigned; |
(k) | tenders, sales or other transfers pursuant to a bona fide third-party tender offer, merger, consolidation or other similar transaction made to all holders of shares of Common Stock involving a change of control (as defined below) of the Company (provided that if such transaction is not consummated, the undersigneds shares of Common Stock shall remain subject to the restrictions set forth herein). For purposes of this clause (k), change of control means the consummation of any bona fide third party tender offer, merger, consolidation or other similar transaction the result of which is that any person (as defined in Section 13(d)(3) of the Exchange Act, or group of persons, other than the Company, becomes the beneficial owner (as defined in Rules 13d-3 and 13d-5 of the Exchange Act) of more than 50% of total voting power of the voting stock of the Company; |
(l) | transfers pursuant to an order of a court or regulatory agency (for purposes of this Lock-Up Letter Agreement, a court or regulatory agency means any domestic or foreign, federal, state or local government, including any political subdivision thereof, any governmental or quasi-governmental authority, department, agency or official, any court or administrative body, and any national securities exchange or similar self-regulatory body or organization, in each case of competent jurisdiction); provided that any filing under Section 16(a) of the Exchange Act in connection with such transfer shall indicate, to the extent permitted by such section and the related rules and regulations, that such transfer is pursuant to an order of a court or regulatory agency; |
(m) | transfers to the Company pursuant to any call or put provisions of existing employment agreements and equity grant documents; provided that any filing under Section 16(a) of the Exchange Act in connection with such transfer shall indicate, to the extent permitted by such section and the related rules and regulations, the reason for such disposition and that such transfer was solely to the Company; |
(n) | transfers of Common Stock or securities convertible into, or exchangeable or exercisable for, Common Stock, pursuant to any contract, instruction or plan that satisfies all of the requirements of Rule 10b5-1 under the Exchange Act (a Rule 10b5-1 Plan), or the establishment of a Rule 10b5-1 Plan; provided, however, that no sales of Common Stock or securities convertible into, or exchangeable or exercisable for, Common Stock, shall be made pursuant to a Rule 10b5-1 Plan prior to the expiration of the Lock-Up Period (as the same may be extended pursuant to the provisions hereof) other than pursuant to a Rule 10b5-1 Plan in effect on the date hereof; provided further, that neither the undersigned nor the Company is required to report the establishment of such Rule 10b5-1 Plan in any public report or filing with the Commission under the Exchange Act during the Lock-Up Period and does not otherwise voluntarily effect any such public filing or report regarding such Rule 10b5-1 Plan; |
(o) | any demands or requests for, exercises of any right with respect to, or taking of any action in preparation of, the registration by the Company under the Securities Act of the undersigneds shares of Common Stock, provided that no transfer of the undersigneds shares of Common Stock registered pursuant to the exercise of any such right and no registration statement shall be filed under the Securities Act with respect to any of the undersigneds shares of Common Stock during the Lock-Up Period; and |
(p) | the distribution of Shares by the undersigned in one or more distributions in kind to the partners, members or equityholders of the undersigned and/or its affiliates up to the number of Shares disclosed in the Prospectus related to this Offering in the definition of SLP Distribution in the section titled Basis of Presentation (and if the underwriters option to purchase additional shares pursuant to the Underwriting Agreement is exercised, up to the number of Shares disclosed in the parenthetical in the definition of SLP Distribution in the section titled Basis of Presentation); provided that it shall be a condition to any transfer pursuant to this clause (p) to a partner, member or equityholder of the undersigned that (1) is a current employee of Silver Lake Group, L.L.C or any of its affiliates (other than any portfolio company thereof), that the undersigned notifies such employee in writing that s/he is restricted from selling, trading or otherwise disposing of Shares received by such employee in the SLP Distribution for the period beginning on the date hereof and ending on the date that is 30 days from the date of the Prospectus (but subject to the exceptions set forth in foregoing clauses (a) through (o)) or (2) is an entity that is controlled by or under common control with SLP Fastball Aggregator, L.P. (each, a Silver Lake GP Entity) that the transferee agrees to be bound by the terms of this Lock-Up Letter Agreement (including, without limitation, the restrictions set forth in the preceding sentence) to the same extent as if the transferee were a party hereto but only for a period beginning on the date hereof and ending on the date that is 30 days from the date of the Prospectus; provided further, that the Silver Lake GP Entities be permitted to offer for sale, sell or otherwise dispose of, in the aggregate, up to 5.0% of all of the Shares distributed to the general partners in the SLP Distribution as such term is defined in the Prospectus related to this Offering. |
In furtherance of the foregoing, the Company and its transfer agent are hereby authorized to decline to make any transfer of securities if such transfer would constitute a violation or breach of this Lock-Up Letter Agreement.
It is understood that, if the Company notifies the Underwriters that it does not intend to proceed with the Offering through the Representatives, if the Underwriters notify the Company that they do not intend to proceed with the Offering, if the Underwriting Agreement does not become effective, or if the Underwriting Agreement (other than the provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Stock, the undersigned will be released from its obligations under this Lock-Up Letter Agreement.
The undersigned understands that the Company and the Underwriters will proceed with the Offering in reliance on this Lock-Up Letter Agreement.
Whether or not the Offering actually occurs depends on a number of factors, including, without limitation, market conditions. Any Offering will only be made pursuant to an Underwriting Agreement, the terms of which are subject to negotiation between the Company, the Selling Stockholders named therein and the Underwriters.
The undersigned acknowledges and agrees that the Underwriters have not provided any recommendation or investment advice nor have the Underwriters solicited any action from the undersigned with respect to the Offering and the undersigned has consulted their own legal, accounting, financial, regulatory and tax advisors to the extent deemed appropriate.
This Lock-Up Letter Agreement and any transaction contemplated by this Lock-Up Letter Agreement shall be governed by and construed in accordance with the laws of the State of New York without regard to conflict of laws principles that would result in the application of any other law than the laws of the State of New York (other than Section 5-1401 of the General Obligations Law).
This Lock-Up Letter Agreement shall automatically terminate upon the termination of the Underwriting Agreement before the sale of any Stock to the Underwriters.
[Signature page follows]
The undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this Lock-Up Letter Agreement and that, upon request, the undersigned will execute any additional documents necessary in connection with the enforcement hereof. Any obligations of the undersigned shall be binding upon the heirs and executors (in the case of individuals), personal representatives, successors and assigns of the undersigned.
Very truly yours, | ||
By: |
| |
Name: | ||
Title: |
Dated: _______________
Exhibit 5.1
425 LEXINGTON AVENUE
NEW YORK, NY 10017-3954
TELEPHONE: +1-212-455-2000
FACSIMILE: +1-212-455-2502
November 8, 2021
First Advantage Corporation
1 Concourse Parkway NE, Suite 200
Atlanta, Georgia 30328
Ladies and Gentlemen:
We have acted as counsel to First Advantage Corporation, a Delaware corporation (the Company), in connection with the Registration Statement on Form S-1 (the Registration Statement) filed by the Company with the Securities and Exchange Commission (the Commission) under the Securities Act of 1933, as amended (the Act), relating to the sale by the selling stockholders referred to in the Registration Statement of an aggregate of up to 17,250,000 shares of common stock, par value $0.001 per share (the Common Stock), of the Company (together with any additional shares of such Common Stock that may be sold by the selling stockholders pursuant to Rule 462(b) (as prescribed by the Commission pursuant to the Act) in connection with the offering described in the Registration Statement, the Shares) currently issued and outstanding.
We have examined the Registration Statement. In addition, we have examined, and have relied as to matters of fact upon, originals, or duplicates or certified or conformed copies, of such records, agreements, documents and other instruments and such certificates or comparable documents of public officials and of officers and representatives of the Company and have made such other investigations as we have deemed relevant and necessary in connection with the opinion hereinafter set forth.
BEIJING HONG KONG HOUSTON LONDON LOS ANGELES PALO ALTO SÃO PAULO SEOUL TOKYO WASHINGTON, D.C.
In rendering the opinion set forth below, we have assumed the genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as duplicates or certified or conformed copies and the authenticity of the originals of such latter documents.
Based upon the foregoing, and subject to the qualifications, assumptions and limitations stated herein, we are of the opinion that the Shares have been validly issued and are fully paid and nonassessable.
We do not express any opinion herein concerning any law other than the Delaware General Corporation Law.
We hereby consent to the filing of this opinion letter as Exhibit 5.1 to the Registration Statement and to the use of our name under the caption Legal Matters in the prospectus included in the Registration Statement.
Very truly yours, |
/s/ Simpson Thacher & Bartlett LLP |
SIMPSON THACHER & BARTLETT LLP |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on Form S-1 of our report dated April 2, 2021 (June 14, 2021 as to the effects of the stock split described in Note 17), relating to the financial statements of First Advantage Corporation (formerly Fastball Intermediate, Inc.). We also consent to the reference to us under the heading Experts in such Registration Statement.
/s/ Deloitte & Touche LLP
Atlanta, GA
November 8, 2021
Exhibit 23.3
Consent of Stax Inc.
November 8, 2021
First Advantage Corporation
1 Concourse Pkwy NE, Suite 200
Atlanta, GA 30328
Ladies and Gentlemen:
Stax Inc. hereby consents to references to its name in the registration statement on Form S-1 (the Registration Statement) in relation to the public offering of shares of common stock of First Advantage Corporation (the Company) to be filed with the United States Securities and Exchange Commission (the SEC) under the Securities Act of 1933, as amended, any written correspondences with the SEC and any other future filings with the SEC, including filings on Form 10-K or Form 8-K or other SEC filings (collectively, the SEC Filings).
Stax Inc. hereby further consents to inclusion of, summary of and reference to (i) any data contained in the reports and materials it provides to the Company and (ii) any other information, data and statements prepared by Stax Inc., whether or not publicly available, as well as citation of any of the foregoing in the Companys Registration Statement and SEC Filings and in roadshow and other promotional materials in connection with the proposed offering under the Registration Statement.
Stax Inc. also hereby consents to the filing of this letter as an exhibit to the Registration Statement.
Yours faithfully | ||
For and on behalf of | ||
Stax Inc. | ||
/s/ Palash Misra | ||
Name: | Palash Misra | |
Title: | Director |